CHD8chromodomain helicase DNA binding protein 8
Autism Reports / Total Reports
79 / 121Rare Variants / Common Variants
319 / 0Chromosome Band
14q11.2Associated Disorders
SCZ, DD/NDD, ADHD, ID, EPS, ASDGenetic Category
Rare Single Gene Mutation, Syndromic, FunctionalRelevance to Autism
Recurrent mutations in the CHD8 gene have been identified in multiple individuals with ASD as described below. O'Roak et al., 2012a reported 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families (PMID 22495309). In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, O'Roak et al., 2012b identified 6 additional de novo CHD8 LoF mutations (PMID 23160995). A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in Iossifov et al., 2014 (PMID 25363768). Talkowski et al., 2012 (PMID 22521361) showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) in De Rubeis et al., 2014 identified CHD8 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017). Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in Bernier et al., 2014 (PMID 24998929); a phenotypic comparison of patients with CHD8 variants in this report identified recurrent phenotypes and dysmorphic facial features suggestive of a syndromic form of ASD. A two-stage analysis of rare de novo and inherited coding variants in 42,607 ASD cases, including 35,130 new cases from the SPARK cohort, in Zhou et al., 2022 identified CHD8 as a gene reaching exome-wide significance (P < 2.5E-06).
Molecular Function
This gene encodes a DNA helicase that functions as a transcription repressor by remodeling chromatin structure. It binds beta-catenin and negatively regulates Wnt signaling pathway, which plays a pivotal role in vertebrate early development and morphogenesis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
External Links
SFARI Genomic Platforms
Reports related to CHD8 (121 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Support | Novel deletions of 14q11.2 associated with developmental delay, cognitive impairment and similar minor anomalies in three children | Zahir F , et al. (2007) | No | Cognitive impairment |
2 | Support | CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome | Batsukh T , et al. (2010) | No | - |
3 | Primary | Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations | O'Roak BJ , et al. (2012) | Yes | - |
4 | Support | Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries | Talkowski ME , et al. (2012) | Yes | - |
5 | Support | Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders | O'Roak BJ , et al. (2012) | Yes | - |
6 | Support | De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability | McCarthy SE , et al. (2014) | No | - |
7 | Recent Recommendation | Disruptive CHD8 mutations define a subtype of autism early in development | Bernier R , et al. (2014) | Yes | DD, ID |
8 | Support | Recurrent ?100 Kb microdeletion in the chromosomal region 14q11.2, involving CHD8 gene, is associated with autism and macrocephaly | Prontera P , et al. (2014) | Yes | - |
9 | Recent Recommendation | CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors | Sugathan A , et al. (2014) | No | - |
10 | Recent Recommendation | Synaptic, transcriptional and chromatin genes disrupted in autism | De Rubeis S , et al. (2014) | Yes | - |
11 | Support | The contribution of de novo coding mutations to autism spectrum disorder | Iossifov I et al. (2014) | Yes | - |
12 | Support | Recurrent de novo mutations implicate novel genes underlying simplex autism risk | O'Roak BJ , et al. (2014) | Yes | - |
13 | Support | Large-scale discovery of novel genetic causes of developmental disorders | Deciphering Developmental Disorders Study (2014) | Yes | - |
14 | Recent Recommendation | The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment | Cotney J , et al. (2015) | No | - |
15 | Recent Recommendation | The autism-associated gene chromodomain helicase DNA-binding protein 8 (CHD8) regulates noncoding RNAs and autism-related genes | Wilkinson B , et al. (2015) | No | - |
16 | Recent Recommendation | Low load for disruptive mutations in autism genes and their biased transmission | Iossifov I , et al. (2015) | Yes | - |
17 | Support | Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci | Sanders SJ , et al. (2015) | Yes | - |
18 | Support | Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms | D'Gama AM , et al. (2015) | Yes | - |
19 | Support | A de novo frameshift mutation in chromodomain helicase DNA-binding domain 8 (CHD8): A case report and literature review | Merner N , et al. (2016) | Yes | ID, SCZ |
20 | Support | Novel 14q11.2 microduplication including the CHD8 and SUPT16H genes associated with developmental delay | Smyk M , et al. (2016) | No | - |
21 | Support | CHD8 intragenic deletion associated with autism spectrum disorder | Stolerman ES , et al. (2016) | Yes | - |
22 | Support | Identification of a rare variant in CHD8 that contributes to schizophrenia and autism spectrum disorder susceptibility | Kimura H et al. (2016) | No | DD, ID, autistic features, stereotypy |
23 | Recent Recommendation | Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling | Durak O , et al. (2016) | No | - |
24 | Support | De novo genic mutations among a Chinese autism spectrum disorder cohort | Wang T , et al. (2016) | Yes | - |
25 | Support | The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies | Redin C , et al. (2016) | Yes | - |
26 | Support | Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases | Stessman HA , et al. (2017) | Yes | - |
27 | Support | Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder | C Yuen RK et al. (2017) | Yes | - |
28 | Support | Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism | Chen R , et al. (2017) | Yes | - |
29 | Support | Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability | Tatton-Brown K , et al. (2017) | No | Macrocephaly, tall stature |
30 | Support | Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder | Lim ET , et al. (2017) | Yes | - |
31 | Support | Targeted sequencing and functional analysis reveal brain-size-related genes and their networks in autism spectrum disorders | Li J , et al. (2017) | Yes | - |
32 | Support | Exome Pool-Seq in neurodevelopmental disorders | Popp B , et al. (2017) | No | Autistic featues (social difficulties) |
33 | Recent Recommendation | Sexually dimorphic behavior, neuronal activity, and gene expression in Chd8-mutant mice | Jung H , et al. (2018) | No | - |
34 | Support | The autism spectrum phenotype in ADNP syndrome | Arnett AB , et al. (2018) | Yes | ID |
35 | Support | Oligodendrocyte precursor survival and differentiation requires chromatin remodeling by Chd7 and Chd8 | Marie C , et al. (2018) | No | - |
36 | Support | Autism-linked CHD gene expression patterns during development predict multi-organ disease phenotypes | Kasah S , et al. (2018) | No | - |
37 | Support | Autism spectrum disorder early in development associated with CHD8 mutations among two Chinese children | Wang J , et al. (2018) | Yes | - |
38 | Support | Genomic landscapes of Chinese sporadic autism spectrum disorders revealed by whole-genome sequencing | Wu J , et al. (2018) | Yes | - |
39 | Support | Diagnostic approach with genetic tests for global developmental delay and/or intellectual disability: Single tertiary center experience | Han JY et al. (2019) | No | - |
40 | Support | Genetic Diagnostic Evaluation of Trio-Based Whole Exome Sequencing Among Children With Diagnosed or Suspected Autism Spectrum Disorder | Du X , et al. (2018) | Yes | DD/ID |
41 | Support | Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model | Guo H , et al. (2018) | Yes | - |
42 | Support | Targeted Next-Generation Sequencing of Korean Patients With Developmental Delay and/or Intellectual Disability | Han JY , et al. (2019) | No | ADHD |
43 | Support | A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8 | Yasin H , et al. (2019) | Yes | - |
44 | Support | The clinical presentation caused by truncating CHD8 variants | Douzgou S , et al. (2019) | Yes | Macrocephaly |
45 | Support | Neurological Diseases With Autism Spectrum Disorder: Role of ASD Risk Genes | Xiong J , et al. (2019) | Yes | ID |
46 | Support | Whole genome sequencing and variant discovery in the ASPIRE autism spectrum disorder cohort | Callaghan DB , et al. (2019) | Yes | - |
47 | Support | Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population | Monies D , et al. (2019) | Yes | ID, epilepsy/seizures |
48 | Support | Characterization of intellectual disability and autism comorbidity through gene panel sequencing | Aspromonte MC , et al. (2019) | Yes | - |
49 | Support | Autism-associated missense genetic variants impact locomotion and neurodevelopment in Caenorhabditis elegans | Wong WR , et al. (2019) | Yes | - |
50 | Support | Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks | Ruzzo EK , et al. (2019) | Yes | - |
51 | Support | Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes | Feliciano P et al. (2019) | Yes | - |
52 | Support | The CHD8 overgrowth syndrome: A detailed evaluation of an emerging overgrowth phenotype in 27 patients | Ostrowski PJ , et al. (2019) | No | ASD, overgrowth |
53 | Support | Genetic investigation of patients with tall stature | Vasco de Albuquerque Albuquerque E et al. (2020) | No | Tall stature, macrocephaly |
54 | Support | De Novo Damaging DNA Coding Mutations Are Associated With Obsessive-Compulsive Disorder and Overlap With Tourette's Disorder and Autism | Cappi C , et al. (2019) | No | - |
55 | Support | De novo variants in the Helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth | An Y , et al. (2020) | Yes | - |
56 | Support | Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism | Satterstrom FK et al. (2020) | Yes | - |
57 | Support | Rare genetic susceptibility variants assessment in autism spectrum disorder: detection rate and practical use | Husson T , et al. (2020) | Yes | - |
58 | Support | Genetic landscape of autism spectrum disorder in Vietnamese children | Tran KT et al. (2020) | Yes | - |
59 | Support | Excess of de novo variants in genes involved in chromatin remodelling in patients with marfanoid habitus and intellectual disability | Chevarin M et al. (2020) | No | Marfanoid habitus |
60 | Support | A de novo variant of CHD8 in a patient with autism spectrum disorder | Alotaibi M et al. (2020) | No | Autistic behavior, stereotypy |
61 | Support | Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders | Wang T et al. (2020) | Yes | - |
62 | Support | - | Jiménez JA et al. (2020) | Yes | - |
63 | Recent recommendation | - | Sadler B et al. (2021) | No | ASD, DD |
64 | Support | - | Rodin RE et al. (2021) | Yes | - |
65 | Support | - | Brunet T et al. (2021) | Yes | - |
66 | Support | - | Kawamura A et al. (2021) | Yes | - |
67 | Support | - | Ellingford RA et al. (2021) | Yes | - |
68 | Recent Recommendation | - | Coll-Tané M et al. (2021) | No | - |
69 | Support | - | Doummar D et al. (2021) | No | ASD, ID |
70 | Support | - | Takanezawa Y et al. (2021) | No | - |
71 | Support | - | Mahjani B et al. (2021) | Yes | - |
72 | Recent Recommendation | - | Paulsen B et al. (2022) | Yes | - |
73 | Support | - | Chen X et al. (2022) | No | - |
74 | Support | - | Yu Y et al. (2022) | Yes | - |
75 | Support | - | Villa CE et al. (2022) | Yes | - |
76 | Support | - | Chuan Z et al. (2022) | No | ID |
77 | Support | - | Hu C et al. (2022) | Yes | - |
78 | Support | - | Krgovic D et al. (2022) | Yes | DD |
79 | Support | - | Tu Z et al. (2022) | No | - |
80 | Support | - | Zhou X et al. (2022) | Yes | ADHD |
81 | Support | - | Dong C et al. (2022) | No | - |
82 | Recent Recommendation | - | Dingemans AJM et al. (2022) | Yes | ID, epilepsy/seizures, stereotypy |
83 | Support | - | Coakley-Youngs E et al. (2022) | Yes | - |
84 | Support | - | Hayot G et al. (2022) | No | - |
85 | Support | - | Lee SY et al. (2022) | Yes | - |
86 | Support | - | Shimelis H et al. (2023) | No | Epilepsy/seizures |
87 | Support | - | Kerschbamer E et al. (2022) | No | - |
88 | Support | - | Haddad Derafshi B et al. (2022) | No | - |
89 | Support | - | Kim C et al. (2023) | Yes | - |
90 | Recent Recommendation | - | Tabbaa M et al. (2023) | Yes | - |
91 | Support | - | Lee SY et al. (2023) | Yes | - |
92 | Support | - | Li B et al. (2023) | Yes | - |
93 | Recent Recommendation | - | Weinschutz Mendes H et al. (2023) | Yes | - |
94 | Support | - | Hu C et al. (2023) | Yes | - |
95 | Recent Recommendation | - | Munz M et al. (2023) | Yes | - |
96 | Support | - | Kawamura A et al. (2023) | No | - |
97 | Support | - | Wang J et al. (2023) | Yes | - |
98 | Recent Recommendation | - | Ipsita Chatterjee et al. (2023) | Yes | - |
99 | Support | - | Amerh S Alqahtani et al. (2023) | Yes | - |
100 | Recent Recommendation | - | Xi Shi et al. (2023) | Yes | - |
101 | Support | - | Erica Rosina et al. (2024) | Yes | - |
102 | Support | - | Marketa Wayhelova et al. (2024) | No | - |
103 | Support | - | Tamam Khalaf et al. (2024) | Yes | - |
104 | Recent Recommendation | - | Taichi Shiraishi et al. () | Yes | - |
105 | Support | - | Ugo Sorrentino et al. (2024) | No | DD, ID |
106 | Support | - | Emily L Hendricks et al. (2024) | No | - |
107 | Support | - | Robert A Ellingford et al. (2024) | Yes | - |
108 | Support | - | Manal Tabbaa et al. (2024) | Yes | - |
109 | Support | - | Emily Neuhaus et al. (2024) | Yes | Anxiety |
110 | Support | - | Ruohao Wu et al. (2024) | Yes | - |
111 | Support | - | Angelo Niosi et al. () | No | - |
112 | Support | - | Axel Schmidt et al. (2024) | No | Cognitive impairment |
113 | Support | - | Suhua Chang et al. () | Yes | - |
114 | Support | - | Karen Lob et al. () | Yes | DD |
115 | Support | - | Maider Astorkia et al. (2024) | Yes | - |
116 | Support | - | Soo-Whee Kim et al. (2024) | Yes | - |
117 | Support | - | Hosneara Akter et al. () | No | - |
118 | Support | - | Guihua Lai et al. (2024) | No | Autistic behavior |
119 | Support | - | Jesper Eisfeldt et al. (2024) | Yes | - |
120 | Support | - | Chengyan Li et al. (2024) | No | - |
121 | Support | - | Mariia A Parfenenko et al. (2024) | Yes | ADHD, ID, epilepsy/seizures |
Rare Variants (319)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
- | - | translocation | De novo | - | - | 27841880 | Redin C , et al. (2016) | |
- | - | copy_number_loss | De novo | - | - | 30670789 | Yasin H , et al. (2019) | |
- | - | translocation | De novo | - | - | 22521361 | Talkowski ME , et al. (2012) | |
- | - | copy_number_loss | De novo | - | - | 25257502 | Prontera P , et al. (2014) | |
- | - | copy_number_gain | De novo | - | Simplex | 26834018 | Smyk M , et al. (2016) | |
- | - | copy_number_loss | De novo | - | Simplex | 17545556 | Zahir F , et al. (2007) | |
- | - | copy_number_gain | Unknown | - | Unknown | 24998929 | Bernier R , et al. (2014) | |
c.142C>T | p.Gln48Ter | stop_gained | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.464C>G | p.Ser155Ter | stop_gained | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.727C>T | p.Arg243Ter | stop_gained | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.529C>T | p.Gln177Ter | stop_gained | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.2226+2T>C | - | splice_site_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.2486+1G>A | - | splice_site_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.2730+1G>A | - | splice_site_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.3307+1G>A | - | splice_site_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.3882+1G>A | - | splice_site_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.4817+1G>A | - | splice_site_variant | Unknown | - | - | 35982159 | Zhou X et al. (2022) | |
c.5127+1G>A | - | splice_site_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.4210C>T | p.Gln1404Ter | stop_gained | De novo | - | - | 39136901 | Karen Lob et al. () | |
c.2854C>T | p.Arg952Ter | stop_gained | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.1444C>T | p.Arg482Ter | stop_gained | Unknown | - | - | 35982159 | Zhou X et al. (2022) | |
c.1744C>T | p.Arg582Ter | stop_gained | Unknown | - | - | 35982159 | Zhou X et al. (2022) | |
c.2157dup | p.Asn720Ter | stop_gained | Unknown | - | - | 35982159 | Zhou X et al. (2022) | |
c.2643G>A | p.Trp881Ter | stop_gained | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.1716+9A>T | - | intron_variant | Familial | Maternal | - | 37007974 | Hu C et al. (2023) | |
c.4204C>T | p.Arg1402Ter | stop_gained | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.5179G>T | p.Glu1727Ter | stop_gained | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.5389C>T | p.Arg1797Ter | stop_gained | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.6103C>T | p.Arg2035Ter | stop_gained | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.6649C>T | p.Arg2217Ter | stop_gained | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.4009C>T | p.Arg1337Ter | stop_gained | Unknown | - | - | 35982159 | Zhou X et al. (2022) | |
c.4665T>G | p.Tyr1555Ter | stop_gained | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.4799T>G | p.Leu1600Ter | stop_gained | Unknown | - | - | 35982159 | Zhou X et al. (2022) | |
c.5389C>T | p.Arg1797Ter | stop_gained | Unknown | - | - | 35982159 | Zhou X et al. (2022) | |
c.6649C>T | p.Arg2217Ter | stop_gained | Unknown | - | - | 35982159 | Zhou X et al. (2022) | |
c.7054C>T | p.Arg2352Ter | stop_gained | Unknown | - | - | 35982159 | Zhou X et al. (2022) | |
c.7087C>T | p.Gln2363Ter | stop_gained | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.1601+6T>G | - | splice_region_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
- | - | copy_number_loss | De novo | - | Multiplex | 26921529 | Stolerman ES , et al. (2016) | |
c.3882+1G>A | - | splice_site_variant | De novo | - | - | 30107084 | Arnett AB , et al. (2018) | |
c.1899+1G>T | - | splice_site_variant | De novo | - | - | 31001818 | Douzgou S , et al. (2019) | |
c.3518+1G>T | - | splice_site_variant | De novo | - | - | 31001818 | Douzgou S , et al. (2019) | |
c.7183-1G>A | - | splice_site_variant | Unknown | - | - | 36475376 | Shimelis H et al. (2023) | |
c.2072A>G | p.Asp691Gly | missense_variant | De novo | - | - | 28831199 | Li J , et al. (2017) | |
c.2854C>T | p.Arg952Ter | stop_gained | De novo | - | - | 30107084 | Arnett AB , et al. (2018) | |
c.2059C>T | p.Gln687Ter | stop_gained | De novo | - | - | 31001818 | Douzgou S , et al. (2019) | |
c.2706del | p.Tyr902Ter | stop_gained | Unknown | - | - | 31001818 | Douzgou S , et al. (2019) | |
c.706C>T | p.Gln236Ter | stop_gained | De novo | - | - | 31452935 | Feliciano P et al. (2019) | |
c.6857A>G | p.Lys2286Arg | missense_variant | Unknown | - | - | 31980904 | An Y , et al. (2020) | |
c.4818-1G>A | - | splice_site_variant | De novo | - | Simplex | 31980904 | An Y , et al. (2020) | |
c.1477C>T | p.Arg493Trp | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1504C>T | p.Arg502Cys | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.2854C>G | p.Arg952Gly | missense_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.2855G>A | p.Arg952Gln | missense_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.2972T>A | p.Leu991His | missense_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.1745G>A | p.Arg582Gln | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.3340G>T | p.Glu1114Ter | stop_gained | De novo | - | - | 24998929 | Bernier R , et al. (2014) | |
c.4204C>T | p.Arg1402Ter | stop_gained | De novo | - | - | 30107084 | Arnett AB , et al. (2018) | |
c.5179G>T | p.Glu1727Ter | stop_gained | De novo | - | - | 30107084 | Arnett AB , et al. (2018) | |
c.3617T>G | p.Leu1206Ter | stop_gained | De novo | - | - | 31001818 | Douzgou S , et al. (2019) | |
c.3724C>T | p.Arg1242Ter | stop_gained | De novo | - | - | 31001818 | Douzgou S , et al. (2019) | |
c.5017C>T | p.Arg1673Ter | stop_gained | Unknown | - | - | 36475376 | Shimelis H et al. (2023) | |
c.2065G>T | p.Glu689Ter | stop_gained | De novo | - | Simplex | 31980904 | An Y , et al. (2020) | |
c.2854C>T | p.Arg952Ter | stop_gained | De novo | - | Simplex | 36731504 | Kim C et al. (2023) | |
c.5488C>T | p.Arg1830Cys | missense_variant | De novo | - | - | 30402882 | Han JY et al. (2019) | |
c.4405C>T | p.Arg1469Cys | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.4484G>A | p.Arg1495His | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.5077G>T | p.Asp1693Tyr | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.5222C>T | p.Pro1741Leu | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.5314C>T | p.Arg1772Cys | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.5483G>A | p.Arg1828His | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.5575C>T | p.Arg1859Cys | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.5665C>T | p.Arg1889Cys | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.5684G>A | p.Arg1895His | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.5816G>A | p.Arg1939His | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.7000C>T | p.Arg2334Trp | missense_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.4658G>A | p.Arg1553Gln | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.634C>T | p.Arg212Ter | stop_gained | De novo | - | Simplex | 30564305 | Guo H , et al. (2018) | |
c.5051+2T>A | - | splice_site_variant | De novo | - | Simplex | 33004838 | Wang T et al. (2020) | |
c.1096C>T | p.Gln366Ter | stop_gained | De novo | - | - | 28191889 | Stessman HA , et al. (2017) | |
c.751C>T | p.Gln251Ter | stop_gained | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.3518+5G>C | - | splice_site_variant | De novo | - | - | 31721432 | Ostrowski PJ , et al. (2019) | |
c.5599+2T>C | - | splice_site_variant | Unknown | - | - | 31721432 | Ostrowski PJ , et al. (2019) | |
c.2731-2A>G | - | splice_site_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.4062+5G>C | - | splice_site_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.3562C>T | p.Arg1188Ter | stop_gained | De novo | - | Simplex | 31980904 | An Y , et al. (2020) | |
c.5488C>T | p.Arg1830Cys | missense_variant | De novo | - | - | 30631761 | Han JY , et al. (2019) | |
c.5275A>C | p.Ser1759Arg | missense_variant | Unknown | - | - | 35571021 | Chuan Z et al. (2022) | |
c.2230G>A | p.Val744Ile | missense_variant | De novo | - | - | 33432195 | Rodin RE et al. (2021) | |
c.4871G>A | p.Trp1624Ter | stop_gained | Unknown | - | - | 38438125 | Tamam Khalaf et al. (2024) | |
c.5690G>A | p.Trp1897Ter | stop_gained | De novo | - | - | 39039281 | Axel Schmidt et al. (2024) | |
c.6730C>T | p.Arg2244Ter | stop_gained | De novo | - | - | 39039281 | Axel Schmidt et al. (2024) | |
c.1690C>T | p.Arg564Ter | stop_gained | De novo | - | - | 31721432 | Ostrowski PJ , et al. (2019) | |
c.2140G>T | p.Glu714Ter | stop_gained | De novo | - | - | 31721432 | Ostrowski PJ , et al. (2019) | |
c.1744C>T | p.Arg582Ter | stop_gained | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.4062+5G>C | - | splice_site_variant | Unknown | - | - | 34088660 | Coll-Tané M et al. (2021) | |
c.5769G>A | p.Trp1923Ter | stop_gained | De novo | - | Simplex | 35982159 | Zhou X et al. (2022) | |
c.2647G>T | p.Glu883Ter | stop_gained | De novo | - | Simplex | 30376831 | Wang J , et al. (2018) | |
c.4571-1G>A | - | splice_site_variant | De novo | - | Simplex | 31771860 | Cappi C , et al. (2019) | |
c.2907+1G>T | - | splice_site_variant | De novo | - | Simplex | 33352116 | Sadler B et al. (2021) | |
c.2182A>G | p.Arg728Gly | missense_variant | Unknown | - | - | 34615535 | Mahjani B et al. (2021) | |
c.2024+5G>A | p.? | splice_site_variant | De novo | - | - | 39334436 | Soo-Whee Kim et al. (2024) | |
c.3562C>T | p.Arg1188Ter | stop_gained | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.4009C>T | p.Arg1337Ter | stop_gained | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.4131G>A | p.Trp1377Ter | stop_gained | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.4204C>T | p.Arg1402Ter | stop_gained | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.4984C>T | p.Arg1662Ter | stop_gained | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.5017C>T | p.Arg1673Ter | stop_gained | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.5771G>A | p.Trp1924Ter | stop_gained | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.5892T>G | p.Tyr1964Ter | stop_gained | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.6649C>T | p.Arg2217Ter | stop_gained | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.7054C>T | p.Arg2352Ter | stop_gained | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.1601+6T>A | - | splice_region_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.2024+5G>A | - | splice_site_variant | De novo | - | - | 28475857 | Tatton-Brown K , et al. (2017) | |
c.5051+1G>C | - | splice_site_variant | Unknown | - | - | 28475857 | Tatton-Brown K , et al. (2017) | |
c.6085G>A | p.Glu2029Lys | missense_variant | Unknown | - | - | 26789910 | Merner N , et al. (2016) | |
c.6538C>T | p.Arg2180Cys | missense_variant | Unknown | - | - | 26789910 | Merner N , et al. (2016) | |
c.6830G>C | p.Gly2277Ala | missense_variant | Unknown | - | - | 26789910 | Merner N , et al. (2016) | |
c.3650A>G | p.Asn1217Ser | missense_variant | Unknown | - | - | 34615535 | Mahjani B et al. (2021) | |
c.7181A>G | p.Lys2394Arg | missense_variant | Unknown | - | - | 35813072 | Krgovic D et al. (2022) | |
c.7620C>T | p.Asp2540= | synonymous_variant | Unknown | - | - | 26789910 | Merner N , et al. (2016) | |
c.5051+2T>A | - | splice_site_variant | De novo | - | Simplex | 28263302 | C Yuen RK et al. (2017) | |
c.2562_2563del | p.Tyr854Ter | stop_gained | De novo | - | - | 31001818 | Douzgou S , et al. (2019) | |
c.2317G>A | p.Glu773Lys | missense_variant | Unknown | - | - | 39342494 | Hosneara Akter et al. () | |
- | p.Glu1932SerfsTer3 | frameshift_variant | De novo | - | - | 24998929 | Bernier R , et al. (2014) | |
- | p.Glu2136ArgfsTer6 | frameshift_variant | De novo | - | - | 24998929 | Bernier R , et al. (2014) | |
c.185C>G | p.Ser62Ter | stop_gained | De novo | - | Simplex | 23160955 | O'Roak BJ , et al. (2012) | |
c.3724C>T | p.Arg1242Ter | stop_gained | De novo | - | Multiplex | 35982159 | Zhou X et al. (2022) | |
c.4414C>T | p.Arg1472Ter | stop_gained | De novo | - | Simplex | 33352116 | Sadler B et al. (2021) | |
c.4515G>A | p.Trp1505Ter | stop_gained | De novo | - | Simplex | 33352116 | Sadler B et al. (2021) | |
c.4378C>T | p.Arg1460Ter | stop_gained | De novo | - | Unknown | 33619735 | Brunet T et al. (2021) | |
c.4818-2A>C | - | splice_site_variant | Familial | - | Simplex | 28263302 | C Yuen RK et al. (2017) | |
c.4259_4260del | p.Ser1420Ter | stop_gained | De novo | - | - | 31001818 | Douzgou S , et al. (2019) | |
c.3519-2A>G | - | splice_site_variant | De novo | - | Simplex | 23160955 | O'Roak BJ , et al. (2012) | |
c.1599C>G | p.Leu533= | synonymous_variant | De novo | - | - | 31452935 | Feliciano P et al. (2019) | |
c.4062+42C>T | - | intron_variant | De novo | - | Simplex | 31981491 | Satterstrom FK et al. (2020) | |
c.4204C>T | p.Arg1402Ter | stop_gained | Unknown | - | - | 28475857 | Tatton-Brown K , et al. (2017) | |
c.4414C>T | p.Arg1472Ter | stop_gained | De novo | - | - | 28475857 | Tatton-Brown K , et al. (2017) | |
- | - | copy_number_gain | Familial | Paternal | Simplex | 39472019 | Jesper Eisfeldt et al. (2024) | |
c.4984C>T | p.Arg1662Ter | stop_gained | De novo | - | Simplex | 31130284 | Monies D , et al. (2019) | |
c.1601+38del | - | splice_site_variant | De novo | - | Simplex | 25363768 | Iossifov I et al. (2014) | |
c.3312del | p.Glu1105LysfsTer5 | frameshift_variant | De novo | - | - | 35741772 | Hu C et al. (2022) | |
c.3502T>A | p.Tyr1168Asn | missense_variant | De novo | - | Simplex | 31980904 | An Y , et al. (2020) | |
c.837dup | p.Thr280TyrfsTer4 | frameshift_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.2711T>G | p.Met904Arg | missense_variant | De novo | - | Simplex | 30564305 | Guo H , et al. (2018) | |
c.1733G>A | p.Arg578His | missense_variant | Unknown | - | Simplex | 33004838 | Wang T et al. (2020) | |
c.7182+3dup | - | splice_site_variant | Familial | - | Multiplex | 28263302 | C Yuen RK et al. (2017) | |
c.3712C>T | p.Gln1238Ter | stop_gained | De novo | - | Simplex | 22495309 | O'Roak BJ , et al. (2012) | |
c.4009C>T | p.Arg1337Ter | stop_gained | De novo | - | Simplex | 23160955 | O'Roak BJ , et al. (2012) | |
c.5500C>T | p.Arg1834Ter | stop_gained | De novo | - | Simplex | 25418537 | O'Roak BJ , et al. (2014) | |
c.4984C>T | p.Arg1662Ter | stop_gained | De novo | - | Simplex | 32309624 | Alotaibi M et al. (2020) | |
c.2868dup | p.Asn957Ter | stop_gained | De novo | - | Simplex | 39528574 | Chengyan Li et al. (2024) | |
c.5690G>A | p.Arg1897Gln | missense_variant | De novo | - | - | 39334436 | Soo-Whee Kim et al. (2024) | |
c.4818-2A>C | - | splice_site_variant | De novo | - | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.5051+2T>A | - | splice_site_variant | De novo | - | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.2617A>G | p.Asn873Asp | missense_variant | De novo | - | - | 31721432 | Ostrowski PJ , et al. (2019) | |
c.2927C>A | p.Thr976Lys | missense_variant | De novo | - | - | 31721432 | Ostrowski PJ , et al. (2019) | |
c.1928T>G | p.Ile643Ser | missense_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.2252G>T | p.Trp751Leu | missense_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.2522G>A | p.Gly841Asp | missense_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.3338G>A | p.Arg1113His | missense_variant | Familial | Maternal | - | 37007974 | Hu C et al. (2023) | |
c.2345del | p.His782ProfsTer7 | frameshift_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.6122_6123del | p.Tyr2041Ter | frameshift_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.3274C>T | p.Arg1092Cys | missense_variant | De novo | - | Simplex | 35982159 | Zhou X et al. (2022) | |
c.3518G>A | p.Arg1173Lys | missense_variant | De novo | - | Simplex | 35982159 | Zhou X et al. (2022) | |
c.4523T>G | p.Ile1508Ser | missense_variant | De novo | - | Simplex | 35982159 | Zhou X et al. (2022) | |
c.4738C>T | p.Arg1580Trp | missense_variant | De novo | - | Simplex | 35982159 | Zhou X et al. (2022) | |
c.2514G>T | p.Met838Ile | missense_variant | De novo | - | Simplex | 30376831 | Wang J , et al. (2018) | |
c.3665A>T | p.Asp1222Val | missense_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.3922A>G | p.Arg1308Gly | missense_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.3964G>C | p.Gly1322Arg | missense_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.4523T>G | p.Ile1508Ser | missense_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.4895C>T | p.Ser1632Leu | missense_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.2104A>G | p.Lys702Glu | missense_variant | Unknown | - | - | 31209962 | Aspromonte MC , et al. (2019) | |
c.7085A>G | p.Lys2362Arg | missense_variant | Familial | Paternal | - | 31980904 | An Y , et al. (2020) | |
c.7310G>A | p.Ser2437Asn | missense_variant | Familial | Maternal | - | 31980904 | An Y , et al. (2020) | |
c.2477G>T | p.Trp826Leu | missense_variant | Familial | Maternal | - | 33004838 | Wang T et al. (2020) | |
c.2812C>T | p.Arg938Cys | missense_variant | Familial | Maternal | - | 33004838 | Wang T et al. (2020) | |
c.1494del | p.Glu499ArgfsTer13 | frameshift_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.1869del | p.Glu624ArgfsTer21 | frameshift_variant | De novo | - | - | 33004838 | Wang T et al. (2020) | |
c.6404dup | p.Glu2136ArgfsTer6 | frameshift_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.347del | p.Thr116AsnfsTer14 | frameshift_variant | De novo | - | - | 29158550 | Popp B , et al. (2017) | |
c.3284G>A | p.Cys1095Tyr | missense_variant | De novo | - | Simplex | 28344757 | Chen R , et al. (2017) | |
c.3790G>A | p.Glu1264Lys | missense_variant | De novo | - | Simplex | 28714951 | Lim ET , et al. (2017) | |
c.3575T>C | p.Ile1192Thr | missense_variant | De novo | - | Simplex | 32193494 | Tran KT et al. (2020) | |
c.6518C>A | p.Ser2173Ter | stop_gained | De novo | - | Simplex | 24776741 | McCarthy SE , et al. (2014) | |
c.5393G>A | p.Trp1798Ter | stop_gained | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.5422C>T | p.Arg1808Ter | stop_gained | De novo | - | Simplex | 38041506 | Erica Rosina et al. (2024) | |
c.2025-1G>T | - | splice_site_variant | De novo | - | Simplex | 31981491 | Satterstrom FK et al. (2020) | |
c.5371C>T | p.Arg1791Trp | missense_variant | Familial | Paternal | - | 33004838 | Wang T et al. (2020) | |
c.5390G>T | p.Arg1797Leu | missense_variant | Familial | Maternal | - | 33004838 | Wang T et al. (2020) | |
c.6473G>A | p.Arg2158His | missense_variant | Familial | Paternal | - | 33004838 | Wang T et al. (2020) | |
c.5063del | p.Asp1688ValfsTer26 | frameshift_variant | Unknown | - | - | 35982159 | Zhou X et al. (2022) | |
c.6984del | p.Glu2329ArgfsTer26 | frameshift_variant | Unknown | - | - | 35982159 | Zhou X et al. (2022) | |
c.2250del | p.Lys750AsnfsTer14 | frameshift_variant | De novo | - | - | 27824329 | Wang T , et al. (2016) | |
c.6997C>T | p.Arg2333Cys | missense_variant | Unknown | - | Simplex | 27595554 | Kimura H et al. (2016) | |
c.3979G>A | p.Glu1327Lys | missense_variant | De novo | - | Simplex | 31771860 | Cappi C , et al. (2019) | |
c.1807G>A | p.Asp603Asn | missense_variant | Unknown | - | Unknown | 31130284 | Monies D , et al. (2019) | |
c.6859_6861del | p.Lys2287del | inframe_deletion | Unknown | - | - | 24998929 | Bernier R , et al. (2014) | |
c.635G>A | p.Arg212Gln | missense_variant | De novo | - | Simplex | 25418537 | O'Roak BJ , et al. (2014) | |
c.4367A>G | p.Tyr1456Cys | missense_variant | Unknown | - | - | 28475857 | Tatton-Brown K , et al. (2017) | |
c.5288A>G | p.Glu1763Gly | missense_variant | Familial | Paternal | - | 27824329 | Wang T , et al. (2016) | |
c.3704del | p.Asn1235MetfsTer18 | frameshift_variant | De novo | - | - | 27824329 | Wang T , et al. (2016) | |
c.5688dup | p.Arg1897ThrfsTer23 | frameshift_variant | De novo | - | - | 27824329 | Wang T , et al. (2016) | |
c.856C>T | p.Arg286Cys | missense_variant | Familial | Paternal | - | 26789910 | Merner N , et al. (2016) | |
c.7287G>A | p.Met2429Ile | missense_variant | Unknown | - | Simplex | 31130284 | Monies D , et al. (2019) | |
c.2729G>A | p.Arg910Gln | missense_variant | Unknown | - | Unknown | 24998929 | Bernier R , et al. (2014) | |
c.2086C>A | p.Gln696Lys | missense_variant | De novo | - | Simplex | 25418537 | O'Roak BJ , et al. (2014) | |
c.2712G>A | p.Met904Ile | missense_variant | De novo | - | Simplex | 25418537 | O'Roak BJ , et al. (2014) | |
c.2230G>A | p.Val744Ile | missense_variant | Unknown | - | Unknown | 26637798 | D'Gama AM , et al. (2015) | |
- | - | copy_number_gain | Familial | Paternal | Possible multiplex | 24998929 | Bernier R , et al. (2014) | |
c.5803A>T | p.Arg1935Ter | stop_gained | Familial | Maternal | Simplex | 30564305 | Guo H , et al. (2018) | |
c.3879T>A | p.Thr1293%3D | synonymous_variant | De novo | - | Multiplex | 35982159 | Zhou X et al. (2022) | |
c.1323G>C | p.Gly441= | synonymous_variant | Familial | Paternal | - | 26789910 | Merner N , et al. (2016) | |
c.2345del | p.His782ProfsTer7 | frameshift_variant | De novo | - | - | 30107084 | Arnett AB , et al. (2018) | |
c.1423dup | p.Arg475ProfsTer3 | frameshift_variant | Unknown | - | - | 36475376 | Shimelis H et al. (2023) | |
c.4738C>T | p.Arg1580Trp | missense_variant | De novo | - | Simplex | 25418537 | O'Roak BJ , et al. (2014) | |
c.410G>T | p.Gly137Val | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.494C>T | p.Pro165Leu | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.4811T>C | p.Ile1604Thr | missense_variant | Familial | Maternal | - | 26789910 | Merner N , et al. (2016) | |
c.6472C>T | p.Arg2158Cys | missense_variant | Familial | Maternal | - | 26789910 | Merner N , et al. (2016) | |
c.4752A>G | p.Leu1584= | synonymous_variant | Familial | Maternal | - | 26789910 | Merner N , et al. (2016) | |
c.5916A>G | p.Ala1972= | synonymous_variant | Familial | Maternal | - | 26789910 | Merner N , et al. (2016) | |
c.6312G>A | p.Glu2104= | synonymous_variant | Familial | Paternal | - | 26789910 | Merner N , et al. (2016) | |
c.6804C>T | p.His2268= | synonymous_variant | Familial | Paternal | - | 26789910 | Merner N , et al. (2016) | |
c.2420del | p.Asn807ThrfsTer78 | frameshift_variant | De novo | - | - | 30107084 | Arnett AB , et al. (2018) | |
c.3322dup | p.Ile1108AsnfsTer7 | frameshift_variant | De novo | - | - | 30107084 | Arnett AB , et al. (2018) | |
c.1635del | p.Lys545AsnfsTer47 | frameshift_variant | Unknown | - | - | 31001818 | Douzgou S , et al. (2019) | |
c.2240dup | p.Tyr747Ter | frameshift_variant | De novo | - | Simplex | 23160955 | O'Roak BJ , et al. (2012) | |
c.2501T>C | p.Leu834Pro | missense_variant | De novo | - | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.1733G>A | p.Arg578His | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.5129G>T | p.Gly1710Val | missense_variant | Familial | Maternal | - | 24998929 | Bernier R , et al. (2014) | |
c.3322dup | p.Ile1108AsnfsTer7 | frameshift_variant | De novo | - | - | 31452935 | Feliciano P et al. (2019) | |
c.2613dup | p.Thr872TyrfsTer2 | frameshift_variant | De novo | - | - | 39334436 | Soo-Whee Kim et al. (2024) | |
c.3725G>A | p.Arg1242Gln | missense_variant | De novo | - | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.3214C>T | p.Leu1072Phe | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.5665C>T | p.Arg1889Cys | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.5683C>T | p.Arg1895Cys | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.5936G>A | p.Arg1979His | missense_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.2734C>T | p.Arg912Cys | missense_variant | Unknown | - | Simplex | 31038196 | Callaghan DB , et al. (2019) | |
c.4744C>T | p.Arg1582Ter | stop_gained | Unknown | - | Unknown | 37799141 | Amerh S Alqahtani et al. (2023) | |
c.2318G>A | p.Arg773Gln | missense_variant | Familial | Maternal | Simplex | 31980904 | An Y , et al. (2020) | |
c.4611dup | p.Val1538SerfsTer8 | frameshift_variant | De novo | - | Simplex | 30555518 | Du X , et al. (2018) | |
c.4578_4581del | p.Ile1527LeufsTer11 | frameshift_variant | Unknown | - | - | 33004838 | Wang T et al. (2020) | |
c.3511C>T | p.Gln1171Ter | stop_gained | Familial | Paternal | Simplex | 32094338 | Husson T , et al. (2020) | |
c.3315dup | p.Glu1106ArgfsTer9 | frameshift_variant | De novo | - | - | 28191889 | Stessman HA , et al. (2017) | |
c.58_59del | p.Leu20AspfsTer2 | frameshift_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.1733G>A | p.Arg578His | missense_variant | De novo | - | Simplex | 31981491 | Satterstrom FK et al. (2020) | |
c.2086C>A | p.Gln696Lys | missense_variant | De novo | - | Simplex | 31981491 | Satterstrom FK et al. (2020) | |
c.2712G>A | p.Met904Ile | missense_variant | De novo | - | Simplex | 31981491 | Satterstrom FK et al. (2020) | |
c.1716+4908A>C | p.? | intron_variant | Unknown | - | Simplex | 39576488 | Mariia A Parfenenko et al. (2024) | |
c.7562T>C | p.Val2521Ala | missense_variant | Familial | Maternal | Simplex | 31980904 | An Y , et al. (2020) | |
c.5688dup | p.Arg1897ThrfsTer23 | frameshift_variant | De novo | - | Simplex | 28831199 | Li J , et al. (2017) | |
c.4800del | p.Gly1602ValfsTer13 | frameshift_variant | De novo | - | - | 28191889 | Stessman HA , et al. (2017) | |
c.3284G>A | p.Cys1095Tyr | missense_variant | De novo | - | Simplex | 31981491 | Satterstrom FK et al. (2020) | |
c.4738C>T | p.Arg1580Trp | missense_variant | De novo | - | Simplex | 31981491 | Satterstrom FK et al. (2020) | |
c.6349G>T | p.Glu2117Ter | stop_gained | Unknown | - | Simplex | 39576488 | Mariia A Parfenenko et al. (2024) | |
c.4800del | p.Gly1602ValfsTer13 | frameshift_variant | De novo | - | Simplex | 30564305 | Guo H , et al. (2018) | |
c.6649C>T | p.Arg2217Ter | stop_gained | Familial | Maternal | Multiplex | 34415117 | Doummar D et al. (2021) | |
c.7493_7495del | p.His2498del | inframe_deletion | De novo | - | Simplex | 23160955 | O'Roak BJ , et al. (2012) | |
c.5386del | p.Gln1796AsnfsTer40 | frameshift_variant | De novo | - | - | 31721432 | Ostrowski PJ , et al. (2019) | |
c.3050del | p.Gln1017ArgfsTer12 | frameshift_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.6270del | p.Ser2091ProfsTer16 | frameshift_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.470del | p.Pro157LeufsTer50 | frameshift_variant | De novo | - | - | 28475857 | Tatton-Brown K , et al. (2017) | |
c.2332A>G | p.Ile778Val | missense_variant | Familial | Paternal | Multiplex | 30564305 | Guo H , et al. (2018) | |
c.6359del | p.Leu2120ProfsTer19 | frameshift_variant | De novo | - | Simplex | 39126614 | Suhua Chang et al. () | |
c.6276dup | p.Ser2093LeufsTer4 | frameshift_variant | De novo | - | Simplex | 26789910 | Merner N , et al. (2016) | |
c.3011_3012del | p.Glu1004ValfsTer22 | frameshift_variant | De novo | - | - | 31001818 | Douzgou S , et al. (2019) | |
c.764_769delinsT | p.Gly255fs | frameshift_variant | De novo | - | Simplex | 39439447 | Guihua Lai et al. (2024) | |
c.517_533del | p.Ala173SerfsTer43 | frameshift_variant | De novo | - | - | 31721432 | Ostrowski PJ , et al. (2019) | |
c.2372C>T | p.Pro791Leu | missense_variant | Unknown | Not materal | - | 31209962 | Aspromonte MC , et al. (2019) | |
c.6115del | p.Gln2039LysfsTer37 | frameshift_variant | Unknown | - | - | 28475857 | Tatton-Brown K , et al. (2017) | |
c.7511dup | p.His2504GlnfsTer34 | frameshift_variant | De novo | - | - | 28475857 | Tatton-Brown K , et al. (2017) | |
c.4342dup | p.Arg1448ProfsTer29 | frameshift_variant | De novo | - | Simplex | 38764027 | Ruohao Wu et al. (2024) | |
c.7112dup | p.Asn2371LysfsTer2 | frameshift_variant | De novo | - | Simplex | 23160955 | O'Roak BJ , et al. (2012) | |
c.5661_5662del | p.Tyr1888ProfsTer31 | frameshift_variant | De novo | - | Simplex | 28831199 | Li J , et al. (2017) | |
c.5661_5662del | p.Tyr1888ProfsTer31 | frameshift_variant | De novo | - | Simplex | 30392784 | Wu J , et al. (2018) | |
c.6032dup | p.Thr2012AspfsTer31 | frameshift_variant | Familial | Maternal | - | 31031587 | Xiong J , et al. (2019) | |
c.5390G>A | p.Arg1797Gln | missense_variant | Familial | Paternal | Simplex | 24998929 | Bernier R , et al. (2014) | |
c.3338del | p.Arg1113LeufsTer41 | frameshift_variant | De novo | - | Simplex | 32277047 | Chevarin M et al. (2020) | |
c.5513_5519del | p.Lys1838MetfsTer51 | frameshift_variant | De novo | - | - | 39334436 | Soo-Whee Kim et al. (2024) | |
c.4093_4094del | p.Asp1365TyrfsTer5 | frameshift_variant | Unknown | - | - | 31721432 | Ostrowski PJ , et al. (2019) | |
c.5500C>T | p.Arg1834Ter | stop_gained | Familial | Maternal | Unknown | 28475857 | Tatton-Brown K , et al. (2017) | |
c.5654G>A | p.Arg1885Gln | missense_variant | Unknown | - | Simplex | 39576488 | Mariia A Parfenenko et al. (2024) | |
c.6437A>C | p.Gln2146Pro | missense_variant | Unknown | - | Simplex | 39576488 | Mariia A Parfenenko et al. (2024) | |
c.6104G>A | p.Arg2035Gln | missense_variant | Familial | Maternal | Multiplex | 26789910 | Merner N , et al. (2016) | |
c.6148dup | p.Thr2050AsnfsTer17 | frameshift_variant | De novo | - | Multiplex | 28263302 | C Yuen RK et al. (2017) | |
c.1478G>C | p.Arg493Pro | missense_variant | Familial | Maternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.3532C>T | p.Arg1178Cys | missense_variant | Familial | Paternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.4913T>G | p.Phe1638Cys | missense_variant | Familial | Maternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.5666G>A | p.Arg1889His | missense_variant | Familial | Paternal | Simplex | 25363760 | De Rubeis S , et al. (2014) | |
c.4805del | p.Gly1602ValfsTer13 | frameshift_variant | Unknown | - | Unknown | 25363760 | De Rubeis S , et al. (2014) | |
c.7463_7464insTC | p.Ser2489ProfsTer24 | frameshift_variant | De novo | - | Simplex | 37393044 | Wang J et al. (2023) | |
c.1582_1583del | p.Lys528GlyfsTer14 | frameshift_variant | De novo | - | Simplex | 32094338 | Husson T , et al. (2020) | |
c.3528_3529insAA | p.Glu1177LysfsTer77 | frameshift_variant | De novo | - | - | 31721432 | Ostrowski PJ , et al. (2019) | |
c.4744_4745ins16 | p.Arg1582LeufsTer31 | frameshift_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.1172dup | p.Gln392ThrfsTer29 | frameshift_variant | De novo | - | Simplex | 38441608 | Ugo Sorrentino et al. (2024) | |
c.3832dup | p.Asp1278GlyfsTer2 | frameshift_variant | Unknown | - | Simplex | 38441608 | Ugo Sorrentino et al. (2024) | |
c.2654del | p.Asn885ThrfsTer14 | frameshift_variant | Familial | Paternal | Simplex | 30564305 | Guo H , et al. (2018) | |
c.6308_6311del | p.Glu2103GlyfsTer3 | frameshift_variant | De novo | - | Simplex | 23160955 | O'Roak BJ , et al. (2012) | |
c.2798_2804delinsTT | p.Asp933ValfsTer2 | frameshift_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.1772T>A | p.Ile591Lys | missense_variant | Familial | Paternal | Multiplex | 36182950 | Dingemans AJM et al. (2022) | |
c.1123_1124del | p.Leu375ValfsTer45 | frameshift_variant | De novo | - | - | 38321498 | Marketa Wayhelova et al. (2024) | |
c.6355_6356del | p.Leu2120ProfsTer13 | frameshift_variant | De novo | - | Simplex | 22495309 | O'Roak BJ , et al. (2012) | |
c.3852_3853insTCCA | p.Met1285ProfsTer17 | frameshift_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.5796_5797insGCTT | p.Leu1933AlafsTer75 | frameshift_variant | Unknown | - | - | 36182950 | Dingemans AJM et al. (2022) | |
c.4800del | p.Gly1602ValfsTer13 | frameshift_variant | De novo | - | Multiplex | 31981491 | Satterstrom FK et al. (2020) | |
c.2937_2939delinsTC | p.Leu980ArgfsTer5 | frameshift_variant | De novo | - | Simplex | 32094338 | Husson T , et al. (2020) | |
c.3524_3525insC | p.Leu1175PhefsTer3 | frameshift_variant | Unknown | - | Simplex | 38441608 | Ugo Sorrentino et al. (2024) | |
c.1690C>T | p.Arg564Ter | stop_gained | Familial | Maternal | Multi-generational | 28475857 | Tatton-Brown K , et al. (2017) | |
c.6031_6032insT | p.Glu2011ValfsTer32 | frameshift_variant | Familial | Maternal | Simplex | 30564305 | Guo H , et al. (2018) | |
c.4435_4436insGTGGAGACCAT | p.Val1479GlyfsTer33 | frameshift_variant | De novo | - | Simplex | 35982159 | Zhou X et al. (2022) | |
c.4435_4436delinsTA | p.Val1479Ter | frameshift_variant | Familial | Maternal | Simplex | 24998929 | Bernier R , et al. (2014) | |
c.4105_4109del | p.Asp1369ProfsTer12 | frameshift_variant | Unknown | - | Simplex | 39576488 | Mariia A Parfenenko et al. (2024) | |
c.4800_4801del | p.Gly1602CysfsTer5 | frameshift_variant | Unknown | Not maternal | Simplex | 34415117 | Doummar D et al. (2021) | |
c.2154dup | p.Phe719LeufsTer2 | frameshift_variant | Unknown | - | - | 31751304 | Vasco de Albuquerque Albuquerque E et al. (2020) | |
c.7112dup | p.Asn2371LysfsTer2 | frameshift_variant | Familial | Maternal | Simplex | 39576488 | Mariia A Parfenenko et al. (2024) | |
c.3512A>C | p.Gln1171Pro | missense_variant | Familial | Paternal | Simplex | 25533962 | Deciphering Developmental Disorders Study (2014) | |
c.6569_6587del | p.Ile2190ThrfsTer3 | frameshift_variant | Familial | Maternal | Multi-generational | 28475857 | Tatton-Brown K , et al. (2017) |
Common Variants
No common variants reported.
SFARI Gene score
High Confidence, Syndromic


Score Delta: Score remained at 1S
criteria met
See SFARI Gene'scoring criteriaWe considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.
The syndromic category includes mutations that are associated with a substantial degree of increased risk and consistently linked to additional characteristics not required for an ASD diagnosis. If there is independent evidence implicating a gene in idiopathic ASD, it will be listed as "#S" (e.g., 2S, 3S, etc.). If there is no such independent evidence, the gene will be listed simply as "S."
4/1/2021

Score remained at 1
Description
PMID 22495309 reported 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
1/1/2021

Score remained at 1
Description
PMID 22495309 reported 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
Reports Added
[Rare and de novo coding variants in chromodomain genes in Chiari I malformation2021] [The landscape of somatic mutation in cerebral cortex of autistic and neurotypical individuals revealed by ultra-deep whole-genome sequencing2021] [De novo variants in neurodevelopmental disorders-experiences from a tertiary care center2021]10/1/2020

Score remained at 1
Description
PMID 22495309 reported 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
Reports Added
[Identification of a rare variant in CHD8 that contributes to schizophrenia and autism spectrum disorder susceptibility2016] [Diagnostic approach with genetic tests for global developmental delay and/or intellectual disability: Single tertiary center experience2019] [Genetic investigation of patients with tall stature2020] [Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders2020]4/1/2020

Score remained at 1
Description
PMID 22495309 reported 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
Reports Added
[Genetic landscape of autism spectrum disorder in Vietnamese children2020] [Excess of de novo variants in genes involved in chromatin remodelling in patients with marfanoid habitus and intellectual disability2020] [A de novo variant of CHD8 in a patient with autism spectrum disorder2020]1/1/2020

Score remained at 1
Description
PMID 22495309 reported 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
Reports Added
[Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci.2015] [De Novo Damaging DNA Coding Mutations Are Associated With Obsessive-Compulsive Disorder and Overlap With Tourette's Disorder and Autism.2019] [De novo variants in the Helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth.2020] [Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism2020] [Rare genetic susceptibility variants assessment in autism spectrum disorder: detection rate and practical use.2020]10/1/2019

Score remained at 1
New Scoring Scheme
Description
PMID 22495309 reported 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
Reports Added
[Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability.2017] [Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes2019] [The CHD8 overgrowth syndrome: A detailed evaluation of an emerging overgrowth phenotype in 27 patients.2019] [New Scoring Scheme]7/1/2019

Score remained at 1S
Description
PMID 22495309 reported 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
Reports Added
[Lessons Learned from Large-Scale, First-Tier Clinical Exome Sequencing in a Highly Consanguineous Population.2019] [Characterization of intellectual disability and autism comorbidity through gene panel sequencing.2019] [Autism-associated missense genetic variants impact locomotion and neurodevelopment in Caenorhabditis elegans.2019] [Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks.2019]4/1/2019

Score remained at 1S
Description
PMID 22495309 reported 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
1/1/2019

Score remained at 1S
Description
PMID 22495309 reported 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
Reports Added
[Novel deletions of 14q11.2 associated with developmental delay, cognitive impairment and similar minor anomalies in three children.2007] [Genetic Diagnostic Evaluation of Trio-Based Whole Exome Sequencing Among Children With Diagnosed or Suspected Autism Spectrum Disorder.2018] [Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model.2018] [Targeted Next-Generation Sequencing of Korean Patients With Developmental Delay and/or Intellectual Disability.2019] [A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by...2019]10/1/2018

Score remained at 1S
Description
PMID 22495309 reported 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
Reports Added
[Recurrent de novo mutations implicate novel genes underlying simplex autism risk.2014] [Autism-linked CHD gene expression patterns during development predict multi-organ disease phenotypes.2018] [Autism spectrum disorder early in development associated with CHD8 mutations among two Chinese children.2018] [Genomic landscapes of Chinese sporadic autism spectrum disorders revealed by whole-genome sequencing.2018]7/1/2018

Score remained at 1S
Description
PMID 22495309 reported 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR 0.01, meaning that this gene had a 99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
10/1/2017

Score remained at 1S
Description
PMID 22495309 reported 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR ? 0.01, meaning that this gene had a ? 99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
7/1/2017

Score remained at 1S
Description
PMID 22495309 reported 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR ? 0.01, meaning that this gene had a ? 99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
4/1/2017

Score remained at 1S
Description
PMID 22495309 showed 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
Reports Added
[Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.2012] [Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries.2012] [Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.2012] [Disruptive CHD8 mutations define a subtype of autism early in development.2014] [Recurrent 100 Kb microdeletion in the chromosomal region 14q11.2, involving CHD8 gene, is associated with autism and macrocephaly.2014] [Synaptic, transcriptional and chromatin genes disrupted in autism.2014] [The contribution of de novo coding mutations to autism spectrum disorder2014] [Large-scale discovery of novel genetic causes of developmental disorders.2014] [De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability.2014] [CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome.2010] [CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors.2014] [The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment.2015] [The autism-associated gene chromodomain helicase DNA-binding protein 8 (CHD8) regulates noncoding RNAs and autism-related genes.2015] [Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms.2015] [Low load for disruptive mutations in autism genes and their biased transmission.2015] [A de novo frameshift mutation in chromodomain helicase DNA-binding domain 8 (CHD8): A case report and literature review.2016] [Novel 14q11.2 microduplication including the CHD8 and SUPT16H genes associated with developmental delay.2016] [CHD8 intragenic deletion associated with autism spectrum disorder.2016] [Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling.2016] [De novo genic mutations among a Chinese autism spectrum disorder cohort.2016] [The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies.2016] [Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.2017] [Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder2017] [Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism.2017]1/1/2017

Score remained at 1S
Description
PMID 22495309 showed 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
10/1/2016

Score remained at 1S
Description
PMID 22495309 showed 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
Reports Added
[Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling.2016] [De novo genic mutations among a Chinese autism spectrum disorder cohort.2016] [The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies.2016]1/1/2016

Score remained at 1S
Description
PMID 22495309 showed 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD. This gene was identified in Iossifov et al. 2015 as a strong candidate to be an ASD risk gene based on a combination of de novo mutational evidence and the absence or very low frequency of mutations in controls (PMID 26401017).
Reports Added
[Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.2012] [Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries.2012] [Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.2012] [Disruptive CHD8 mutations define a subtype of autism early in development.2014] [Recurrent 100 Kb microdeletion in the chromosomal region 14q11.2, involving CHD8 gene, is associated with autism and macrocephaly.2014] [Synaptic, transcriptional and chromatin genes disrupted in autism.2014] [The contribution of de novo coding mutations to autism spectrum disorder2014] [Large-scale discovery of novel genetic causes of developmental disorders.2014] [De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability.2014] [CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome.2010] [CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors.2014] [The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment.2015] [The autism-associated gene chromodomain helicase DNA-binding protein 8 (CHD8) regulates noncoding RNAs and autism-related genes.2015] [Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms.2015] [Low load for disruptive mutations in autism genes and their biased transmission.2015] [A de novo frameshift mutation in chromodomain helicase DNA-binding domain 8 (CHD8): A case report and literature review.2016] [Novel 14q11.2 microduplication including the CHD8 and SUPT16H genes associated with developmental delay.2016] [CHD8 intragenic deletion associated with autism spectrum disorder.2016]4/1/2015

Score remained at 1S
Description
PMID 22495309 showed 2 de novo loss-of-function (LoF) mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LoF mutations. A ninth de novo LoF variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LoF variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760). A phenotypic comparison of patients with CHD8 variants in PMID 24998929 identified recurrent dysmorphic facial features suggestive of a syndromic form of ASD.
1/1/2015

Score remained at 1
Description
PMID 22495309 showed 2 de novo LGD mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LGD mutations. A ninth de novo LGD variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LGD variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760).
10/1/2014

Score remained at 1
Description
PMID 22495309 showed 2 de novo LGD mutations in CHD8 among 209 simplex ASD families. In a screen of 44 genes in 2,446 ASD probands from the Simons Simplex Collection, PMID 23160955 found 6 additional de novo CHD8 LGD mutations. A ninth de novo LGD variant in CHD8 in an ASD proband from the Simons Simplex Collection was observed in PMID 25363768. Additional LGD variants in CHD8 were identified in children with developmental delay and ASD in PMID 24998929. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders. Analysis of rare coding variation in 3,871 ASD cases and 9,937 ancestry-matched or paternal controls from the Autism Sequencing Consortium (ASC) identified CHD8 as a gene meeting high statistical significance with a FDR ?0.01, meaning that this gene had a ?99% chance of being a true autism gene (PMID 25363760).
Reports Added
[Recurrent 100 Kb microdeletion in the chromosomal region 14q11.2, involving CHD8 gene, is associated with autism and macrocephaly.2014] [CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors.2014] [Synaptic, transcriptional and chromatin genes disrupted in autism.2014] [The contribution of de novo coding mutations to autism spectrum disorder2014]7/1/2014

Increased from No data to 1
Description
PMID 22495309 showed 2 de novo LGD mutations in CHD8 among 209 ASD families. PMID 22495311 reported 3 additional CHD8 LGD mutations in 935 cases and none among 870 controls. In a screen of 44 genes in 2,446 ASD probands, PMID 23160955 found 9 additional de novo CHD8 LGD mutations. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders.
Reports Added
[CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome.2010] [Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.2012] [Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries.2012] [Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.2012] [De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability.2014] [Disruptive CHD8 mutations define a subtype of autism early in development.2014]4/1/2014

Increased from No data to 1
Description
PMID 22495309 showed 2 de novo LGD mutations in CHD8 among 209 ASD families. PMID 22495311 reported 3 additional CHD8 LGD mutations in 935 cases and none among 870 controls. In a screen of 44 genes in 2,446 ASD probands, PMID 23160955 found 9 additional de novo CHD8 LGD mutations. PMID 22521361 showed that CHD8 is among 33 loci with balanced chromosomal abnormalities in individuals with ASD or other neurodevelopmental disorders.
Krishnan Probability Score
Score 0.48605406881788
Ranking 7247/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 0.99999999999809
Ranking 45/18225 scored genes
[Show Scoring Methodology]
Iossifov Probability Score
Score 0.998
Ranking 7/239 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 3.056711550542E-10
Ranking 1/18665 scored genes
[Show Scoring Methodology]
Larsen Cumulative Evidence Score
Score 262
Ranking 2/461 scored genes
[Show Scoring Methodology]
Zhang D Score
Score 0.43689316255242
Ranking 1064/20870 scored genes
[Show Scoring Methodology]
External PIN Data
Interactome
Notice: due to the large number of CHD8's protein interactions, this visualization has been limited to connections with genes present in the SFARI Gene database.
- Protein Binding
- DNA Binding
- RNA Binding
- Protein Modification
- Direct Regulation
- ASD-Linked Genes
Interaction Table
Interactor Symbol | Interactor Name | Interactor Organism | Interactor Type | Entrez ID | Uniprot ID |
---|---|---|---|---|---|
41703 | membrane-associated ring finger (C3HC4) 5 | Human | DNA Binding | NM_017824 | Q9NX47 |
41704 | membrane-associated ring finger (C3HC4) 6, E3 ubiquitin protein ligase | Human | DNA Binding | NM_005885 | O60337 |
41707 | membrane-associated ring finger (C3HC4) 9 | Human | DNA Binding | NM_138396 | Q86YJ5 |
41884 | septin 2 | Human | DNA Binding | NM_004404 | Q15019 |
41886 | septin 4 | Human | DNA Binding | NM_004574 | O43236 |
41889 | membrane-associated ring finger (C3HC4) 7, E3 ubiquitin protein ligase | Human | DNA Binding | NM_022826 | B7ZAR7 |
41893 | 15 kDa selenoprotein | Human | DNA Binding | NM_004261 | O60613 |
AAK1 | AP2 associated kinase 1 | Human | DNA Binding | 22848 | Q2M2I8 |
AAMDC | Mth938 domain-containing protein | Human | DNA Binding | 28971 | Q9H7C9 |
AASDH | aminoadipate-semialdehyde dehydrogenase | Human | DNA Binding | 132949 | Q4L235 |
ABCA17P | ATP-binding cassette, sub-family A (ABC1), member 17, pseudogene | Human | DNA Binding | 650655 | NA |
ABCA3 | Human | DNA Binding | |||
ABCC5 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | Human | DNA Binding | 10057 | O15440 |
ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | Human | DNA Binding | 5825 | P28288 |
ABCE1 | ATP-binding cassette, sub-family E (OABP), member 1 | Human | DNA Binding | 6059 | P61221 |
ABHD10 | abhydrolase domain containing 10 | Human | DNA Binding | 55347 | Q9NUJ1 |
ABHD14A | abhydrolase domain containing 14A | Human | DNA Binding | NM_015407 | Q9BUJ0 |
ABHD3 | abhydrolase domain containing 3 | Human | DNA Binding | NM_138340 | Q8WU67 |
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | Human | DNA Binding | 25 | P00519 |
ABT1 | activator of basal transcription 1 | Human | DNA Binding | 29777 | Q9ULW3 |
ABTB2 | ankyrin repeat and BTB (POZ) domain containing 2 | Human | DNA Binding | 25841 | Q8N961 |
ACACA | acetyl-CoA carboxylase alpha | Human | DNA Binding | 31 | Q13085 |
ACADM | acyl-CoA dehydrogenase, C-4 to C-12 straight chain | Human | DNA Binding | 34 | P11310 |
ACADSB | Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial | Human | DNA Binding | 36 | P45954 |
ACAT1 | acetyl-CoA acetyltransferase 1 | Human | DNA Binding | 38 | P24752 |
ACBD5 | acyl-CoA binding domain containing 5 | Human | DNA Binding | 91452 | Q5T8D3 |
ACBD6 | acyl-CoA binding domain containing 6 | Human | DNA Binding | 84320 | B2RAA8 |
ACIN1 | apoptotic chromatin condensation inducer 1 | Human | DNA Binding | 22985 | Q9UKV3 |
ACO1 | aconitase 1, soluble | Human | DNA Binding | 48 | P21399 |
ACO2 | aconitase 2, mitochondrial | Human | DNA Binding | 50 | Q99798 |
ACOX3 | acyl-CoA oxidase 3, pristanoyl | Human | DNA Binding | NM_003501 | O15254 |
ACP1 | acid phosphatase 1, soluble | Human | DNA Binding | 52 | B5MCC7 |
ACP2 | acid phosphatase 2, lysosomal | Human | DNA Binding | 53 | P11117 |
ACPL2 | 2-phosphoxylose phosphatase 1 | Human | DNA Binding | 92370 | Q8TE99 |
ACSL3 | acyl-CoA synthetase long-chain family member 3 | Human | DNA Binding | 2181 | B3KMA6 |
ACTL6A | actin-like 6A | Human | DNA Binding | 86 | O96019 |
ACTR2 | ARP2 actin-related protein 2 homolog (yeast) | Human | DNA Binding | 10097 | E9PF41 |
ACTR6 | ARP6 actin-related protein 6 homolog (yeast) | Human | DNA Binding | NM_022496 | Q9GZN1 |
ACVR1B | activin A receptor, type IB | Human | DNA Binding | 91 | P36896 |
ACVR2A | activin A receptor, type IIA | Human | DNA Binding | 92 | P27037 |
ACYP1 | acylphosphatase 1, erythrocyte (common) type | Human | DNA Binding | NM_001107 | P07311 |
ACYP2 | Acylphosphatase-2 | Human | DNA Binding | 98 | P14621 |
ADAL | adenosine deaminase-like | Human | DNA Binding | 161823 | Q6DHV7 |
ADAM17 | ADAM metallopeptidase domain 17 | Human | DNA Binding | 6868 | B2RNB2 |
ADAM8 | ADAM metallopeptidase domain 8 | Human | DNA Binding | NM_001109 | P78325 |
ADAM9 | ADAM metallopeptidase domain 9 | Human | DNA Binding | 8754 | Q13443 |
ADAMTS10 | A disintegrin and metalloproteinase with thrombospondin motifs 10 | Human | DNA Binding | 81794 | Q9H324 |
ADAR | adenosine deaminase, RNA-specific | Human | DNA Binding | 103 | P55265 |
ADAT2 | adenosine deaminase, tRNA-specific 2 | Human | DNA Binding | 134637 | Q7Z6V5 |
ADCK4 | aarF domain containing kinase 4 | Human | DNA Binding | 79934 | Q96D53 |
ADCY5 | Adenylate cyclase type 5 | Human | DNA Binding | 111 | O95622 |
ADD1 | adducin 1 (alpha) | Human | DNA Binding | 118 | P35611 |
ADK | adenosine kinase | Human | DNA Binding | 132 | P55263 |
ADM | adrenomedullin | Human | DNA Binding | NM_001124 | P35318 |
ADO | 2-aminoethanethiol (cysteamine) dioxygenase | Human | DNA Binding | 84890 | B3KXN9 |
ADRM1 | adhesion regulating molecule 1 | Human | DNA Binding | 11047 | Q16186 |
ADSL | adenylosuccinate lyase | Human | DNA Binding | 158 | P30566 |
ADSS | adenylosuccinate synthase | Human | DNA Binding | 159 | P30520 |
AEBP2 | AE binding protein 2 | Human | DNA Binding | 121536 | Q6ZN18 |
AFTPH | aftiphilin | Human | DNA Binding | 54812 | Q6ULP2 |
AGA | aspartylglucosaminidase | Human | DNA Binding | NM_000027 | P20933 |
AGAP3 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 | Human | DNA Binding | NM_001042535 | Q86ST5 |
AGK | acylglycerol kinase | Human | DNA Binding | 55750 | A4D1U5 |
AGO2 | argonaute RISC catalytic component 2 | Human | DNA Binding | 27161 | A4FVC0 |
AGPAT1 | 1-acylglycerol-3-phosphate O-acyltransferase 1 | Human | DNA Binding | 10554 | Q99943 |
AGPAT3 | 1-acylglycerol-3-phosphate O-acyltransferase 3 | Human | DNA Binding | 56894 | Q9NRZ7 |
AGPAT6 | 1-acylglycerol-3-phosphate O-acyltransferase 6 | Human | DNA Binding | 137964 | Q2TU73 |
AHCYL2 | adenosylhomocysteinase-like 2 | Human | DNA Binding | 23382 | Q96HN2 |
AHSA1 | AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast) | Human | DNA Binding | 10598 | O95433 |
AK3 | adenylate kinase 3 | Human | DNA Binding | 50808 | Q7Z4Y4 |
AKAP4 | A kinase (PRKA) anchor protein 4 | Human | DNA Binding | 8852 | Q5JQC9 |
AKAP8 | A kinase (PRKA) anchor protein 8 | Human | DNA Binding | 10270 | O43823 |
AKAP8L | A kinase (PRKA) anchor protein 8-like | Human | DNA Binding | 26993 | Q9ULX6 |
AKIRIN1 | akirin 1 | Human | DNA Binding | 79647 | Q9H9L7 |
AKIRIN2 | akirin 2 | Human | DNA Binding | 55122 | Q53H80 |
AKT1S1 | AKT1 substrate 1 (proline-rich) | Human | DNA Binding | 84335 | Q96B36 |
AKT2 | v-akt murine thymoma viral oncogene homolog 2 | Human | DNA Binding | 208 | B4DG79 |
ALG10B | ALG10B, alpha-1,2-glucosyltransferase | Human | DNA Binding | 144245 | Q5I7T1 |
ALG14 | ALG14, UDP-N-acetylglucosaminyltransferase subunit | Human | DNA Binding | NM_144988 | Q96F25 |
ALG5 | ALG5, dolichyl-phosphate beta-glucosyltransferase | Human | DNA Binding | 29880 | Q9Y673 |
ALG9 | ALG9, alpha-1,2-mannosyltransferase | Human | DNA Binding | 79796 | Q9H6U8 |
ALKBH5 | alkB, alkylation repair homolog 5 (E. coli) | Human | DNA Binding | 54890 | Q6P6C2 |
ALKBH8 | alkB, alkylation repair homolog 8 (E. coli) | Human | DNA Binding | 91801 | Q96BT7 |
ALMS1 | Alstrom syndrome 1 | Human | DNA Binding | 7840 | Q8TCU4 |
ALOXE3 | Hydroperoxide isomerase ALOXE3 | Human | DNA Binding | 59344 | Q9BYJ1 |
ALS2 | amyotrophic lateral sclerosis 2 (juvenile) | Human | DNA Binding | NM_001135745 | Q96Q42 |
AMBRA1 | autophagy/beclin-1 regulator 1 | Human | DNA Binding | 55626 | Q9C0C7 |
AMHR2 | anti-Mullerian hormone receptor, type II | Human | DNA Binding | 269 | Q16671 |
AMMECR1L | AMMECR1-like | Human | DNA Binding | 83607 | Q6DCA0 |
AMOTL2 | CDH10 | Human | DNA Binding | 51421 | Q9Y2J4 |
ANAPC10 | anaphase promoting complex subunit 10 | Human | DNA Binding | 10393 | Q9UM13 |
ANAPC13 | anaphase promoting complex subunit 13 | Human | DNA Binding | 25847 | A8K3Z6 |
ANAPC5 | anaphase promoting complex subunit 5 | Human | DNA Binding | 51433 | Q9UJX4 |
ANAPC7 | anaphase promoting complex subunit 7 | Human | DNA Binding | 51434 | Q9UJX3 |
ANGEL2 | angel homolog 2 (Drosophila) | Human | DNA Binding | 90806 | Q5VTE6 |
ANKH | ankylosis, progressive homolog (mouse) | Human | DNA Binding | 56172 | Q9HCJ1 |
ANKLE2 | Ankyrin repeat and LEM domain-containing protein 2 | Human | DNA Binding | 23141 | Q86XL3 |
ANKRD13A | ankyrin repeat domain 13A | Human | DNA Binding | 88455 | Q3ZTS7 |
ANKRD13C | ankyrin repeat domain 13C | Human | DNA Binding | 81573 | Q8N6S4 |
ANKRD16 | ankyrin repeat domain 16 | Human | DNA Binding | 54522 | Q6P6B7 |
ANKRD32 | ankyrin repeat domain 32 | Human | DNA Binding | 84250 | I6L9F1 |
ANKRD34A | ankyrin repeat domain 34A | Human | DNA Binding | NM_001039888 | Q69YU3 |
ANKRD40 | ankyrin repeat domain 40 | Human | DNA Binding | 91369 | A8IK34 |
ANKRD42 | ankyrin repeat domain 42 | Human | DNA Binding | NM_182603 | Q8N9B4 |
ANKRD50 | ankyrin repeat domain 50 | Human | DNA Binding | 57182 | Q8TB46 |
ANKRD52 | Human | DNA Binding | |||
ANLN | anillin, actin binding protein | Human | DNA Binding | 54443 | Q9NQW6 |
ANO8 | anoctamin 8 | Human | DNA Binding | 57719 | Q9HCE9 |
ANP32B | acidic (leucine-rich) nuclear phosphoprotein 32 family, member B | Human | DNA Binding | 10541 | Q92688 |
ANXA2 | annexin A2 | Human | DNA Binding | 302 | P07355 |
AP1G1 | adaptor-related protein complex 1, gamma 1 subunit | Human | DNA Binding | 164 | O43747 |
AP1M1 | adaptor-related protein complex 1, mu 1 subunit | Human | DNA Binding | 8907 | Q59EK3 |
AP1S3 | adaptor-related protein complex 1, sigma 3 subunit | Human | DNA Binding | 130340 | Q96PC3 |
AP2A2 | adaptor-related protein complex 2, alpha 2 subunit | Human | DNA Binding | 161 | O94973 |
AP4E1 | adaptor-related protein complex 4, epsilon 1 subunit | Human | DNA Binding | 23431 | B4DM48 |
AP4M1 | adaptor-related protein complex 4, mu 1 subunit | Human | DNA Binding | 9179 | O00189 |
AP4S1 | adaptor-related protein complex 4, sigma 1 subunit | Human | DNA Binding | 11154 | Q9Y587 |
AP5B1 | AP-5 complex subunit beta-1 | Human | DNA Binding | 91056 | Q2VPB7 |
AP5M1 | AP-5 complex subunit mu-1 | Human | DNA Binding | 55745 | Q9H0R1 |
AP5S1 | AP-5 complex subunit sigma-1 | Human | DNA Binding | 55317 | Q9NUS5 |
APEH | N-acylaminoacyl-peptide hydrolase | Human | DNA Binding | 327 | P13798 |
APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | Human | DNA Binding | 328 | P27695 |
API5 | apoptosis inhibitor 5 | Human | DNA Binding | 8539 | Q9BZZ5 |
APIP | APAF1 interacting protein | Human | DNA Binding | 51074 | Q96GX9 |
APITD1 | Centromere protein S | Human | DNA Binding | 1325 | Q8N2Z9 |
APITD1-CORT | Centromere protein S | Human | DNA Binding | 100526739 | Q8N2Z9 |
APLP1 | amyloid beta (A4) precursor-like protein 1 | Human | DNA Binding | 333 | P51693 |
APLP2 | amyloid beta (A4) precursor-like protein 2 | Human | DNA Binding | 334 | Q06481 |
APOLD1 | apolipoprotein L domain containing 1 | Human | DNA Binding | 81575 | Q96LR9 |
APOO | apolipoprotein O | Human | DNA Binding | NM_024122 | Q9BUR5 |
APOPT1 | Apoptogenic protein 1, mitochondrial | Human | DNA Binding | 84334 | Q96IL0 |
APPBP2 | amyloid beta precursor protein (cytoplasmic tail) binding protein 2 | Human | DNA Binding | 10513 | Q92624 |
APPL1 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 | Human | DNA Binding | 26060 | Q9UKG1 |
APTX | aprataxin | Human | DNA Binding | 54840 | Q7Z2E3 |
AR | androgen receptor | Human | Protein Binding | 367 | P10275 |
ARF4 | ADP-ribosylation factor 4 | Human | DNA Binding | 378 | P18085 |
ARF6 | ADP-ribosylation factor 6 | Human | DNA Binding | 382 | P62330 |
ARFGAP1 | ADP-ribosylation factor GTPase activating protein 1 | Human | DNA Binding | 55738 | Q8N6T3 |
ARFGAP2 | ADP-ribosylation factor GTPase activating protein 2 | Human | DNA Binding | 84364 | B4DX29 |
ARFGEF1 | Human | DNA Binding | |||
ARFRP1 | ADP-ribosylation factor related protein 1 | Human | DNA Binding | NM_003224 | Q13795 |
ARHGAP11B | Rho GTPase activating protein 11B | Human | DNA Binding | NM_001039841 | Q3KRB8 |
ARHGAP21 | Rho GTPase activating protein 21 | Human | DNA Binding | 57584 | Q5T5U3 |
ARHGAP33 | Rho GTPase-activating protein 33 | Human | DNA Binding | 115703 | O14559 |
ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | Human | DNA Binding | 396 | P52565 |
ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 | Human | DNA Binding | 9826 | O15085 |
ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | Human | DNA Binding | 23365 | B4E2K6 |
ARHGEF7 | Human | DNA Binding | |||
ARID1B | AT rich interactive domain 1B (SWI1-like) | Human | DNA Binding | 57492 | Q8NFD5 |
ARID3A | AT rich interactive domain 3A (BRIGHT-like) | Human | DNA Binding | 1820 | Q99856 |
ARID4A | AT rich interactive domain 4A (RBP1-like) | Human | DNA Binding | 5926 | P29374 |
ARIH1 | ariadne homolog, ubiquitin-conjugating enzyme E2 binding protein, 1 (Drosophila) | Human | DNA Binding | 25820 | Q9Y4X5 |
ARL13B | ADP-ribosylation factor-like 13B | Human | DNA Binding | 200894 | Q3SXY8 |
ARL17P1 | ADP-ribosylation factor-like 17A | Human | DNA Binding | NM_001113738 | A8K0M5 |
ARL2BP | ADP-ribosylation factor-like 2 binding protein | Human | DNA Binding | 23568 | Q9Y2Y0 |
ARL3 | ADP-ribosylation factor-like 3 | Human | DNA Binding | NM_004311 | P36405 |
ARL4A | ADP-ribosylation factor-like 4A | Human | DNA Binding | NM_001037164 | A0A024R9Z2 |
ARL5A | ADP-ribosylation factor-like 5A | Human | DNA Binding | 26225 | Q9Y689 |
ARL5B | ADP-ribosylation factor-like 5B | Human | DNA Binding | 221079 | B0YIW9 |
ARL6 | ADP-ribosylation factor-like 6 | Human | DNA Binding | NM_177976 | Q9H0F7 |
ARL6IP6 | ADP-ribosylation-like factor 6 interacting protein 6 | Human | DNA Binding | 151188 | B3KMZ5 |
ARL8A | ADP-ribosylation factor-like 8A | Human | DNA Binding | 127829 | Q96BM9 |
ARMC1 | armadillo repeat containing 1 | Human | DNA Binding | 55156 | Q9NVT9 |
ARMC5 | armadillo repeat containing 5 | Human | DNA Binding | 79798 | Q96C12 |
ARMC6 | armadillo repeat containing 6 | Human | DNA Binding | 93436 | Q6NXE6 |
ARMCX5 | armadillo repeat containing, X-linked 5 | Human | DNA Binding | NM_022838 | Q6P1M9 |
ARPC4 | actin related protein 2/3 complex, subunit 4, 20kDa | Human | DNA Binding | 10093 | F6TTL5 |
ARPC4-TTLL3 | Protein ARPC4-TTLL3 | Human | DNA Binding | 100526693 | A0A0A6YYG9 |
ARPC5 | actin related protein 2/3 complex, subunit 5, 16kDa | Human | DNA Binding | 10092 | O15511 |
ARPP19 | cAMP-regulated phosphoprotein, 19kDa | Human | DNA Binding | 10776 | P56211 |
ARRDC3-AS1 | ARRDC3 antisense RNA 1 | Human | DNA Binding | 100129716 | NA |
ARSB | arylsulfatase B | Human | DNA Binding | 411 | P15848 |
ARSK | arylsulfatase family, member K | Human | DNA Binding | NM_198150 | Q6UWY0 |
ARV1 | ARV1 homolog (S. cerevisiae) | Human | DNA Binding | 64801 | Q9H2C2 |
ASB6 | ankyrin repeat and SOCS box containing 6 | Human | DNA Binding | 140459 | Q9NWX5 |
ASB7 | ankyrin repeat and SOCS box containing 7 | Human | DNA Binding | 140460 | Q9H672 |
ASCC3 | activating signal cointegrator 1 complex subunit 3 | Human | DNA Binding | 10973 | Q8N3C0 |
ASF1A | Histone chaperone ASF1A | Human | DNA Binding | 25842 | Q9Y294 |
ASF1B | ASF1 anti-silencing function 1 homolog B (S. cerevisiae) | Human | DNA Binding | 55723 | Q9NVP2 |
ASH1L | ash1 (absent, small, or homeotic)-like (Drosophila) | Human | DNA Binding | 55870 | Q9NR48 |
ASH1L-AS1 | ASH1L antisense RNA 1 | Human | DNA Binding | 645676 | NA |
ASH2L | ash2 (absent, small, or homeotic)-like (Drosophila) | Human | Protein Binding | 9070 | Q9UBL3 |
ASNA1 | arsA arsenite transporter, ATP-binding, homolog 1 (bacterial) | Human | DNA Binding | NM_004317 | O43681 |
ASPSCR1 | alveolar soft part sarcoma chromosome region, candidate 1 | Human | DNA Binding | 79058 | Q9BZE9 |
ASXL1 | additional sex combs like 1 (Drosophila) | Human | DNA Binding | 171023 | Q498B9 |
ATAD2B | ATPase family, AAA domain containing 2B | Human | DNA Binding | 54454 | Q9ULI0 |
ATAD3A | ATPase family, AAA domain containing 3A | Human | DNA Binding | 55210 | Q9NVI7 |
ATAD5 | ATPase family, AAA domain containing 5 | Human | DNA Binding | 79915 | Q96QE3 |
ATE1 | arginyltransferase 1 | Human | DNA Binding | 11101 | O95260 |
ATF6 | activating transcription factor 6 | Human | DNA Binding | 22926 | A8K383 |
ATF7 | activating transcription factor 7 | Human | DNA Binding | NM_006856 | P17544 |
ATF7IP | activating transcription factor 7 interacting protein | Human | DNA Binding | 55729 | Q6VMQ6 |
ATG16L1 | autophagy related 16-like 1 (S. cerevisiae) | Human | DNA Binding | 55054 | Q53SV2 |
ATG16L2 | autophagy related 16-like 2 (S. cerevisiae) | Human | DNA Binding | NM_033388 | Q8NAA4 |
ATG3 | Ubiquitin-like-conjugating enzyme ATG3 | Human | DNA Binding | 64422 | Q9NT62 |
ATL1 | Atlastin-1 | Human | DNA Binding | 51062 | Q8WXF7 |
ATL3 | atlastin GTPase 3 | Human | DNA Binding | 25923 | Q6DD88 |
ATN1 | atrophin 1 | Human | DNA Binding | 1822 | P54259 |
ATP10D | CYFIP1 | Human | DNA Binding | 57205 | Q9P241 |
ATP11A | ATPase, class VI, type 11A | Human | DNA Binding | 23250 | P98196 |
ATP11B | ATPase, class VI, type 11B | Human | DNA Binding | 23200 | B4DKX1 |
ATP1B1 | Human | DNA Binding | |||
ATP2A1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | Human | DNA Binding | 487 | O14983 |
ATP5E | ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit | Human | DNA Binding | NM_006886 | P56381 |
ATP5F1 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 | Human | DNA Binding | 515 | P24539 |
ATP5G1 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) | Human | DNA Binding | 516 | P05496 |
ATP5G2 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) | Human | DNA Binding | 517 | Q06055 |
ATP5I | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E | Human | DNA Binding | 521 | P56385 |
ATP6V0C | ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c | Human | DNA Binding | 527 | P27449 |
ATP6V0D1 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 | Human | DNA Binding | NM_004691 | P61421 |
ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A | Human | DNA Binding | 523 | P38606 |
ATP6V1G1 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 | Human | DNA Binding | 9550 | O75348 |
ATP6V1G2 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 | Human | DNA Binding | 534 | Q2L6F8 |
ATP6V1G2-DDX39B | ATP6V1G2-DDX39B readthrough (NMD candidate) | Human | DNA Binding | 100532737 | NA |
ATRAID | All-trans retinoic acid-induced differentiation factor | Human | DNA Binding | 51374 | Q6UW56 |
ATRN | attractin | Human | DNA Binding | 8455 | B4DZ36 |
ATXN10 | ataxin 10 | Human | DNA Binding | 25814 | Q9UBB4 |
ATXN2 | ataxin 2 | Human | DNA Binding | 6311 | Q99700 |
ATXN2L | ataxin 2-like | Human | DNA Binding | 11273 | Q8WWM7 |
ATXN3 | ataxin 3 | Human | DNA Binding | 4287 | E9PB63 |
ATXN7 | ataxin 7 | Human | DNA Binding | 6314 | O15265 |
ATXN7L2 | ataxin 7-like 2 | Human | DNA Binding | 127002 | Q5T6C5 |
AUP1 | ancient ubiquitous protein 1 | Human | DNA Binding | 550 | Q9Y679 |
AVEN | Cell death regulator Aven | Human | DNA Binding | 57099 | Q9NQS1 |
AVL9 | AVL9 homolog (S. cerevisiase) | Human | DNA Binding | 23080 | Q8NBF6 |
B2M | beta-2-microglobulin | Human | DNA Binding | 567 | P61769 |
B3GALNT2 | beta-1,3-N-acetylgalactosaminyltransferase 2 | Human | DNA Binding | 148789 | Q8NCR0 |
B4GALNT1 | Beta-1,4 N-acetylgalactosaminyltransferase 1 | Human | DNA Binding | 2583 | Q00973 |
B4GALT5 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5 | Human | DNA Binding | 9334 | O43286 |
B4GALT6 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 6 | Human | DNA Binding | 9331 | Q9UBX8 |
B4GALT7 | DNM1L | Human | DNA Binding | 11285 | Q9UBV7 |
B9D1 | B9 protein domain 1 | Human | DNA Binding | NM_015681 | B4DN64 |
BACH2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 | Human | DNA Binding | 60468 | Q9BYV9 |
BAD | Bcl2-associated agonist of cell death | Human | DNA Binding | 572 | Q92934 |
BAG2 | BCL2-associated athanogene 2 | Human | DNA Binding | 9532 | O95816 |
BAG5 | BCL2-associated athanogene 5 | Human | DNA Binding | 9529 | Q9UL15 |
BAHCC1 | DPP6 | Human | DNA Binding | 57597 | Q9P281 |
BANF1 | barrier to autointegration factor 1 | Human | DNA Binding | 8815 | O75531 |
BANP | BTG3 associated nuclear protein | Human | DNA Binding | 54971 | B3KM38 |
BAT1 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B | Human | DNA Binding | NM_080598 | A0A024RCM3 |
BAT2 | proline-rich coiled-coil 2A | Human | DNA Binding | 7916 | P48634 |
BAT2L | proline-rich coiled-coil 2B | Human | DNA Binding | NM_013318 | Q5JSZ5 |
BAT3 | BCL2-associated athanogene 6 | Human | DNA Binding | 7917 | P46379 |
BAT4 | G patch domain and ankyrin repeats 1 | Human | DNA Binding | NM_033177 | A0A024RCU2 |
BAT5 | DUSP22 | Human | DNA Binding | 7920 | B3KNX9 |
BAZ1B | bromodomain adjacent to zinc finger domain, 1B | Human | DNA Binding | 9031 | Q9UIG0 |
BBS10 | Bardet-Biedl syndrome 10 | Human | DNA Binding | 79738 | Q8TAM1 |
BBS4 | Bardet-Biedl syndrome 4 | Human | DNA Binding | 585 | Q96RK4 |
BBS5 | Bardet-Biedl syndrome 5 | Human | DNA Binding | 129880 | Q8N3I7 |
BBX | bobby sox homolog (Drosophila) | Human | DNA Binding | 56987 | A8K6U2 |
BCAR1 | breast cancer anti-estrogen resistance 1 | Human | DNA Binding | 9564 | B4DEV4 |
BCAS2 | breast carcinoma amplified sequence 2 | Human | DNA Binding | 10286 | B2R7W3 |
BCAS4 | breast carcinoma amplified sequence 4 | Human | DNA Binding | NM_017843 | H7BXG3 |
BCAT1 | branched chain amino-acid transaminase 1, cytosolic | Human | DNA Binding | 586 | P54687 |
BCL2 | B-cell CLL/lymphoma 2 | Human | DNA Binding | 596 | P10415 |
BCL2L1 | BCL2-like 1 | Human | DNA Binding | 598 | Q07817 |
BCL2L12 | BCL2-like 12 (proline rich) | Human | DNA Binding | 83596 | Q9HB09 |
BCL2L13 | BCL2-like 13 (apoptosis facilitator) | Human | DNA Binding | 23786 | Q9BXK5 |
BCL9 | B-cell CLL/lymphoma 9 | Human | DNA Binding | 607 | O00512 |
BCR | breakpoint cluster region | Human | DNA Binding | 613 | P11274 |
BEND3 | BEN domain containing 3 | Human | DNA Binding | 57673 | Q5T5X7 |
BFAR | bifunctional apoptosis regulator | Human | DNA Binding | 51283 | Q9NZS9 |
BHLHE41 | basic helix-loop-helix family, member e41 | Human | DNA Binding | 79365 | Q8TAT1 |
BICD2 | bicaudal D homolog 2 (Drosophila) | Human | DNA Binding | 23299 | Q8TD16 |
BIRC6 | baculoviral IAP repeat containing 6 | Human | DNA Binding | 57448 | Q9NR09 |
BLMH | bleomycin hydrolase | Human | DNA Binding | 642 | Q13867 |
BLOC1S6 | biogenesis of lysosomal organelles complex-1, subunit 6, pallidin | Human | DNA Binding | 26258 | B3KY40 |
BLZF1 | basic leucine zipper nuclear factor 1 | Human | DNA Binding | 8548 | Q9H2G9 |
BMPR1A | bone morphogenetic protein receptor, type IA | Human | DNA Binding | 657 | P36894 |
BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | Human | DNA Binding | 659 | Q13873 |
BMS1 | BMS1 homolog, ribosome assembly protein (yeast) | Human | DNA Binding | 9790 | Q14692 |
BMS1P4 | BMS1 pseudogene 4 | Human | DNA Binding | NR_026592 | |
BMS1P5 | BMS1 pseudogene 5 | Human | DNA Binding | NR_003611 | |
BNC2 | basonuclin 2 | Human | DNA Binding | 54796 | Q6ZN30 |
BNIP1 | BCL2/adenovirus E1B 19kDa interacting protein 1 | Human | DNA Binding | NM_013980 | Q12981 |
BNIP2 | BCL2/adenovirus E1B 19kDa interacting protein 2 | Human | DNA Binding | 663 | J3KN59 |
BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like | Human | DNA Binding | 665 | O60238 |
BOD1 | biorientation of chromosomes in cell division 1 | Human | DNA Binding | 91272 | Q96IK1 |
BOD1L | biorientation of chromosomes in cell division 1-like 1 | Human | DNA Binding | 259282 | Q8NFC6 |
BOLA3 | bolA homolog 3 (E. coli) | Human | DNA Binding | 388962 | Q53S33 |
BOLA3-AS1 | BOLA3 antisense RNA 1 (head to head) | Human | DNA Binding | 100507171 | NA |
BPGM | 2,3-bisphosphoglycerate mutase | Human | DNA Binding | 669 | P07738 |
BPNT1 | 3'(2'), 5'-bisphosphate nucleotidase 1 | Human | DNA Binding | NM_006085 | O95861 |
BPTF | bromodomain PHD finger transcription factor | Human | DNA Binding | 2186 | Q12830 |
BRAF | Serine/threonine-protein kinase B-raf | Human | DNA Binding | 673 | P15056 |
BRD8 | bromodomain containing 8 | Human | DNA Binding | 10902 | Q9H0E9 |
BRD9 | Bromodomain-containing protein 9 | Human | DNA Binding | 65980 | Q9H8M2 |
BRF2 | BRF2, subunit of RNA polymerase III transcription initiation factor, BRF1-like | Human | DNA Binding | 55290 | Q9HAW0 |
BRIX1 | BRX1, biogenesis of ribosomes, homolog (S. cerevisiae) | Human | DNA Binding | 55299 | Q8TDN6 |
BRWD1-AS1 | BRWD1 antisense RNA 1 | Human | DNA Binding | 100874093 | NA |
BRWD1-IT2 | Human | DNA Binding | 103091865 | NA | |
BSCL2 | Berardinelli-Seip congenital lipodystrophy 2 (seipin) | Human | DNA Binding | NM_001130702 | A0A024R540 |
BTAF1 | BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa (Mot1 homolog, S. cerevisiae) | Human | DNA Binding | 9044 | O14981 |
BTBD1 | BTB (POZ) domain containing 1 | Human | DNA Binding | 53339 | Q9H0C5 |
BTBD2 | BTB (POZ) domain containing 2 | Human | DNA Binding | 55643 | Q9BX70 |
BTF3 | basic transcription factor 3 | Human | DNA Binding | 689 | P20290 |
BTF3L4 | basic transcription factor 3-like 4 | Human | DNA Binding | 91408 | Q96K17 |
BTG3 | BTG family, member 3 | Human | DNA Binding | 10950 | Q14201 |
BUD13 | BUD13 homolog (S. cerevisiae) | Human | DNA Binding | 84811 | Q9BRD0 |
BZW1 | basic leucine zipper and W2 domains 1 | Human | DNA Binding | 9689 | Q3LIC9 |
C10orf104 | anaphase promoting complex subunit 16 | Human | DNA Binding | NM_173473 | C5H3H2 |
C10orf114 | cancer susceptibility candidate 10 | Human | DNA Binding | NM_001010911 | Q5T4H9 |
C10orf119 | minichromosome maintenance complex binding protein | Human | DNA Binding | NM_024834 | Q9BTE3 |
C10orf137 | chromosome 10 open reading frame 137 | Human | DNA Binding | 26098 | Q3B7T1 |
C10orf140 | chromosome 10 open reading frame 140 | Human | DNA Binding | 387640 | Q1XH10 |
C10orf2 | chromosome 10 open reading frame 2 | Human | DNA Binding | 56652 | Q96RR1 |
C10ORF25 | Uncharacterized protein C10orf25 | Human | DNA Binding | 220979 | Q5T742 |
C10orf28 | R3H domain and coiled-coil containing 1-like | Human | DNA Binding | 27291 | D3DR60 |
C10orf4 | fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 | Human | DNA Binding | NM_145246 | Q70Z53 |
C10orf57 | transmembrane protein 254 | Human | DNA Binding | NM_025125 | B4DU43 |
C10orf78 | SWI5-dependent recombination repair 1 | Human | DNA Binding | NM_145247 | Q86XK3 |
C11orf10 | transmembrane protein 258 | Human | DNA Binding | NM_014206 | P61165 |
C11orf46 | ADP-ribosylation factor-like 14 effector protein | Human | DNA Binding | 120534 | Q8N8R7 |
C11orf48 | chromosome 11 open reading frame 48 | Human | DNA Binding | 79081 | Q9BQE6 |
C11orf58 | chromosome 11 open reading frame 58 | Human | DNA Binding | 10944 | O00193 |
C11orf59 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 | Human | DNA Binding | NM_017907 | Q6IAA8 |
C11ORF68 | UPF0696 protein C11orf68 | Human | DNA Binding | 83638 | Q9H3H3 |
C11orf82 | chromosome 11 open reading frame 82 | Human | DNA Binding | 220042 | Q8IXT1 |
C11ORF84 | chromosome 11 open reading frame 84 | Human | DNA Binding | 144097 | Q9BUA3 |
C11ORF95 | Uncharacterized protein C11orf95 | Human | DNA Binding | 65998 | C9JLR9 |
C12orf10 | chromosome 12 open reading frame 10 | Human | DNA Binding | 60314 | Q86UA3 |
C12ORF23 | chromosome 12 open reading frame 23 | Human | DNA Binding | 90488 | Q8WUH6 |
C12orf30 | N(alpha)-acetyltransferase 25, NatB auxiliary subunit | Human | DNA Binding | NM_024953 | Q14CX7 |
C12ORF52 | chromosome 12 open reading frame 52 | Human | DNA Binding | 84934 | Q96K30 |
C12orf57 | chromosome 12 open reading frame 57 | Human | DNA Binding | 113246 | Q99622 |
C12ORF60 | Uncharacterized protein C12orf60 | Human | DNA Binding | 144608 | Q5U649 |
C12ORF61 | Putative uncharacterized protein encoded by LINC01465 | Human | DNA Binding | 283416 | Q8N7H1 |
C12orf65 | chromosome 12 open reading frame 65 | Human | DNA Binding | 91574 | Q9H3J6 |
C12orf72 | methyltransferase like 20 | Human | DNA Binding | NM_173802 | Q8IXQ9 |
C13orf23 | proline and serine rich 1 | Human | DNA Binding | NM_025138 | Q86XN7 |
C14orf101 | transmembrane protein 260 | Human | DNA Binding | NM_017799 | B3KN73 |
C14orf106 | MIS18 binding protein 1 | Human | DNA Binding | NM_018353 | Q6P0N0 |
C14orf119 | chromosome 14 open reading frame 119 | Human | DNA Binding | NM_017924 | Q9NWQ9 |
C14orf135 | chromosome 14 open reading frame 135 | Human | DNA Binding | 64430 | Q63HM2 |
C14orf178 | chromosome 14 open reading frame 178 | Human | DNA Binding | NM_174943 | F8WAD5 |
C14orf181 | Human | DNA Binding | NM_207442 | ||
C14orf33 | KTN1 antisense RNA 1 | Human | DNA Binding | NR_027123 | Q86SY8 |
C14ORF80 | chromosome 14 open reading frame 80 | Human | DNA Binding | 283643 | E9PAQ4 |
C14orf93 | chromosome 14 open reading frame 93 | Human | DNA Binding | NM_001130706 | Q9H972 |
C15orf23 | kinetochore-localized astrin/SPAG5 binding protein | Human | DNA Binding | 90417 | Q9Y448 |
C15orf33 | family with sequence similarity 227, member B | Human | DNA Binding | NM_152647 | Q96M60 |
C16orf45 | chromosome 16 open reading frame 45 | Human | DNA Binding | NM_033201 | Q96MC5 |
C16orf58 | chromosome 16 open reading frame 58 | Human | DNA Binding | 64755 | Q96GQ5 |
C16orf61 | C-x(9)-C motif containing 2 | Human | DNA Binding | NM_020188 | Q9NRP2 |
C16orf62 | chromosome 16 open reading frame 62 | Human | DNA Binding | 57020 | E7EWW0 |
C16orf7 | VPS9 domain containing 1 | Human | DNA Binding | NM_004913 | Q9Y2B5 |
C16orf72 | chromosome 16 open reading frame 72 | Human | DNA Binding | 29035 | Q14CZ0 |
C16orf80 | chromosome 16 open reading frame 80 | Human | DNA Binding | 29105 | Q9Y6A4 |
C16ORF87 | chromosome 16 open reading frame 87 | Human | DNA Binding | 388272 | Q6PH81 |
C16orf88 | chromosome 16 open reading frame 88 | Human | DNA Binding | 400506 | Q1ED39 |
C17orf59 | chromosome 17 open reading frame 59 | Human | DNA Binding | NM_017622 | Q96GS4 |
C17orf70 | chromosome 17 open reading frame 70 | Human | DNA Binding | 80233 | A4ZI32 |
C17ORF75 | chromosome 17 open reading frame 75 | Human | DNA Binding | 64149 | Q9HAS0 |
C18orf25 | chromosome 18 open reading frame 25 | Human | DNA Binding | 147339 | Q96B23 |
C18orf54 | chromosome 18 open reading frame 54 | Human | DNA Binding | 162681 | I7GY12 |
C18orf55 | translocase of inner mitochondrial membrane 21 homolog (yeast) | Human | DNA Binding | 29090 | A8K1K8 |
C19orf12 | chromosome 19 open reading frame 12 | Human | DNA Binding | 83636 | Q9NSK7 |
C19orf2 | URI1, prefoldin-like chaperone | Human | DNA Binding | 8725 | O94763 |
C19orf39 | SWIM-type zinc finger 7 associated protein 1 | Human | DNA Binding | NM_175871 | Q6NVH7 |
C19ORF43 | chromosome 19 open reading frame 43 | Human | DNA Binding | 79002 | Q9BQ61 |
C19orf48 | chromosome 19 open reading frame 48 | Human | DNA Binding | 84798 | Q6RUI8 |
C19orf54 | chromosome 19 open reading frame 54 | Human | DNA Binding | 284325 | Q5BKX5 |
C19orf55 | chromosome 19 open reading frame 55 | Human | DNA Binding | 148137 | Q2NL68 |
C19ORF60 | Uncharacterized protein C19orf60 | Human | DNA Binding | 55049 | Q96EN9 |
C19orf61 | SMG9 nonsense mediated mRNA decay factor | Human | DNA Binding | NM_019108 | A0A024R0Q0 |
C19orf62 | BRISC and BRCA1 A complex member 1 | Human | DNA Binding | NM_014173 | A0A024R7L2 |
C19orf76 | adrenomedullin 5 (putative) | Human | DNA Binding | NM_001101340 | C9JUS6 |
C1D | C1D nuclear receptor corepressor | Human | DNA Binding | 10438 | Q13901 |
C1orf107 | digestive organ expansion factor homolog (zebrafish) | Human | DNA Binding | NM_014388 | Q68CQ4 |
C1orf109 | chromosome 1 open reading frame 109 | Human | DNA Binding | 54955 | Q9NX04 |
C1orf112 | chromosome 1 open reading frame 112 | Human | DNA Binding | 55732 | Q9NSG2 |
C1ORF122 | chromosome 1 open reading frame 122 | Human | DNA Binding | 127687 | E9PQ13 |
C1orf151 | mitochondrial inner membrane organizing system 1 | Human | DNA Binding | NM_001032363 | Q5TGZ0 |
C1orf156 | methyltransferase like 18 | Human | DNA Binding | NM_033418 | A0A024R8Y7 |
C1ORF174 | chromosome 1 open reading frame 174 | Human | DNA Binding | 339448 | Q8IYL3 |
C1orf182 | TSSK6 activating co-chaperone | Human | DNA Binding | NM_144627 | Q96A04 |
C1ORF198 | chromosome 1 open reading frame 198 | Human | DNA Binding | 84886 | B3KTW1 |
C1ORF21 | chromosome 1 open reading frame 21 | Human | DNA Binding | 81563 | Q9H246 |
C1orf213 | chromosome 1 open reading frame 213 | Human | DNA Binding | 148898 | Q8NC38 |
C1orf231 | coiled-coil domain containing 163, pseudogene | Human | DNA Binding | NM_001102601 | |
C1orf27 | chromosome 1 open reading frame 27 | Human | DNA Binding | 54953 | Q5SWX8 |
C1ORF35 | chromosome 1 open reading frame 35 | Human | DNA Binding | 79169 | Q9BU76 |
C1orf43 | chromosome 1 open reading frame 43 | Human | DNA Binding | 25912 | Q9BWL3 |
C1orf52 | chromosome 1 open reading frame 52 | Human | DNA Binding | 148423 | Q8N6N3 |
C1orf55 | SDE2 telomere maintenance homolog (S. pombe) | Human | DNA Binding | NM_152608 | Q6IQ49 |
C1orf71 | consortin, connexin sorting protein | Human | DNA Binding | NM_001139459 | Q6PJW8 |
C1orf83 | transcription elongation factor A (SII) N-terminal and central domain containing 2 | Human | DNA Binding | NM_153035 | Q96MN5 |
C1orf9 | SUN domain containing ossification factor | Human | DNA Binding | 51430 | Q9UBS9 |
C1orf96 | centriole, cilia and spindle-associated protein | Human | DNA Binding | 126731 | Q6IQ19 |
C1orf97 | long intergenic non-protein coding RNA 467 | Human | DNA Binding | NR_026761 | Q9BRT7 |
C20ORF112 | chromosome 20 open reading frame 112 | Human | DNA Binding | 140688 | Q6P0R2 |
C20ORF196 | chromosome 20 open reading frame 196 | Human | DNA Binding | 149840 | Q8IYI0 |
C20orf199 | ZNFX1 antisense RNA 1 | Human | DNA Binding | NR_003604 | |
C20orf24 | chromosome 20 open reading frame 24 | Human | DNA Binding | 55969 | Q9BUV8 |
C20orf29 | adaptor-related protein complex 5, sigma 1 subunit | Human | DNA Binding | 55317 | Q9NUS5 |
C20orf3 | adipocyte plasma membrane associated protein | Human | DNA Binding | 57136 | Q9HDC9 |
C20orf30 | transmembrane protein 230 | Human | DNA Binding | NM_014145 | Q96A57 |
C20orf4 | AAR2 splicing factor homolog (S. cerevisiae) | Human | DNA Binding | 25980 | Q9Y312 |
C20orf72 | mitochondrial genome maintenance exonuclease 1 | Human | DNA Binding | 92667 | Q9BQP7 |
C20orf94 | SLX4 interacting protein | Human | DNA Binding | 128710 | Q5VYV7 |
C21orf2 | chromosome 21 open reading frame 2 | Human | DNA Binding | NM_004928 | O43822 |
C21orf34 | mir-99a-let-7c cluster host gene (non-protein coding) | Human | DNA Binding | NR_027790 | A1L4M7 |
C21orf45 | MIS18 kinetochore protein A | Human | DNA Binding | NM_018944 | Q9NYP9 |
C21ORF49 | Putative uncharacterized protein C21orf62-AS1 | Human | DNA Binding | 54067 | Q17RA5 |
C21orf57 | ybeY metallopeptidase (putative) | Human | DNA Binding | NM_001006114 | Q8TBC8 |
C21orf91 | chromosome 21 open reading frame 91 | Human | DNA Binding | 54149 | Q68DA1 |
C22ORF24 | Uncharacterized protein C22orf24 | Human | DNA Binding | 25775 | Q9Y442 |
C22orf28 | chromosome 22 open reading frame 28 | Human | DNA Binding | 51493 | Q9Y3I0 |
C22ORF29 | chromosome 22 open reading frame 29 | Human | DNA Binding | 79680 | Q7L3V2 |
C22orf32 | single-pass membrane protein with aspartate-rich tail 1 | Human | DNA Binding | NM_033318 | Q9H4I9 |
C2orf28 | all-trans retinoic acid-induced differentiation factor | Human | DNA Binding | 51374 | Q6UW56 |
C2orf29 | CCR4-NOT transcription complex, subunit 11 | Human | DNA Binding | 55571 | Q9UKZ1 |
C2orf3 | GC-rich sequence DNA-binding factor 2 | Human | DNA Binding | 6936 | A4UHR0 |
C2orf34 | calmodulin-lysine N-methyltransferase | Human | DNA Binding | NM_024766 | Q7Z624 |
C2orf42 | chromosome 2 open reading frame 42 | Human | DNA Binding | NM_017880 | Q9NWW7 |
C2orf43 | chromosome 2 open reading frame 43 | Human | DNA Binding | 60526 | Q9H6V9 |
C2ORF47 | chromosome 2 open reading frame 47 | Human | DNA Binding | 79568 | Q8WWC4 |
C2orf52 | long intergenic non-protein coding RNA 471 | Human | DNA Binding | NR_024079 | |
C2orf64 | cytochrome c oxidase assembly factor 5 | Human | DNA Binding | NM_001008215 | Q86WW8 |
C2orf69 | chromosome 2 open reading frame 69 | Human | DNA Binding | 205327 | Q8N8R5 |
C2orf79 | peptidyl-tRNA hydrolase domain containing 1 | Human | DNA Binding | NM_001013663 | Q6GMV3 |
C2orf86 | WD repeat containing planar cell polarity effector | Human | DNA Binding | NM_015910 | O95876 |
C3orf1 | translocase of inner mitochondrial membrane domain containing 1 | Human | DNA Binding | NM_016589 | Q9NPL8 |
C3orf19 | coiled-coil domain containing 174 | Human | DNA Binding | 51244 | Q6PII3 |
C4orf21 | chromosome 4 open reading frame 21 | Human | DNA Binding | 55345 | B4DSN6 |
C4orf34 | small integral membrane protein 14 | Human | DNA Binding | 201895 | Q96QK8 |
C4orf41 | trafficking protein particle complex 11 | Human | DNA Binding | 60684 | Q7Z392 |
C4orf43 | translation machinery associated 16 homolog (S. cerevisiae) | Human | DNA Binding | 55319 | Q96EY4 |
C4orf46 | chromosome 4 open reading frame 46 | Human | DNA Binding | NM_001008393 | Q504U0 |
C4ORF48 | Neuropeptide-like protein C4orf48 | Human | DNA Binding | 401115 | Q5BLP8 |
C5orf15 | chromosome 5 open reading frame 15 | Human | DNA Binding | 56951 | Q8NC54 |
C5orf24 | chromosome 5 open reading frame 24 | Human | DNA Binding | 134553 | Q7Z6I8 |
C5ORF28 | chromosome 5 open reading frame 28 | Human | DNA Binding | 64417 | Q0VDI3 |
C5orf34 | chromosome 5 open reading frame 34 | Human | DNA Binding | 375444 | Q96MH7 |
C5orf35 | SET domain containing 9 | Human | DNA Binding | NM_153706 | Q8NE22 |
C5orf36 | KIAA0825 | Human | DNA Binding | NM_173665 | Q8IV33 |
C5orf37 | POC5 centriolar protein | Human | DNA Binding | NM_001099271 | Q8NA72 |
C5orf39 | annexin A2 receptor | Human | DNA Binding | NM_001014279 | Q3ZCQ2 |
C5orf41 | CREB3 regulatory factor | Human | DNA Binding | 153222 | Q8IUR6 |
C5orf44 | trafficking protein particle complex 13 | Human | DNA Binding | NR_003545 | A5PLN9 |
C5orf51 | chromosome 5 open reading frame 51 | Human | DNA Binding | 285636 | A6NDU8 |
C6orf115 | ABRA C-terminal like | Human | DNA Binding | NM_021243 | Q9P1F3 |
C6orf120 | chromosome 6 open reading frame 120 | Human | DNA Binding | 387263 | Q7Z4R8 |
C6orf129 | coiled-coil domain containing 167 | Human | DNA Binding | NM_138493 | Q9P0B6 |
C6ORF136 | Uncharacterized protein C6orf136 | Human | DNA Binding | 221545 | Q5SQH8 |
C6orf142 | muscular LMNA-interacting protein | Human | DNA Binding | NM_138569 | Q5VWP3 |
C6orf145 | PX domain containing 1 | Human | DNA Binding | 221749 | Q5TGL8 |
C6orf162 | small integral membrane protein 8 | Human | DNA Binding | 57150 | Q96KF7 |
C6ORF211 | chromosome 6 open reading frame 211 | Human | DNA Binding | 79624 | Q9H993 |
C6orf217 | long intergenic non-protein coding RNA 271 | Human | DNA Binding | NR_026805 | P0C7V0 |
C6orf57 | chromosome 6 open reading frame 57 | Human | DNA Binding | NM_145267 | Q5VUM1 |
C6orf62 | chromosome 6 open reading frame 62 | Human | DNA Binding | 81688 | Q9GZU0 |
C7ORF10 | chromosome 7 open reading frame 10 | Human | DNA Binding | 79783 | Q9HAC7 |
C7ORF25 | chromosome 7 open reading frame 25 | Human | DNA Binding | 79020 | J3KR36 |
C7ORF26 | chromosome 7 open reading frame 26 | Human | DNA Binding | 79034 | Q96N11 |
C7orf30 | mitochondrial assembly of ribosomal large subunit 1 | Human | DNA Binding | 115416 | Q96EH3 |
C7orf36 | Yae1 domain containing 1 | Human | DNA Binding | 57002 | B2RC46 |
C7orf38 | family with sequence similarity 200, member A | Human | DNA Binding | NM_145111 | Q8TCP9 |
C7orf55 | chromosome 7 open reading frame 55 | Human | DNA Binding | NM_197964 | Q96HJ9 |
C7ORF55-LUC7L2 | UPF0562 protein C7orf55 | Human | DNA Binding | 100996928 | Q96HJ9 |
C7orf60 | chromosome 7 open reading frame 60 | Human | DNA Binding | 154743 | Q1RMZ1 |
C8G | Complement component C8 gamma chain | Human | DNA Binding | 733 | P07360 |
C8orf37 | chromosome 8 open reading frame 37 | Human | DNA Binding | NM_177965 | F4Y588 |
C8orf39 | RBM12B antisense RNA 1 | Human | DNA Binding | NR_027259 | Q9P1G2 |
C8orf40 | small integral membrane protein 19 | Human | DNA Binding | 114926 | Q96E16 |
C8orf41 | TELO2 interacting protein 2 | Human | DNA Binding | 80185 | Q6NXR4 |
C8orf59 | chromosome 8 open reading frame 59 | Human | DNA Binding | NM_001099670 | A0A024R838 |
C9orf130 | long intergenic non-protein coding RNA 476 | Human | DNA Binding | NR_023389 | Q8WZB0 |
C9orf156 | chromosome 9 open reading frame 156 | Human | DNA Binding | 51531 | Q9BU70 |
C9ORF169 | Cysteine-rich tail protein 1 | Human | DNA Binding | 375791 | A8MQ03 |
C9orf30 | chromosome 9 open reading frame 30 | Human | DNA Binding | 91283 | Q96H12 |
C9orf40 | chromosome 9 open reading frame 40 | Human | DNA Binding | 55071 | Q8IXQ3 |
C9orf41 | chromosome 9 open reading frame 41 | Human | DNA Binding | 138199 | Q8N4J0 |
C9ORF43 | Uncharacterized protein C9orf43 | Human | DNA Binding | 257169 | Q8TAL5 |
C9orf5 | transmembrane protein 245 | Human | DNA Binding | 23731 | Q9H330 |
C9ORF69 | Protein C9orf69 | Human | DNA Binding | 90120 | H0YL14 |
C9orf78 | chromosome 9 open reading frame 78 | Human | DNA Binding | 51759 | Q9NZ63 |
C9orf82 | caspase activity and apoptosis inhibitor 1 | Human | DNA Binding | 79886 | Q9H8G2 |
C9ORF96 | Serine/threonine kinase-like domain-containing protein STKLD1 | Human | DNA Binding | 169436 | Q8NE28 |
CA11 | carbonic anhydrase XI | Human | DNA Binding | NM_001217 | O75493 |
CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit | Human | Direct Regulation | 8913 | O43497 |
CACTIN | Cactin | Human | DNA Binding | 58509 | Q8WUQ7 |
CACYBP | calcyclin binding protein | Human | DNA Binding | 27101 | B3KSF1 |
CAMK2N1 | Human | DNA Binding | |||
CAMSAP1 | calmodulin regulated spectrin-associated protein 1 | Human | DNA Binding | 157922 | Q5T5Y3 |
CAMSAP1L1 | calmodulin regulated spectrin-associated protein family, member 2 | Human | DNA Binding | 23271 | B3KTI4 |
CAND1 | cullin-associated and neddylation-dissociated 1 | Human | DNA Binding | 55832 | Q86VP6 |
CAPRIN1 | cell cycle associated protein 1 | Human | DNA Binding | 4076 | Q14444 |
CAPRIN2 | caprin family member 2 | Human | DNA Binding | 65981 | Q6IMN6 |
CAPZA1 | capping protein (actin filament) muscle Z-line, alpha 1 | Human | DNA Binding | 829 | P52907 |
CAPZA2 | capping protein (actin filament) muscle Z-line, alpha 2 | Human | DNA Binding | 830 | P47755 |
CAPZB | capping protein (actin filament) muscle Z-line, beta | Human | DNA Binding | 832 | P47756 |
CARD8 | caspase recruitment domain family, member 8 | Human | DNA Binding | 22900 | B5KVR6 |
CARM1 | coactivator-associated arginine methyltransferase 1 | Human | DNA Binding | 10498 | Q86X55 |
CARS2 | cysteinyl-tRNA synthetase 2, mitochondrial (putative) | Human | DNA Binding | 79587 | B7Z7E6 |
CASC5 | cancer susceptibility candidate 5 | Human | DNA Binding | 57082 | Q8NG31 |
CASKIN2 | CASK interacting protein 2 | Human | DNA Binding | 57513 | Q8WXE0 |
CASP2 | caspase 2, apoptosis-related cysteine peptidase | Human | DNA Binding | 835 | D3DXD9 |
CASP3 | caspase 3, apoptosis-related cysteine peptidase | Human | DNA Binding | 836 | P42574 |
CASP8AP2 | caspase 8 associated protein 2 | Human | DNA Binding | NM_012115 | Q9UKL3 |
CBLL1 | Cbl proto-oncogene, E3 ubiquitin protein ligase-like 1 | Human | DNA Binding | 79872 | B4DDV7 |
CBWD2 | COBW domain containing 2 | Human | DNA Binding | 150472 | Q8IUF1 |
CBX3P2 | chromobox homolog 3 pseudogene 2 | Human | DNA Binding | 645158 | NA |
CBX4 | chromobox homolog 4 | Human | DNA Binding | 8535 | O00257 |
CBX8 | chromobox homolog 8 | Human | DNA Binding | 57332 | Q9HC52 |
CCAR1 | cell division cycle and apoptosis regulator 1 | Human | DNA Binding | 55749 | Q8IX12 |
CCBL1 | cysteine conjugate-beta lyase, cytoplasmic | Human | DNA Binding | 883 | A8K563 |
CCDC102B | coiled-coil domain containing 102B | Human | DNA Binding | NM_001093729 | A1A4H1 |
CCDC109A | mitochondrial calcium uniporter | Human | DNA Binding | NM_138357 | Q8NE86 |
CCDC111 | DNA-directed primase/polymerase protein | Human | DNA Binding | 201973 | Q96LW4 |
CCDC115 | Coiled-coil domain-containing protein 115 | Human | DNA Binding | 84317 | Q96NT0 |
CCDC136 | coiled-coil domain containing 136 | Human | DNA Binding | 64753 | Q96JN2 |
CCDC137 | coiled-coil domain containing 137 | Human | DNA Binding | 339230 | Q6PK04 |
CCDC142 | coiled-coil domain containing 142 | Human | DNA Binding | 84865 | Q17RM4 |
CCDC18 | coiled-coil domain containing 18 | Human | DNA Binding | 343099 | E9PFB9 |
CCDC45 | centrosomal protein 95kDa | Human | DNA Binding | NM_138363 | Q96GE4 |
CCDC47 | coiled-coil domain containing 47 | Human | DNA Binding | 57003 | Q96A33 |
CCDC49 | CWC25 spliceosome-associated protein homolog (S. cerevisiae) | Human | DNA Binding | NM_017748 | Q9NXE8 |
CCDC50 | coiled-coil domain containing 50 | Human | DNA Binding | 152137 | Q8IVM0 |
CCDC55 | nuclear speckle splicing regulatory protein 1 | Human | DNA Binding | NM_032141 | A0A024QZ33 |
CCDC56 | coiled-coil domain containing 56 | Human | DNA Binding | 28958 | Q9Y2R0 |
CCDC57 | coiled-coil domain containing 57 | Human | DNA Binding | 284001 | Q2TAC2 |
CCDC58 | coiled-coil domain containing 58 | Human | DNA Binding | NM_001017928 | Q4VC31 |
CCDC66 | coiled-coil domain containing 66 | Human | DNA Binding | 285331 | A2RUB6 |
CCDC71L | Coiled-coil domain-containing protein 71L | Human | DNA Binding | 168455 | Q8N9Z2 |
CCDC76 | tRNA methyltransferase 13 homolog (S. cerevisiae) | Human | DNA Binding | NM_019083 | Q9NUP7 |
CCDC77 | Coiled-coil domain-containing protein 77 | Human | DNA Binding | 84318 | Q9BR77 |
CCDC83 | coiled-coil domain containing 83 | Human | DNA Binding | NM_173556 | Q8IWF9 |
CCDC84 | coiled-coil domain containing 84 | Human | DNA Binding | NM_198489 | Q86UT8 |
CCDC85C | coiled-coil domain containing 85C | Human | DNA Binding | 317762 | A6NKD9 |
CCDC88A | coiled-coil domain containing 88A | Human | DNA Binding | 55704 | Q3V6T2 |
CCDC90B | coiled-coil domain containing 90B | Human | DNA Binding | 60492 | Q9GZT6 |
CCDC92 | Coiled-coil domain-containing protein 92 | Human | DNA Binding | 80212 | Q53HC0 |
CCDC97 | coiled-coil domain containing 97 | Human | DNA Binding | 90324 | Q96F63 |
CCM2 | cerebral cavernous malformation 2 | Human | DNA Binding | 83605 | Q9BSQ5 |
CCNE2 | cyclin E2 | Human | DNA Binding | 9134 | O96020 |
CCNG2 | cyclin G2 | Human | DNA Binding | 901 | Q16589 |
CCNI | cyclin I | Human | DNA Binding | 10983 | Q14094 |
CCNL1 | cyclin L1 | Human | DNA Binding | 57018 | Q9UK58 |
CCPG1 | HUWE1 | Human | DNA Binding | 9236 | Q9ULG6 |
CCSAP | Centriole, cilia and spindle-associated protein | Human | DNA Binding | 126731 | Q6IQ19 |
CD164 | CD164 molecule, sialomucin | Human | DNA Binding | 8763 | Q04900 |
CD276 | CD276 molecule | Human | DNA Binding | 80381 | Q5ZPR3 |
CD3EAP | CD3e molecule, epsilon associated protein | Human | DNA Binding | 10849 | O15446 |
CD47 | CD47 molecule | Human | DNA Binding | 961 | Q08722 |
CDC123 | cell division cycle 123 homolog (S. cerevisiae) | Human | DNA Binding | 8872 | O75794 |
CDC14A | cell division cycle 14A | Human | DNA Binding | NM_033313 | Q59EF4 |
CDC20 | cell division cycle 20 | Human | DNA Binding | 991 | Q12834 |
CDC2L5 | cyclin-dependent kinase 13 | Human | DNA Binding | NM_003718 | A0A024RA85 |
CDC42BPB | CDC42 binding protein kinase beta (DMPK-like) | Human | DNA Binding | 9578 | Q86XZ8 |
CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 | Human | DNA Binding | 10602 | Q9UKI2 |
CDC42SE1 | CDC42 small effector 1 | Human | DNA Binding | 56882 | Q9NRR8 |
CDC45L | cell division cycle 45 | Human | DNA Binding | NM_003504 | O75419 |
CDC6 | cell division cycle 6 homolog (S. cerevisiae) | Human | DNA Binding | 990 | Q99741 |
CDC7 | cell division cycle 7 | Human | DNA Binding | 8317 | O00311 |
CDC73 | cell division cycle 73 | Human | DNA Binding | 79577 | Q6P1J9 |
CDK13 | cyclin-dependent kinase 13 | Human | DNA Binding | 8621 | Q14004 |
CDK19 | cyclin-dependent kinase 19 | Human | DNA Binding | 23097 | Q9BWU1 |
CDK2AP1 | cyclin-dependent kinase 2 associated protein 1 | Human | DNA Binding | 8099 | F5GYA4 |
CDK5RAP2 | CDK5 regulatory subunit associated protein 2 | Human | DNA Binding | 55755 | B3KVI2 |
CDK7 | cyclin-dependent kinase 7 | Human | DNA Binding | 1022 | P50613 |
CDKAL1 | CDK5 regulatory subunit associated protein 1-like 1 | Human | DNA Binding | 54901 | Q5VV42 |
CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | Human | Direct Regulation | 1029 | P42771 |
CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | Human | DNA Binding | 1030 | P42772 |
CDKN2BAS | CDKN2B antisense RNA 1 | Human | DNA Binding | NR_003529 | |
CDS2 | CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 | Human | DNA Binding | 8760 | O95674 |
CDV3 | CDV3 homolog (mouse) | Human | DNA Binding | 55573 | Q9UKY7 |
CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | Human | DNA Binding | NM_005195 | P49716 |
CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon | Human | DNA Binding | NM_001805 | Q15744 |
CEBPG | CCAAT/enhancer binding protein (C/EBP), gamma | Human | DNA Binding | 1054 | P53567 |
CECR2 | cat eye syndrome chromosome region, candidate 2 | Human | DNA Binding | 27443 | Q9BXF3 |
CECR6 | Cat eye syndrome critical region protein 6 | Human | DNA Binding | 27439 | Q9BXQ6 |
CELSR3 | cadherin, EGF LAG seven-pass G-type receptor 3 (flamingo homolog, Drosophila) | Human | DNA Binding | 1951 | Q9NYQ7 |
CENPA | centromere protein A | Human | DNA Binding | 1058 | P49450 |
CENPF | centromere protein F, 350/400kDa (mitosin) | Human | DNA Binding | 1063 | P49454 |
CENPH | centromere protein H | Human | DNA Binding | 64946 | Q9H3R5 |
CENPL | centromere protein L | Human | DNA Binding | 91687 | Q8N0S6 |
CENPQ | centromere protein Q | Human | DNA Binding | 55166 | Q7L2Z9 |
CEP104 | centrosomal protein 104kDa | Human | DNA Binding | 9731 | O60308 |
CEP164 | centrosomal protein 164kDa | Human | DNA Binding | 22897 | Q9UPV0 |
CEP170 | centrosomal protein 170kDa | Human | DNA Binding | 9859 | Q5SW79 |
CEP250 | centrosomal protein 250kDa | Human | DNA Binding | 11190 | Q9BV73 |
CEP350 | centrosomal protein 350kDa | Human | DNA Binding | 9857 | Q5VT06 |
CEP68 | centrosomal protein 68kDa | Human | DNA Binding | 23177 | Q76N32 |
CEP95 | Centrosomal protein of 95 kDa | Human | DNA Binding | 90799 | Q96GE4 |
CEP97 | centrosomal protein 97kDa | Human | DNA Binding | 79598 | Q8IW35 |
CERS2 | ceramide synthase 2 | Human | DNA Binding | 29956 | Q96G23 |
CFL1 | cofilin 1 (non-muscle) | Human | DNA Binding | 1072 | P23528 |
CFLAR | CASP8 and FADD-like apoptosis regulator | Human | DNA Binding | 8837 | O15519 |
CGRRF1 | cell growth regulator with ring finger domain 1 | Human | DNA Binding | NM_006568 | Q99675 |
CHAMP1 | Chromosome alignment-maintaining phosphoprotein 1 | Human | DNA Binding | 283489 | Q96JM3 |
CHCHD1 | coiled-coil-helix-coiled-coil-helix domain containing 1 | Human | DNA Binding | 118487 | Q96BP2 |
CHCHD2 | KIT | Human | DNA Binding | 51142 | Q9Y6H1 |
CHCHD3 | coiled-coil-helix-coiled-coil-helix domain containing 3 | Human | DNA Binding | 54927 | A4D1N4 |
CHCHD7 | coiled-coil-helix-coiled-coil-helix domain containing 7 | Human | DNA Binding | 79145 | Q9BUK0 |
CHD1 | chromodomain helicase DNA binding protein 1 | Human | DNA Binding | 1105 | B3KT33 |
CHD9 | chromodomain helicase DNA binding protein 9 | Human | DNA Binding | 80205 | Q3L8U1 |
CHERP | calcium homeostasis endoplasmic reticulum protein | Human | DNA Binding | 10523 | Q8IWX8 |
CHFR | checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase | Human | DNA Binding | 55743 | Q96EP1 |
CHIC2 | cysteine-rich hydrophobic domain 2 | Human | DNA Binding | 26511 | Q9UKJ5 |
CHM | choroideremia (Rab escort protein 1) | Human | DNA Binding | 1121 | P24386 |
CHMP6 | charged multivesicular body protein 6 | Human | DNA Binding | 79643 | Q96FZ7 |
CHP | calcineurin-like EF-hand protein 1 | Human | DNA Binding | 11261 | Q99653 |
CHRAC1 | chromatin accessibility complex 1 | Human | DNA Binding | 54108 | Q9NRG0 |
CHRNA5 | cholinergic receptor, nicotinic, alpha 5 (neuronal) | Human | DNA Binding | 1138 | P30532 |
CHRNB3 | cholinergic receptor, nicotinic, beta 3 (neuronal) | Human | DNA Binding | NM_000749 | Q05901 |
CHUK | conserved helix-loop-helix ubiquitous kinase | Human | DNA Binding | 1147 | O15111 |
CIC | capicua transcriptional repressor | Human | DNA Binding | 23152 | Q96RK0 |
CIRBP-AS1 | CIRBP antisense RNA 1 | Human | DNA Binding | 148046 | Q8TBR5 |
CISD1 | CDGSH iron sulfur domain 1 | Human | DNA Binding | 55847 | Q9NZ45 |
CISD2 | CDGSH iron sulfur domain 2 | Human | DNA Binding | NM_001008388 | Q8N5K1 |
CITED1 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 | Human | DNA Binding | NM_001144886 | Q99966 |
CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | Human | DNA Binding | 10370 | D9ZGF1 |
CIZ1 | CDKN1A interacting zinc finger protein 1 | Human | DNA Binding | 25792 | Q9BTG3 |
CKAP2L | cytoskeleton associated protein 2-like | Human | DNA Binding | 150468 | Q8IYA6 |
CKAP5 | cytoskeleton associated protein 5 | Human | DNA Binding | 9793 | Q14008 |
CKLF | chemokine-like factor | Human | DNA Binding | 51192 | Q9UBR5 |
CKLF-CMTM1 | Protein CKLF-CMTM1 | Human | DNA Binding | 100529251 | A0A087WVB3 |
CKS2 | CDC28 protein kinase regulatory subunit 2 | Human | DNA Binding | 1164 | P33552 |
CLASP1 | cytoplasmic linker associated protein 1 | Human | DNA Binding | 23332 | A2RU21 |
CLCC1 | chloride channel CLIC-like 1 | Human | DNA Binding | 23155 | Q96S66 |
CLCN3 | chloride channel, voltage-sensitive 3 | Human | DNA Binding | 1182 | B7Z932 |
CLIC1 | chloride intracellular channel 1 | Human | DNA Binding | 1192 | O00299 |
CLIC4 | chloride intracellular channel 4 | Human | DNA Binding | 25932 | Q6FIC5 |
CLIP4 | CAP-Gly domain-containing linker protein 4 | Human | DNA Binding | 79745 | Q8N3C7 |
CLK1 | CDC-like kinase 1 | Human | DNA Binding | 1195 | P49759 |
CLK2 | CDC-like kinase 2 | Human | DNA Binding | 1196 | P49760 |
CLK3 | CDC-like kinase 3 | Human | DNA Binding | 1198 | B3KRI8 |
CLK4 | CDC-like kinase 4 | Human | DNA Binding | 57396 | Q9HAZ1 |
CLOCK | clock circadian regulator | Human | DNA Binding | 9575 | O15516 |
CLPTM1 | cleft lip and palate associated transmembrane protein 1 | Human | DNA Binding | 1209 | B3KQH2 |
CLPX | ClpX caseinolytic peptidase X homolog (E. coli) | Human | DNA Binding | 10845 | O76031 |
CLTA | clathrin, light chain A | Human | DNA Binding | 1211 | P09496 |
CLUAP1 | Clusterin-associated protein 1 | Human | DNA Binding | 23059 | Q96AJ1 |
CLUH | Clustered mitochondria protein homolog | Human | DNA Binding | 23277 | O75153 |
CMIP | c-Maf inducing protein | Human | DNA Binding | 80790 | Q8IY22 |
CMPK1 | cytidine monophosphate (UMP-CMP) kinase 1, cytosolic | Human | DNA Binding | 51727 | E9PGI8 |
CMTM8 | CKLF-like MARVEL transmembrane domain containing 8 | Human | DNA Binding | NM_178868 | Q8IZV2 |
CNBP | CCHC-type zinc finger, nucleic acid binding protein | Human | DNA Binding | 7555 | A8K7V4 |
CNEP1R1 | Nuclear envelope phosphatase-regulatory subunit 1 | Human | DNA Binding | 255919 | Q8N9A8 |
CNIH | cornichon homolog (Drosophila) | Human | DNA Binding | 10175 | O95406 |
CNN3 | calponin 3, acidic | Human | DNA Binding | 1266 | Q15417 |
CNNM2 | cyclin M2 | Human | DNA Binding | 54805 | Q9H8M5 |
CNO | biogenesis of lysosomal organelles complex-1, subunit 4, cappuccino | Human | DNA Binding | 55330 | Q9NUP1 |
CNOT1 | CCR4-NOT transcription complex, subunit 1 | Human | DNA Binding | 23019 | A5YKK6 |
CNOT11 | CCR4-NOT transcription complex subunit 11 | Human | DNA Binding | 55571 | Q9UKZ1 |
CNOT2 | CCR4-NOT transcription complex, subunit 2 | Human | DNA Binding | 4848 | B2RDX7 |
CNOT3 | CCR4-NOT transcription complex, subunit 3 | Human | DNA Binding | 4849 | O75175 |
CNOT4 | CCR4-NOT transcription complex, subunit 4 | Human | DNA Binding | 4850 | O95628 |
CNOT6 | CCR4-NOT transcription complex, subunit 6 | Human | DNA Binding | 57472 | Q9ULM6 |
CNOT6L | CCR4-NOT transcription complex, subunit 6-like | Human | DNA Binding | 246175 | Q96LI5 |
CNOT8 | CCR4-NOT transcription complex, subunit 8 | Human | DNA Binding | 9337 | Q9UFF9 |
CNPPD1 | cyclin Pas1/PHO80 domain containing 1 | Human | DNA Binding | 27013 | Q9BV87 |
CNPY3 | canopy FGF signaling regulator 3 | Human | DNA Binding | NM_006586 | Q9BT09 |
CNPY4 | canopy FGF signaling regulator 4 | Human | DNA Binding | NM_152755 | Q8N129 |
COA5 | Cytochrome c oxidase assembly factor 5 | Human | DNA Binding | 493753 | Q86WW8 |
COG2 | component of oligomeric golgi complex 2 | Human | DNA Binding | 22796 | Q14746 |
COIL | coilin | Human | DNA Binding | 8161 | P38432 |
COL4A3BP | collagen, type IV, alpha 3 (Goodpasture antigen) binding protein | Human | DNA Binding | 10087 | Q9Y5P4 |
COL4A6 | collagen, type IV, alpha 6 | Human | DNA Binding | 1288 | Q14031 |
COL5A2 | MKL2 | Human | DNA Binding | 1290 | P05997 |
COMMD2 | COMM domain containing 2 | Human | DNA Binding | 51122 | Q86X83 |
COMMD3 | COMM domain containing 3 | Human | DNA Binding | NM_012071 | Q9UBI1 |
COPA | coatomer protein complex, subunit alpha | Human | DNA Binding | 1314 | P53621 |
COPB1 | coatomer protein complex, subunit beta 1 | Human | DNA Binding | 1315 | P53618 |
COPS4 | COP9 constitutive photomorphogenic homolog subunit 4 (Arabidopsis) | Human | DNA Binding | 51138 | B3KST5 |
COPS5 | COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis) | Human | DNA Binding | 10987 | Q92905 |
COPS7A | COP9 constitutive photomorphogenic homolog subunit 7A (Arabidopsis) | Human | DNA Binding | 50813 | Q9UBW8 |
COPS7B | COP9 signalosome subunit 7B | Human | DNA Binding | 64708 | Q9H9Q2 |
COPS8 | COP9 constitutive photomorphogenic homolog subunit 8 (Arabidopsis) | Human | DNA Binding | 10920 | Q53QS9 |
COPZ1 | coatomer protein complex, subunit zeta 1 | Human | DNA Binding | 22818 | P61923 |
COQ2 | coenzyme Q2 homolog, prenyltransferase (yeast) | Human | DNA Binding | 27235 | Q96H96 |
COQ3 | coenzyme Q3 methyltransferase | Human | DNA Binding | NM_017421 | Q9NZJ6 |
COQ4 | Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial | Human | DNA Binding | 51117 | Q9Y3A0 |
COQ5 | coenzyme Q5 homolog, methyltransferase (S. cerevisiae) | Human | DNA Binding | 84274 | Q5HYK3 |
CORO2B | Coronin-2B | Human | DNA Binding | 10391 | Q9UQ03 |
COX11 | cytochrome c oxidase assembly homolog 11 (yeast) | Human | DNA Binding | 1353 | B4DEY8 |
COX15 | cytochrome c oxidase assembly homolog 15 (yeast) | Human | DNA Binding | 1355 | Q7KZN9 |
COX18 | cytochrome c oxidase assembly homolog 18 (yeast) | Human | DNA Binding | 285521 | Q8N8Q8 |
COX20 | Cytochrome c oxidase protein 20 homolog | Human | DNA Binding | 116228 | Q5RI15 |
COX4I1 | cytochrome c oxidase subunit IV isoform 1 | Human | DNA Binding | 1327 | P13073 |
COX5A | cytochrome c oxidase subunit Va | Human | DNA Binding | 9377 | P20674 |
COX5B | cytochrome c oxidase subunit Vb | Human | DNA Binding | 1329 | P10606 |
COX6A1 | cytochrome c oxidase subunit VIa polypeptide 1 | Human | DNA Binding | 1337 | H6SG15 |
COX6C | cytochrome c oxidase subunit VIc | Human | DNA Binding | NM_004374 | A0A024R9B7 |
COX7A2 | cytochrome c oxidase subunit VIIa polypeptide 2 (liver) | Human | DNA Binding | NM_001865 | H0UI06 |
COX7C | cytochrome c oxidase subunit VIIc | Human | DNA Binding | 1350 | P15954 |
CP110 | centriolar coiled coil protein 110kDa | Human | DNA Binding | 9738 | B4DTZ1 |
CPEB3 | cytoplasmic polyadenylation element binding protein 3 | Human | DNA Binding | 22849 | Q5QP71 |
CPEB4 | cytoplasmic polyadenylation element binding protein 4 | Human | DNA Binding | 80315 | Q17RY0 |
CPNE1 | copine I | Human | DNA Binding | 8904 | B0QZ18 |
CPPED1 | calcineurin-like phosphoesterase domain containing 1 | Human | DNA Binding | 55313 | Q9BRF8 |
CPS1 | carbamoyl-phosphate synthase 1, mitochondrial | Human | DNA Binding | 1373 | J3KQL0 |
CPSF2 | cleavage and polyadenylation specific factor 2, 100kDa | Human | DNA Binding | 53981 | Q9P2I0 |
CPSF3 | cleavage and polyadenylation specific factor 3, 73kDa | Human | DNA Binding | 51692 | Q9UKF6 |
CPSF6 | cleavage and polyadenylation specific factor 6, 68kDa | Human | DNA Binding | 11052 | Q16630 |
CPT1A | carnitine palmitoyltransferase 1A (liver) | Human | DNA Binding | 1374 | P50416 |
CPT1C | carnitine palmitoyltransferase 1C | Human | DNA Binding | NM_152359 | A0A024QZI3 |
CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | Human | DNA Binding | 8738 | P78560 |
CRBN | Protein cereblon | Human | DNA Binding | 51185 | Q96SW2 |
CREB3 | cAMP responsive element binding protein 3 | Human | DNA Binding | NM_006368 | O43889 |
CREBL2 | cAMP responsive element binding protein-like 2 | Human | DNA Binding | 1389 | O60519 |
CREBRF | CREB3 regulatory factor | Human | DNA Binding | 153222 | Q8IUR6 |
CRELD1 | cysteine-rich with EGF-like domains 1 | Human | DNA Binding | 78987 | Q96HD1 |
CREM | cAMP responsive element modulator | Human | DNA Binding | 1390 | Q03060 |
CRIPT | cysteine-rich PDZ-binding protein | Human | DNA Binding | NM_014171 | Q9P021 |
CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | Human | DNA Binding | 1399 | P46109 |
CRLS1 | cardiolipin synthase 1 | Human | DNA Binding | 54675 | Q9UJA2 |
CROCC | ciliary rootlet coiled-coil, rootletin | Human | DNA Binding | 9696 | Q5TZA2 |
CROCCL2 | ciliary rootlet coiled-coil, rootletin pseudogene 3 | Human | DNA Binding | NR_023386 | |
CROT | Human | DNA Binding | NR_026585 | ||
CRY1 | cryptochrome 1 (photolyase-like) | Human | DNA Binding | 1407 | A2I2P0 |
CRYL1 | crystallin, lambda 1 | Human | DNA Binding | NM_015974 | Q9Y2S2 |
CRYZ | crystallin, zeta (quinone reductase) | Human | DNA Binding | NM_001134759 | Q08257 |
CRYZL1 | crystallin, zeta (quinone reductase)-like 1 | Human | DNA Binding | 9946 | O95825 |
CS | citrate synthase | Human | DNA Binding | 1431 | O75390 |
CSNK1G1 | casein kinase 1, gamma 1 | Human | DNA Binding | 53944 | Q9HCP0 |
CSPP1 | centrosome and spindle pole associated protein 1 | Human | DNA Binding | NM_024790 | Q1MSJ5 |
CSTF1 | cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kDa | Human | DNA Binding | 1477 | Q05048 |
CTAGE5 | CTAGE family, member 5 | Human | DNA Binding | 4253 | O15320 |
CTBP1-AS1 | CTBP1 antisense RNA 1 | Human | DNA Binding | 92070 | Q0VAR9 |
CTBP2 | C-terminal binding protein 2 | Human | DNA Binding | 1488 | P56545 |
CTDSP2 | CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 | Human | DNA Binding | 10106 | O14595 |
CTTNBP2 | cortactin binding protein 2 | Human | DNA Binding | 83992 | Q8WZ74 |
CTTNBP2NL | CTTNBP2 N-terminal like | Human | DNA Binding | 55917 | Q9P2B4 |
CTU1 | cytosolic thiouridylase subunit 1 homolog (S. pombe) | Human | DNA Binding | 90353 | Q7Z7A3 |
CUGBP1 | CUGBP, Elav-like family member 1 | Human | DNA Binding | NM_006560 | Q92879 |
CUL1 | cullin 1 | Human | DNA Binding | 8454 | Q13616 |
CUL4A | cullin 4A | Human | DNA Binding | 8451 | Q13619 |
CUTA | cutA divalent cation tolerance homolog (E. coli) | Human | DNA Binding | 51596 | O60888 |
CUTC | cutC copper transporter homolog (E. coli) | Human | DNA Binding | 51076 | Q9NTM9 |
CUX1 | cut like homeobox 1 | Human | DNA Binding | 1523 | Q13948 |
CWC27 | CWC27 spliceosome-associated protein homolog (S. cerevisiae) | Human | DNA Binding | 10283 | Q6UX04 |
CWF19L1 | CWF19-like 1, cell cycle control (S. pombe) | Human | DNA Binding | 55280 | Q69YN2 |
CXorf56 | chromosome X open reading frame 56 | Human | DNA Binding | NM_022101 | Q9H5V9 |
CYB5A | cytochrome b5 type A (microsomal) | Human | DNA Binding | 1528 | P00167 |
CYB5B | cytochrome b5 type B (outer mitochondrial membrane) | Human | DNA Binding | 80777 | J3KNF8 |
CYB5D1 | cytochrome b5 domain containing 1 | Human | DNA Binding | 124637 | Q6P9G0 |
CYB5D2 | cytochrome b5 domain containing 2 | Human | DNA Binding | 124936 | Q8WUJ1 |
CYP39A1 | cytochrome P450, family 39, subfamily A, polypeptide 1 | Human | DNA Binding | NM_016593 | B7Z786 |
CYP51A1 | cytochrome P450, family 51, subfamily A, polypeptide 1 | Human | DNA Binding | 1595 | Q16850 |
CYR61 | NXPH1 | Human | DNA Binding | 3491 | O00622 |
CYTSA | sperm antigen with calponin homology and coiled-coil domains 1-like | Human | DNA Binding | NM_001145468 | B2RMV2 |
DACH1 | dachshund homolog 1 (Drosophila) | Human | DNA Binding | 1602 | D0FY36 |
DALRD3 | DALR anticodon binding domain containing 3 | Human | DNA Binding | 55152 | Q5D0E6 |
DAPK1 | death-associated protein kinase 1 | Human | Direct Regulation | 1612 | P53355 |
DARS2 | aspartyl-tRNA synthetase 2, mitochondrial | Human | DNA Binding | 55157 | Q6PI48 |
DAZAP2 | DAZ associated protein 2 | Human | DNA Binding | 9802 | E9PB45 |
DBF4 | DBF4 homolog (S. cerevisiae) | Human | DNA Binding | 10926 | Q9UBU7 |
DBN1 | drebrin 1 | Human | DNA Binding | 1627 | Q16643 |
DBT | dihydrolipoamide branched chain transacylase E2 | Human | DNA Binding | 1629 | P11182 |
DCAF10 | DDB1 and CUL4 associated factor 10 | Human | DNA Binding | 79269 | Q5QP82 |
DCAF11 | DDB1 and CUL4 associated factor 11 | Human | DNA Binding | 80344 | B3KSW2 |
DCAF17 | DDB1- and CUL4-associated factor 17 | Human | DNA Binding | 80067 | Q5H9S7 |
DCAF5 | DDB1 and CUL4 associated factor 5 | Human | DNA Binding | 8816 | Q96JK2 |
DCAF6 | DDB1 and CUL4 associated factor 6 | Human | DNA Binding | NM_018442 | Q58WW2 |
DCAF8 | DDB1 and CUL4 associated factor 8 | Human | DNA Binding | 50717 | B7Z8C9 |
DCDC2 | doublecortin domain containing 2 | Human | DNA Binding | 51473 | Q9UHG0 |
DCLK2 | Serine/threonine-protein kinase DCLK2 | Human | DNA Binding | 166614 | Q8N568 |
DCLRE1A | DNA cross-link repair 1A | Human | DNA Binding | 9937 | Q6PJP8 |
DCLRE1C | DNA cross-link repair 1C | Human | DNA Binding | 64421 | Q96SD1 |
DCP1A | mRNA-decapping enzyme 1A | Human | DNA Binding | 55802 | Q9NPI6 |
DCP2 | DCP2 decapping enzyme homolog (S. cerevisiae) | Human | DNA Binding | 167227 | Q8IU60 |
DCPS | decapping enzyme, scavenger | Human | DNA Binding | 28960 | Q96C86 |
DCTN4 | dynactin 4 (p62) | Human | DNA Binding | 51164 | Q9UJW0 |
DCUN1D4 | DCN1, defective in cullin neddylation 1, domain containing 4 | Human | DNA Binding | 23142 | Q92564 |
DDAH1 | dimethylarginine dimethylaminohydrolase 1 | Human | DNA Binding | 23576 | B4E3V1 |
DDB2 | damage-specific DNA binding protein 2, 48kDa | Human | DNA Binding | 1643 | Q92466 |
DDHD1 | DDHD domain containing 1 | Human | DNA Binding | 80821 | Q8NEL9 |
DDHD2 | DDHD domain containing 2 | Human | DNA Binding | 23259 | O94830 |
DDI2 | DNA-damage inducible 1 homolog 2 (S. cerevisiae) | Human | DNA Binding | 84301 | Q5TDH0 |
DDOST | dolichyl-diphosphooligosaccharide--protein glycosyltransferase | Human | DNA Binding | 1650 | P39656 |
DDR1 | discoidin domain receptor tyrosine kinase 1 | Human | DNA Binding | 780 | Q08345 |
DDX21 | DEAD (Asp-Glu-Ala-Asp) box helicase 21 | Human | DNA Binding | 9188 | Q9NR30 |
DDX23 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 | Human | DNA Binding | 9416 | Q9BUQ8 |
DDX28 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 28 | Human | DNA Binding | 55794 | Q9NUL7 |
DDX31 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 31 | Human | DNA Binding | 64794 | Q9H8H2 |
DDX39B | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B | Human | DNA Binding | 7919 | Q13838 |
DDX3X | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked | Human | DNA Binding | 1654 | O00571 |
DDX41 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 41 | Human | DNA Binding | 51428 | Q9UJV9 |
DDX46 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 46 | Human | DNA Binding | 9879 | Q7L014 |
DDX49 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 49 | Human | DNA Binding | 54555 | Q9Y6V7 |
DDX5 | DEAD (Asp-Glu-Ala-Asp) box helicase 5 | Human | DNA Binding | 1655 | P17844 |
DDX50 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 50 | Human | DNA Binding | 79009 | Q9BQ39 |
DDX54 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 54 | Human | DNA Binding | 79039 | Q8TDD1 |
DDX59 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 59 | Human | DNA Binding | 83479 | Q5T1V6 |
DEDD | death effector domain containing | Human | DNA Binding | 9191 | O75618 |
DEK | DEK oncogene | Human | DNA Binding | 7913 | P35659 |
DEM1 | exonuclease 5 | Human | DNA Binding | 64789 | Q9H790 |
DENND1B | DENN/MADD domain containing 1B | Human | DNA Binding | 163486 | Q6P3S1 |
DENND4A | DENN/MADD domain containing 4A | Human | DNA Binding | 10260 | Q05C90 |
DENND4C | DENN/MADD domain containing 4C | Human | DNA Binding | 55667 | Q5VZ89 |
DENND5A | DENN/MADD domain containing 5A | Human | DNA Binding | NM_015213 | Q6IQ26 |
DENND5B | DENN/MADD domain containing 5B | Human | DNA Binding | 160518 | Q6ZUT9 |
DENND5B-AS1 | DENND5B antisense RNA 1 | Human | DNA Binding | 100874249 | NA |
DENND6B | Protein DENND6B | Human | DNA Binding | 414918 | Q8NEG7 |
DEPDC1B | DEP domain containing 1B | Human | DNA Binding | 55789 | Q8WUY9 |
DFFA | DNA fragmentation factor, 45kDa, alpha polypeptide | Human | DNA Binding | 1676 | O00273 |
DFFB | DNA fragmentation factor subunit beta | Human | DNA Binding | 1677 | O76075 |
DGKA | diacylglycerol kinase, alpha 80kDa | Human | DNA Binding | NM_001345 | A0A024RB23 |
DHDDS | dehydrodolichyl diphosphate synthase | Human | DNA Binding | 79947 | Q86SQ9 |
DHRS12 | dehydrogenase/reductase (SDR family) member 12 | Human | DNA Binding | NM_024705 | A0PJE2 |
DHRS13 | dehydrogenase/reductase (SDR family) member 13 | Human | DNA Binding | 147015 | Q6UX07 |
DHX15 | DEAH (Asp-Glu-Ala-His) box polypeptide 15 | Human | DNA Binding | 1665 | O43143 |
DHX29 | DEAH (Asp-Glu-Ala-His) box polypeptide 29 | Human | DNA Binding | 54505 | Q7Z478 |
DHX30 | DEAH (Asp-Glu-Ala-His) box polypeptide 30 | Human | DNA Binding | 22907 | Q7L2E3 |
DHX33 | DEAH (Asp-Glu-Ala-His) box polypeptide 33 | Human | DNA Binding | 56919 | B4DIS6 |
DHX34 | DEAH (Asp-Glu-Ala-His) box polypeptide 34 | Human | DNA Binding | 9704 | Q14147 |
DHX35 | DEAH (Asp-Glu-Ala-His) box polypeptide 35 | Human | DNA Binding | 60625 | F5GXM6 |
DHX36 | DEAH (Asp-Glu-Ala-His) box polypeptide 36 | Human | DNA Binding | 170506 | Q9H2U1 |
DHX40 | DEAH (Asp-Glu-Ala-His) box polypeptide 40 | Human | DNA Binding | 79665 | B4DR88 |
DHX57 | DEAH (Asp-Glu-Ala-Asp/His) box polypeptide 57 | Human | DNA Binding | 90957 | Q6P158 |
DIAPH1 | diaphanous homolog 1 (Drosophila) | Human | DNA Binding | 1729 | E9PEZ2 |
DIAPH2 | diaphanous homolog 2 (Drosophila) | Human | DNA Binding | 1730 | O60879 |
DICER1 | dicer 1, ribonuclease type III | Human | DNA Binding | 23405 | Q9UPY3 |
DICER1-AS1 | DICER1 antisense RNA 1 | Human | DNA Binding | 400242 | NA |
DIDO1 | death inducer-obliterator 1 | Human | DNA Binding | 11083 | Q9BTC0 |
DIMT1L | DIM1 dimethyladenosine transferase 1 homolog (S. cerevisiae) | Human | DNA Binding | NM_014473 | Q9UNQ2 |
DIP2C | DIP2 disco-interacting protein 2 homolog C (Drosophila) | Human | DNA Binding | 22982 | Q9Y2E4 |
DIRC2 | disrupted in renal carcinoma 2 | Human | DNA Binding | 84925 | Q96SL1 |
DIS3L | DIS3 mitotic control homolog (S. cerevisiae)-like | Human | DNA Binding | 115752 | Q8TF46 |
DIS3L2 | DIS3 mitotic control homolog (S. cerevisiae)-like 2 | Human | DNA Binding | 129563 | Q8IYB7 |
DKC1 | dyskeratosis congenita 1, dyskerin | Human | Protein Binding | 1736 | O60832 |
DKK1 | dickkopf 1 homolog (Xenopus laevis) | Human | DNA Binding | 22943 | O94907 |
DKKL1 | dickkopf-like 1 | Human | DNA Binding | NM_014419 | Q9UK85 |
DLEU2 | deleted in lymphocytic leukemia 2 (non-protein coding) | Human | DNA Binding | NR_002612 | |
DLG1-AS1 | DLG1 antisense RNA 1 | Human | DNA Binding | 100507086 | NA |
DLG5 | discs, large homolog 5 (Drosophila) | Human | DNA Binding | 9231 | Q8TDM6 |
DLG5-AS1 | DLG5 antisense RNA 1 | Human | DNA Binding | 100128292 | NA |
DLGAP5 | discs, large (Drosophila) homolog-associated protein 5 | Human | DNA Binding | 9787 | Q15398 |
DLST | dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) | Human | DNA Binding | 1743 | B7Z6J1 |
DLX3 | distal-less homeobox 3 | Human | DNA Binding | 1747 | O60479 |
DMBX1 | diencephalon/mesencephalon homeobox 1 | Human | DNA Binding | NM_147192 | Q8NFW5 |
DMTF1 | cyclin D binding myb-like transcription factor 1 | Human | DNA Binding | 9988 | B3KMJ8 |
DMXL1 | Dmx-like 1 | Human | DNA Binding | 1657 | Q9Y485 |
DMXL2 | Dmx-like 2 | Human | DNA Binding | NM_015263 | Q8TDJ6 |
DNAJA1 | DnaJ (Hsp40) homolog, subfamily A, member 1 | Human | DNA Binding | 3301 | P31689 |
DNAJA2 | DnaJ (Hsp40) homolog, subfamily A, member 2 | Human | DNA Binding | 10294 | O60884 |
DNAJB14 | DnaJ (Hsp40) homolog, subfamily B, member 14 | Human | DNA Binding | 79982 | Q8TBM8 |
DNAJB4 | DnaJ (Hsp40) homolog, subfamily B, member 4 | Human | DNA Binding | 11080 | Q9UDY4 |
DNAJB6 | DnaJ (Hsp40) homolog, subfamily B, member 6 | Human | DNA Binding | 10049 | O75190 |
DNAJC10 | DnaJ (Hsp40) homolog, subfamily C, member 10 | Human | DNA Binding | 54431 | Q8IXB1 |
DNAJC11 | DnaJ (Hsp40) homolog, subfamily C, member 11 | Human | DNA Binding | 55735 | Q9NVH1 |
DNAJC16 | DnaJ (Hsp40) homolog, subfamily C, member 16 | Human | DNA Binding | 23341 | Q9Y2G8 |
DNAJC2 | DnaJ (Hsp40) homolog, subfamily C, member 2 | Human | DNA Binding | 27000 | Q99543 |
DNAJC27 | DnaJ (Hsp40) homolog, subfamily C, member 27 | Human | DNA Binding | 51277 | Q9NZQ0 |
DNAJC27-AS1 | DNAJC27 antisense RNA 1 | Human | DNA Binding | 729723 | NA |
DNAJC7 | DnaJ (Hsp40) homolog, subfamily C, member 7 | Human | DNA Binding | 7266 | Q99615 |
DNAJC9 | DnaJ (Hsp40) homolog, subfamily C, member 9 | Human | DNA Binding | 23234 | B2RMW6 |
DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | Human | DNA Binding | 1788 | Q9Y6K1 |
DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | Human | Protein Binding | 1789 | Q9UBC3 |
DOCK7 | dedicator of cytokinesis 7 | Human | DNA Binding | 85440 | Q96N67 |
DOT1L | DOT1-like histone H3K79 methyltransferase | Human | DNA Binding | 84444 | Q8TEK3 |
DPAGT1 | dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) | Human | DNA Binding | 1798 | Q9H3H5 |
DPH5 | DPH5 homolog (S. cerevisiae) | Human | DNA Binding | 51611 | B3KWP1 |
DPM3 | dolichyl-phosphate mannosyltransferase polypeptide 3 | Human | DNA Binding | NM_018973 | Q9P2X0 |
DPP3 | dipeptidyl-peptidase 3 | Human | DNA Binding | 10072 | Q9NY33 |
DPP8 | dipeptidyl-peptidase 8 | Human | DNA Binding | 54878 | Q6V1X1 |
DPP9 | dipeptidyl-peptidase 9 | Human | DNA Binding | 91039 | Q86TI2 |
DPY19L3 | dpy-19-like 3 (C. elegans) | Human | DNA Binding | 147991 | Q6ZPD9 |
DPY19L4 | dpy-19-like 4 (C. elegans) | Human | DNA Binding | 286148 | Q7Z388 |
DPYSL5 | dihydropyrimidinase-like 5 | Human | DNA Binding | 56896 | Q9BPU6 |
DR1 | down-regulator of transcription 1, TBP-binding (negative cofactor 2) | Human | DNA Binding | 1810 | Q01658 |
DRAM2 | DNA-damage regulated autophagy modulator 2 | Human | DNA Binding | 128338 | Q6UX65 |
DRAXIN | Draxin | Human | DNA Binding | 374946 | Q8NBI3 |
DSCR3 | Down syndrome critical region gene 3 | Human | DNA Binding | 10311 | O14972 |
DSE | dermatan sulfate epimerase | Human | DNA Binding | 29940 | Q9UL01 |
DSTYK | dual serine/threonine and tyrosine protein kinase | Human | DNA Binding | 25778 | Q6XUX3 |
DTD1 | D-tyrosyl-tRNA deacylase 1 | Human | DNA Binding | 92675 | Q8TEA8 |
DTWD1 | DTW domain containing 1 | Human | DNA Binding | NM_020234 | Q8N5C7 |
DTYMK | deoxythymidylate kinase (thymidylate kinase) | Human | DNA Binding | 1841 | B7ZW70 |
DULLARD | CTD nuclear envelope phosphatase 1 | Human | DNA Binding | NM_001143775 | O95476 |
DUS2L | tRNA-dihydrouridine(20) synthase [NAD(P)+]-like | Human | DNA Binding | 54920 | Q9NX74 |
DUSP16 | dual specificity phosphatase 16 | Human | DNA Binding | 80824 | Q9BY84 |
DUSP4 | dual specificity phosphatase 4 | Human | DNA Binding | 1846 | Q13115 |
DUSP5P | dual specificity phosphatase 5 pseudogene 1 | Human | DNA Binding | NR_002834 | |
DUSP6 | dual specificity phosphatase 6 | Human | DNA Binding | 1848 | Q16828 |
DUSP7 | dual specificity phosphatase 7 | Human | DNA Binding | 1849 | Q16829 |
DVL3 | dishevelled, dsh homolog 3 (Drosophila) | Human | DNA Binding | 1857 | Q92997 |
DYNC1H1 | dynein, cytoplasmic 1, heavy chain 1 | Human | DNA Binding | 1778 | Q14204 |
DYNC1I2 | dynein, cytoplasmic 1, intermediate chain 2 | Human | DNA Binding | 1781 | Q13409 |
DYNC1LI1 | dynein, cytoplasmic 1, light intermediate chain 1 | Human | DNA Binding | 51143 | Q9Y6G9 |
DYNLRB1 | dynein, light chain, roadblock-type 1 | Human | DNA Binding | 83658 | Q9NP97 |
DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | Human | DNA Binding | 1859 | Q13627 |
DYRK3 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3 | Human | DNA Binding | 8444 | O43781 |
DZIP1 | DAZ interacting protein 1 | Human | DNA Binding | 22873 | Q86YF9 |
E4F1 | E4F transcription factor 1 | Human | DNA Binding | 1877 | Q66K89 |
EARS2 | glutamyl-tRNA synthetase 2, mitochondrial | Human | DNA Binding | 124454 | Q5JPH6 |
ECH1 | enoyl CoA hydratase 1, peroxisomal | Human | DNA Binding | 1891 | Q13011 |
ECHDC1 | enoyl CoA hydratase domain containing 1 | Human | DNA Binding | 55862 | Q9NTX5 |
ECT2 | epithelial cell transforming sequence 2 oncogene | Human | DNA Binding | 1894 | Q9H8V3 |
EDEM1 | ER degradation enhancer, mannosidase alpha-like 1 | Human | DNA Binding | 9695 | Q92611 |
EDEM2 | ER degradation enhancer, mannosidase alpha-like 2 | Human | DNA Binding | 55741 | Q9BV94 |
EED | embryonic ectoderm development | Human | DNA Binding | 8726 | O75530 |
EEF2K | eukaryotic elongation factor-2 kinase | Human | DNA Binding | 29904 | O00418 |
EFCAB11 | EF-hand calcium binding domain 11 | Human | DNA Binding | 90141 | Q9BUY7 |
EFCAB2 | EF-hand calcium binding domain 2 | Human | DNA Binding | NM_032328 | Q5VUJ9 |
EFCAB5 | EF-hand calcium binding domain 5 | Human | DNA Binding | NM_001145053 | A4FU69 |
EFCAB7 | EF-hand calcium binding domain 7 | Human | DNA Binding | 84455 | A8K855 |
EFHA1 | mitochondrial calcium uptake 2 | Human | DNA Binding | NM_152726 | Q8IYU8 |
EFHC1 | EF-hand domain (C-terminal) containing 1 | Human | DNA Binding | 114327 | B2CKC5 |
EFNA5 | ephrin-A5 | Human | DNA Binding | 1946 | P52803 |
EGLN1 | egl nine homolog 1 (C. elegans) | Human | DNA Binding | 54583 | Q9GZT9 |
EGR3 | Human | DNA Binding | |||
EHBP1 | EH domain binding protein 1 | Human | DNA Binding | 23301 | Q8NDI1 |
EHMT2 | euchromatic histone-lysine N-methyltransferase 1 | Human | DNA Binding | 79813 | Q9H9B1 |
EIF1 | eukaryotic translation initiation factor 1 | Human | DNA Binding | 10209 | P41567 |
EIF1AD | eukaryotic translation initiation factor 1A domain containing | Human | DNA Binding | 84285 | Q8N9N8 |
EIF1AX | eukaryotic translation initiation factor 1A, X-linked | Human | DNA Binding | 1964 | P47813 |
EIF2A | eukaryotic translation initiation factor 2A, 65kDa | Human | DNA Binding | 83939 | Q9BY44 |
EIF2B4 | eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa | Human | DNA Binding | 8890 | Q9UI10 |
EIF2C2 | eukaryotic translation initiation factor 2C, 2 | Human | DNA Binding | 27161 | Q9UKV8 |
EIF2S1 | eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa | Human | DNA Binding | 1965 | P05198 |
EIF2S2 | eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa | Human | DNA Binding | 8894 | P20042 |
EIF2S3 | eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa | Human | DNA Binding | 1968 | P41091 |
EIF3A | eukaryotic translation initiation factor 3, subunit A | Human | DNA Binding | 8661 | Q14152 |
EIF3B | eukaryotic translation initiation factor 3, subunit B | Human | DNA Binding | 8662 | P55884 |
EIF3D | eukaryotic translation initiation factor 3, subunit D | Human | DNA Binding | 8664 | O15371 |
EIF3F | eukaryotic translation initiation factor 3, subunit F | Human | DNA Binding | 8665 | O00303 |
EIF3L | eukaryotic translation initiation factor 3, subunit L | Human | DNA Binding | 51386 | B4DYB2 |
EIF3M | eukaryotic translation initiation factor 3, subunit M | Human | DNA Binding | 10480 | Q7L2H7 |
EIF4B | eukaryotic translation initiation factor 4B | Human | DNA Binding | 1975 | P23588 |
EIF4E | eukaryotic translation initiation factor 4E | Human | DNA Binding | 1977 | P06730 |
EIF4E2 | eukaryotic translation initiation factor 4E family member 2 | Human | DNA Binding | 9470 | O60573 |
EIF4ENIF1 | eukaryotic translation initiation factor 4E nuclear import factor 1 | Human | DNA Binding | 56478 | Q9NRA8 |
EIF4G2 | eukaryotic translation initiation factor 4 gamma, 2 | Human | DNA Binding | 1982 | P78344 |
EIF4G3 | Human | DNA Binding | |||
ELAC2 | elaC homolog 2 (E. coli) | Human | DNA Binding | 60528 | Q9BQ52 |
ELF2 | E74-like factor 2 (ets domain transcription factor) | Human | DNA Binding | 1998 | Q15723 |
ELMO2 | Human | DNA Binding | |||
ELMOD3 | ELMO/CED-12 domain containing 3 | Human | DNA Binding | 84173 | Q96FG2 |
ELMSAN1 | ELM2 and SANT domain-containing protein 1 | Human | DNA Binding | 91748 | Q6PJG2 |
ELOVL1 | ELOVL fatty acid elongase 1 | Human | DNA Binding | NM_022821 | Q9BW60 |
ELOVL5 | ELOVL fatty acid elongase 5 | Human | DNA Binding | 60481 | Q9NYP7 |
ELOVL6 | ELOVL fatty acid elongase 6 | Human | DNA Binding | 79071 | Q9H5J4 |
ELP2 | elongator acetyltransferase complex subunit 2 | Human | DNA Binding | 55250 | Q6IA86 |
ELP3 | elongator acetyltransferase complex subunit 3 | Human | DNA Binding | 55140 | Q9H9T3 |
EMC1 | ER membrane protein complex subunit 1 | Human | DNA Binding | 23065 | Q8N766 |
EMC8 | ER membrane protein complex subunit 8 | Human | DNA Binding | 10328 | O43402 |
EMG1 | EMG1 N1-specific pseudouridine methyltransferase | Human | DNA Binding | NM_006331 | Q92979 |
EML1 | echinoderm microtubule associated protein like 1 | Human | DNA Binding | 2009 | O00423 |
EML6 | echinoderm microtubule associated protein like 6 | Human | DNA Binding | NM_001039753 | Q6ZMW3 |
EMP3 | epithelial membrane protein 3 | Human | DNA Binding | NM_001425 | A0A024QZF8 |
ENAH | enabled homolog (Drosophila) | Human | DNA Binding | 55740 | Q8N8S7 |
ENO1 | enolase 1, (alpha) | Human | DNA Binding | 2023 | E2DRY6 |
ENOPH1 | Enolase-phosphatase E1 | Human | DNA Binding | 58478 | Q9UHY7 |
ENOX2 | ecto-NOX disulfide-thiol exchanger 2 | Human | DNA Binding | 10495 | Q16206 |
ENSA | endosulfine alpha | Human | DNA Binding | 2029 | O43768 |
EP400 | E1A binding protein p400 | Human | DNA Binding | 57634 | Q96L91 |
EPB41 | erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) | Human | DNA Binding | 2035 | P11171 |
EPC1 | enhancer of polycomb homolog 1 (Drosophila) | Human | DNA Binding | 80314 | Q9H2F5 |
EPC2 | enhancer of polycomb homolog 2 (Drosophila) | Human | DNA Binding | 26122 | Q52LR7 |
EPM2A | epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) | Human | DNA Binding | 7957 | O95278 |
EPN1 | epsin 1 | Human | DNA Binding | NM_013333 | Q9Y6I3 |
EPR1 | Human | DNA Binding | NR_002219 | ||
EPRS | glutamyl-prolyl-tRNA synthetase | Human | DNA Binding | 2058 | P07814 |
ERAP1 | endoplasmic reticulum aminopeptidase 1 | Human | DNA Binding | NM_001040458 | Q9NZ08 |
ERC1 | ELKS/RAB6-interacting/CAST family member 1 | Human | DNA Binding | 23085 | Q8IUD2 |
ERCC3 | excision repair cross-complementing rodent repair deficiency, complementation group 3 (xeroderma pigmentosum group B complementing) | Human | DNA Binding | 2071 | P19447 |
ERF | Ets2 repressor factor | Human | DNA Binding | 2077 | P50548 |
ERH | enhancer of rudimentary homolog (Drosophila) | Human | DNA Binding | 2079 | P84090 |
ERI1 | exoribonuclease 1 | Human | DNA Binding | 90459 | Q8IV48 |
ERLEC1 | endoplasmic reticulum lectin 1 | Human | DNA Binding | 27248 | B5MC72 |
ERLIN1 | ER lipid raft associated 1 | Human | DNA Binding | 10613 | D3DR65 |
ERN1 | endoplasmic reticulum to nucleus signaling 1 | Human | DNA Binding | NM_001433 | O75460 |
ESCO1 | establishment of cohesion 1 homolog 1 (S. cerevisiae) | Human | DNA Binding | 114799 | Q5FWF5 |
ESF1 | ESF1, nucleolar pre-rRNA processing protein, homolog (S. cerevisiae) | Human | DNA Binding | 51575 | Q9H501 |
ESYT2 | extended synaptotagmin-like protein 2 | Human | DNA Binding | 57488 | A0FGR8 |
ETAA1 | Ewing tumor-associated antigen 1 | Human | DNA Binding | 54465 | Q9NY74 |
ETF1 | eukaryotic translation termination factor 1 | Human | DNA Binding | 2107 | P62495 |
ETV1 | ets variant 1 | Human | DNA Binding | NM_001163148 | P50549 |
ETV3 | ets variant 3 | Human | DNA Binding | 2117 | P41162 |
ETV5 | ets variant 5 | Human | DNA Binding | 2119 | P41161 |
ETV6 | ets variant 6 | Human | DNA Binding | 2120 | P41212 |
EWSR1 | Ewing sarcoma breakpoint region 1 | Human | DNA Binding | 2130 | Q01844 |
EXD2 | exonuclease 3'-5' domain containing 2 | Human | DNA Binding | 55218 | Q9NVH0 |
EXO1 | exonuclease 1 | Human | DNA Binding | 9156 | Q9UQ84 |
EXOC4 | exocyst complex component 4 | Human | DNA Binding | 60412 | E9PED2 |
EXOC5 | exocyst complex component 5 | Human | DNA Binding | 10640 | O00471 |
EXOC6 | exocyst complex component 6 | Human | DNA Binding | 54536 | B3KXY5 |
EXOC7 | exocyst complex component 7 | Human | DNA Binding | 23265 | Q9UPT5 |
EXOSC6 | exosome component 6 | Human | DNA Binding | 118460 | Q5RKV6 |
EXOSC8 | exosome component 8 | Human | DNA Binding | 11340 | Q96B26 |
EXT1 | exostosin 1 | Human | DNA Binding | 2131 | Q16394 |
EXTL3 | exostosin-like glycosyltransferase 3 | Human | DNA Binding | 2137 | O43909 |
FABP5L3 | fatty acid binding protein 5 pseudogene 3 | Human | DNA Binding | NR_002935 | A8MUU1 |
FADS1 | fatty acid desaturase 1 | Human | DNA Binding | 3992 | O60427 |
FADS2 | fatty acid desaturase 2 | Human | DNA Binding | 9415 | O95864 |
FAIM | Fas apoptotic inhibitory molecule | Human | DNA Binding | NM_018147 | Q9NVQ4 |
FAM102A | family with sequence similarity 102, member A | Human | DNA Binding | 399665 | Q5T9C2 |
FAM108B1 | family with sequence similarity 108, member B1 | Human | DNA Binding | 51104 | Q5VST6 |
FAM108C1 | family with sequence similarity 108, member C1 | Human | DNA Binding | 58489 | Q6PCB6 |
FAM110B | Protein FAM110B | Human | DNA Binding | 90362 | Q8TC76 |
FAM116A | DENN/MADD domain containing 6A | Human | DNA Binding | 201627 | Q8IWF6 |
FAM117B | family with sequence similarity 117, member B | Human | DNA Binding | 150864 | Q6P1L5 |
FAM120A | family with sequence similarity 120A | Human | DNA Binding | 23196 | Q9NZB2 |
FAM120AOS | family with sequence similarity 120A opposite strand | Human | DNA Binding | 158293 | Q5T036 |
FAM122B | family with sequence similarity 122B | Human | DNA Binding | 159090 | Q7Z309 |
FAM125A | multivesicular body subunit 12A | Human | DNA Binding | 93343 | Q96EY5 |
FAM133B | Protein FAM133B | Human | DNA Binding | 728640 | Q5BKY9 |
FAM133DP | family with sequence similarity 133, member D, pseudogene | Human | DNA Binding | 728066 | NA |
FAM134A | Protein FAM134A | Human | DNA Binding | 79137 | Q8NC44 |
FAM136A | family with sequence similarity 136, member A | Human | DNA Binding | 84908 | Q96C01 |
FAM13A | family with sequence similarity 13, member A | Human | DNA Binding | 10144 | O94988 |
FAM13B | family with sequence similarity 13, member B | Human | DNA Binding | 51306 | Q9NYF5 |
FAM155A | Transmembrane protein FAM155A | Human | DNA Binding | 728215 | B1AL88 |
FAM160B1 | family with sequence similarity 160, member B1 | Human | DNA Binding | 57700 | Q5W0V3 |
FAM160B2 | family with sequence similarity 160, member B2 | Human | DNA Binding | 64760 | Q86V87 |
FAM164C | zinc finger, C2HC-type containing 1C | Human | DNA Binding | NM_001042430 | A0A024R6E6 |
FAM171A1 | family with sequence similarity 171, member A1 | Human | DNA Binding | 221061 | B3KMX9 |
FAM172A | family with sequence similarity 172, member A | Human | DNA Binding | 83989 | Q8WUF8 |
FAM173A | Protein FAM173A | Human | DNA Binding | 65990 | Q9BQD7 |
FAM178A | family with sequence similarity 178, member A | Human | DNA Binding | 55719 | Q6GMU6 |
FAM179B | family with sequence similarity 179, member B | Human | DNA Binding | 23116 | Q9Y4F4 |
FAM185A | family with sequence similarity 185, member A | Human | DNA Binding | 222234 | Q8N0U4 |
FAM189A1 | family with sequence similarity 189, member A1 | Human | DNA Binding | 23359 | O60320 |
FAM204A | family with sequence similarity 204, member A | Human | DNA Binding | 63877 | Q9H8W3 |
FAM208A | Protein FAM208A | Human | DNA Binding | 23272 | Q9UK61 |
FAM20B | SLC38A10 | Human | DNA Binding | 9917 | O75063 |
FAM211B | Leucine-rich repeat-containing protein 75B | Human | DNA Binding | 388886 | Q2VPJ9 |
FAM219B | Protein FAM219B | Human | DNA Binding | 57184 | Q5XKK7 |
FAM36A | COX20 cytochrome C oxidase assembly factor | Human | DNA Binding | NM_198076 | B3KM21 |
FAM40A | striatin interacting protein 1 | Human | DNA Binding | 85369 | Q5VSL9 |
FAM43A | family with sequence similarity 43, member A | Human | DNA Binding | NM_153690 | Q8N2R8 |
FAM47E | family with sequence similarity 47, member E | Human | DNA Binding | 100129583 | Q6ZV65 |
FAM55C | neurexophilin and PC-esterase domain family, member 3 | Human | DNA Binding | 91775 | Q969Y0 |
FAM57A | family with sequence similarity 57, member A | Human | DNA Binding | 79850 | Q8TBR7 |
FAM63A | family with sequence similarity 63, member A | Human | DNA Binding | 55793 | D3DV11 |
FAM65A | SNTG2 | Human | DNA Binding | 79567 | Q6ZS17 |
FAM69A | family with sequence similarity 69, member A | Human | DNA Binding | 388650 | Q5T7M9 |
FAM72A | family with sequence similarity 72, member A | Human | DNA Binding | NM_001123168 | Q5TYM5 |
FAM72B | family with sequence similarity 72, member B | Human | DNA Binding | NM_001100910 | Q86X60 |
FAM72D | family with sequence similarity 72, member D | Human | DNA Binding | NM_207418 | Q6L9T8 |
FAM73A | family with sequence similarity 73, member A | Human | DNA Binding | 374986 | B4DK63 |
FAM83B | family with sequence similarity 83, member B | Human | DNA Binding | 222584 | Q5T0W9 |
FAM89B | family with sequence similarity 89, member B | Human | DNA Binding | 23625 | Q8N5H3 |
FAM92A1 | family with sequence similarity 92, member A1 | Human | DNA Binding | 137392 | A1XBS5 |
FANCC | Fanconi anemia, complementation group C | Human | DNA Binding | 2176 | Q00597 |
FANCM | Fanconi anemia, complementation group M | Human | DNA Binding | 57697 | Q8IYD8 |
FAR1 | fatty acyl CoA reductase 1 | Human | DNA Binding | 84188 | Q8WVX9 |
FARS2 | phenylalanyl-tRNA synthetase 2, mitochondrial | Human | DNA Binding | 10667 | O95363 |
FASN | fatty acid synthase | Human | DNA Binding | 2194 | P49327 |
FASTKD2 | FAST kinase domains 2 | Human | DNA Binding | 22868 | Q9NYY8 |
FASTKD3 | FAST kinase domains 3 | Human | DNA Binding | 79072 | Q14CZ7 |
FASTKD5 | FAST kinase domain-containing protein 5 | Human | DNA Binding | 60493 | Q7L8L6 |
FAT1 | FAT tumor suppressor homolog 1 (Drosophila) | Human | DNA Binding | 2195 | Q14517 |
FAT4 | FAT atypical cadherin 4 | Human | DNA Binding | NM_024582 | B3KU84 |
FAU | Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed | Human | DNA Binding | 2197 | P35544 |
FAXC | Failed axon connections homolog | Human | DNA Binding | 84553 | Q5TGI0 |
FBLN1 | fibulin 1 | Human | DNA Binding | 2192 | P23142 |
FBXL14 | F-box and leucine-rich repeat protein 14 | Human | DNA Binding | 144699 | Q8N1E6 |
FBXL15 | F-box and leucine-rich repeat protein 15 | Human | DNA Binding | NM_024326 | Q9H469 |
FBXL17 | F-box and leucine-rich repeat protein 17 | Human | DNA Binding | 64839 | Q9UF56 |
FBXL19 | F-box and leucine-rich repeat protein 19 | Human | DNA Binding | 54620 | Q6PCT2 |
FBXL19-AS1 | FBXL19 antisense RNA 1 (head to head) | Human | DNA Binding | 283932 | Q494R0 |
FBXL2 | F-box and leucine-rich repeat protein 2 | Human | DNA Binding | NM_012157 | Q9UKC9 |
FBXL4 | F-box and leucine-rich repeat protein 4 | Human | DNA Binding | 26235 | Q9UKA2 |
FBXL5 | F-box and leucine-rich repeat protein 5 | Human | DNA Binding | 26234 | Q9UKA1 |
FBXO11 | F-box protein 11 | Human | DNA Binding | 80204 | Q86XK2 |
FBXO16 | F-box protein 16 | Human | DNA Binding | NM_172366 | Q8IX29 |
FBXO17 | F-box protein 17 | Human | DNA Binding | 115290 | Q96EF6 |
FBXO18 | F-box protein, helicase, 18 | Human | DNA Binding | 84893 | B3KV95 |
FBXO21 | F-box protein 21 | Human | DNA Binding | 23014 | O94952 |
FBXO24 | F-box only protein 24 | Human | DNA Binding | 26261 | O75426 |
FBXO28 | F-box protein 28 | Human | DNA Binding | 23219 | E9PEM8 |
FBXO33 | F-box protein 33 | Human | DNA Binding | 254170 | Q7Z6M2 |
FBXO36 | F-box protein 36 | Human | DNA Binding | NM_174899 | Q8NEA4 |
FBXO42 | F-box protein 42 | Human | DNA Binding | 54455 | Q6P3S6 |
FBXO43 | F-box protein 43 | Human | DNA Binding | NM_001077528 | Q4G163 |
FBXO5 | F-box protein 5 | Human | DNA Binding | 26271 | Q9UKT4 |
FBXO7 | F-box protein 7 | Human | DNA Binding | 25793 | Q9Y3I1 |
FBXO8 | F-box protein 8 | Human | DNA Binding | NM_012180 | Q8IXA8 |
FBXO9 | F-box protein 9 | Human | DNA Binding | 26268 | Q9UK97 |
FBXW5 | F-box and WD repeat domain containing 5 | Human | DNA Binding | 54661 | Q969U6 |
FCGR1B | Fc fragment of IgG, high affinity Ib, receptor (CD64) | Human | DNA Binding | NM_001017986 | Q92637 |
FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | Human | DNA Binding | NM_001136219 | P12318 |
FCHSD2 | FCH and double SH3 domains 2 | Human | DNA Binding | 9873 | O94868 |
FDFT1 | farnesyl-diphosphate farnesyltransferase 1 | Human | DNA Binding | 2222 | P37268 |
FDPS | farnesyl diphosphate synthase | Human | DNA Binding | 2224 | P14324 |
FDX1L | ferredoxin 1-like | Human | DNA Binding | NM_001031734 | Q6P4F2 |
FEM1B | fem-1 homolog b (C. elegans) | Human | DNA Binding | 10116 | Q9UK73 |
FER | fer (fps/fes related) tyrosine kinase | Human | DNA Binding | 2241 | P16591 |
FGD5-AS1 | FGD5 antisense RNA 1 | Human | DNA Binding | 100505641 | NA |
FGD6 | FYVE, RhoGEF and PH domain containing 6 | Human | DNA Binding | 55785 | Q6ZV73 |
FGF9 | fibroblast growth factor 9 (glia-activating factor) | Human | DNA Binding | 2254 | P31371 |
FHOD3 | formin homology 2 domain containing 3 | Human | DNA Binding | 80206 | Q2V2M9 |
FIP1L1 | FIP1 like 1 (S. cerevisiae) | Human | DNA Binding | 81608 | B4DIR3 |
FIS1 | fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) | Human | DNA Binding | 51024 | Q9Y3D6 |
FITM2 | fat storage-inducing transmembrane protein 2 | Human | DNA Binding | 128486 | Q8N6M3 |
FIZ1 | FLT3-interacting zinc finger 1 | Human | DNA Binding | 84922 | Q96SL8 |
FKBP14 | FK506 binding protein 14, 22 kDa | Human | DNA Binding | 55033 | Q9NWM8 |
FKBP1B | FK506 binding protein 1B, 12.6 kDa | Human | DNA Binding | NM_054033 | P68106 |
FKBP4 | FK506 binding protein 4, 59kDa | Human | DNA Binding | 2288 | Q02790 |
FKBP7 | Peptidyl-prolyl cis-trans isomerase FKBP7 | Human | DNA Binding | 51661 | Q9Y680 |
FKRP | fukutin related protein | Human | DNA Binding | 79147 | Q9H9S5 |
FLAD1 | FAD1 flavin adenine dinucleotide synthetase homolog (S. cerevisiae) | Human | DNA Binding | 80308 | Q8NFF5 |
FLJ10038 | Human | DNA Binding | 55056 | NA | |
FLJ22536 | cancer susceptibility candidate 15 (non-protein coding) | Human | DNA Binding | NR_015410 | |
FLJ31306 | PSMA3 antisense RNA 1 | Human | DNA Binding | 379025 | NA |
FLJ33630 | long intergenic non-protein coding RNA 1184 | Human | DNA Binding | NR_015360 | |
FLJ37453 | cDNA FLJ37453 fis, clone BRAWH2010754 | Human | DNA Binding | 729614 | Q8N9F6 |
FLJ39739 | long intergenic non-protein coding RNA 1138 | Human | DNA Binding | NR_027468 | |
FLJ42709 | NR2F1 antisense RNA 1 | Human | DNA Binding | 441094 | NA |
FLOT1 | flotillin 1 | Human | DNA Binding | 10211 | O75955 |
FLRT2 | Leucine-rich repeat transmembrane protein FLRT2 | Human | DNA Binding | 23768 | O43155 |
FLVCR1 | feline leukemia virus subgroup C cellular receptor 1 | Human | DNA Binding | 28982 | B2RB38 |
FLVCR1-AS1 | FLVCR1 antisense RNA 1 (head to head) | Human | DNA Binding | 642946 | Q8TAF5 |
FMNL3 | formin-like 3 | Human | DNA Binding | 91010 | Q8IVF7 |
FNBP4 | formin binding protein 4 | Human | DNA Binding | 23360 | B3KNP0 |
FNDC3A | fibronectin type III domain containing 3A | Human | DNA Binding | 22862 | Q9Y2H6 |
FOSL2 | FOS-like antigen 2 | Human | DNA Binding | 2355 | P15408 |
FOXJ2 | TNIP2 | Human | DNA Binding | 55810 | Q9P0K8 |
FOXJ3 | forkhead box J3 | Human | DNA Binding | 22887 | Q9UPW0 |
FOXN2 | forkhead box N2 | Human | DNA Binding | 3344 | P32314 |
FOXO1 | forkhead box O1 | Human | DNA Binding | 2308 | Q12778 |
FOXO3 | forkhead box O3 | Human | DNA Binding | 2309 | O43524 |
FRA10AC1 | Protein FRA10AC1 | Human | DNA Binding | 118924 | Q70Z53 |
FRAS1 | Fraser syndrome 1 | Human | DNA Binding | 80144 | A2RRR8 |
FRG1 | FSHD region gene 1 | Human | DNA Binding | 2483 | Q14331 |
FRS2 | fibroblast growth factor receptor substrate 2 | Human | DNA Binding | 10818 | Q8WU20 |
FSD1L | fibronectin type III and SPRY domain containing 1-like | Human | DNA Binding | NM_031919 | Q8N450 |
FSIP1 | fibrous sheath interacting protein 1 | Human | DNA Binding | NM_152597 | A0A024R9J2 |
FTSJD2 | FtsJ methyltransferase domain containing 2 | Human | DNA Binding | 23070 | Q8N1G2 |
FUBP3 | far upstream element (FUSE) binding protein 3 | Human | DNA Binding | 8939 | Q96I24 |
FUK | TSC1 | Human | DNA Binding | 197258 | Q8N0W3 |
FUNDC2 | FUN14 domain containing 2 | Human | DNA Binding | 65991 | Q9BWH2 |
FUS | fused in sarcoma | Human | DNA Binding | 2521 | P35637 |
FUT10 | fucosyltransferase 10 (alpha (1,3) fucosyltransferase) | Human | DNA Binding | 84750 | Q6P4F1 |
FUT11 | fucosyltransferase 11 (alpha (1,3) fucosyltransferase) | Human | DNA Binding | 170384 | Q495W5 |
FUZ | fuzzy planar cell polarity protein | Human | DNA Binding | 80199 | Q9BT04 |
FXN | frataxin | Human | DNA Binding | 2395 | Q16595 |
FXR1 | Fragile X retardation 1 | Human | DNA Binding | 8087 | P51114 |
FYN | FYN oncogene related to SRC, FGR, YES | Human | DNA Binding | 2534 | P06241 |
FZD2 | frizzled family receptor 2 | Human | DNA Binding | 2535 | Q14332 |
FZD8 | frizzled family receptor 8 | Human | DNA Binding | 8325 | Q9H461 |
G3BP2 | GTPase activating protein (SH3 domain) binding protein 2 | Human | DNA Binding | 9908 | Q9UN86 |
GABBR1 | Human | DNA Binding | |||
GABPA | GA binding protein transcription factor, alpha subunit 60kDa | Human | DNA Binding | 2551 | A8IE48 |
GABPB1 | GA binding protein transcription factor, beta subunit 1 | Human | DNA Binding | 2553 | Q06547 |
GABPB1-AS1 | GABPB1 antisense RNA 1 | Human | DNA Binding | 100129387 | NA |
GAD1 | glutamate decarboxylase 1 (brain, 67kDa) | Human | DNA Binding | 2571 | Q8IVA8 |
GADD45A | growth arrest and DNA-damage-inducible, alpha | Human | DNA Binding | NM_001924 | P24522 |
GADD45GIP1 | growth arrest and DNA-damage-inducible, gamma interacting protein 1 | Human | DNA Binding | 90480 | Q8TAE8 |
GALE | UDP-glucose 4-epimerase | Human | DNA Binding | 2582 | Q14376 |
GALK2 | galactokinase 2 | Human | DNA Binding | 2585 | Q01415 |
GALNT7 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) | Human | DNA Binding | 51809 | Q86SF2 |
GALR1 | galanin receptor 1 | Human | DNA Binding | NM_001480 | P47211 |
GANC | glucosidase, alpha; neutral C | Human | DNA Binding | 2595 | Q8TET4 |
GAPVD1 | GTPase activating protein and VPS9 domains 1 | Human | DNA Binding | 26130 | B3KN67 |
GAR1 | GAR1 ribonucleoprotein homolog (yeast) | Human | DNA Binding | 54433 | Q9NY12 |
GARS | glycyl-tRNA synthetase | Human | DNA Binding | 2617 | P41250 |
GART | phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase | Human | DNA Binding | 2618 | P22102 |
GAS1 | growth arrest-specific 1 | Human | DNA Binding | 2619 | P54826 |
GAS5 | growth arrest-specific 5 (non-protein coding) | Human | DNA Binding | NR_002578 | |
GATAD2B | GATA zinc finger domain containing 2B | Human | DNA Binding | 57459 | Q8WXI9 |
GBA | WNT2 | Human | DNA Binding | 2629 | P04062 |
GBA2 | glucosidase, beta (bile acid) 2 | Human | DNA Binding | 57704 | Q9HCG7 |
GBE1 | glucan (1,4-alpha-), branching enzyme 1 | Human | DNA Binding | NM_000158 | Q04446 |
GBF1 | golgi brefeldin A resistant guanine nucleotide exchange factor 1 | Human | DNA Binding | 8729 | Q92538 |
GCC1 | GRIP and coiled-coil domain containing 1 | Human | DNA Binding | 79571 | Q96CN9 |
GCLM | glutamate-cysteine ligase, modifier subunit | Human | DNA Binding | 2730 | P48507 |
GCSH | glycine cleavage system protein H (aminomethyl carrier) | Human | DNA Binding | NM_004483 | P23434 |
GDI2 | GDP dissociation inhibitor 2 | Human | DNA Binding | 2665 | P50395 |
GEMIN4 | gem (nuclear organelle) associated protein 4 | Human | DNA Binding | 50628 | P57678 |
GEMIN5 | gem (nuclear organelle) associated protein 5 | Human | DNA Binding | 25929 | B7ZLC9 |
GEMIN7 | gem (nuclear organelle) associated protein 7 | Human | DNA Binding | 79760 | Q9H840 |
GEMIN8 | gem (nuclear organelle) associated protein 8 | Human | DNA Binding | 54960 | Q9NWZ8 |
GET4 | golgi to ER traffic protein 4 homolog (S. cerevisiae) | Human | DNA Binding | 51608 | Q7L5D6 |
GFM2 | G elongation factor, mitochondrial 2 | Human | DNA Binding | 84340 | Q969S9 |
GFOD2 | glucose-fructose oxidoreductase domain containing 2 | Human | DNA Binding | 81577 | Q3B7J2 |
GGA1 | golgi-associated, gamma adaptin ear containing, ARF binding protein 1 | Human | DNA Binding | 26088 | Q9UJY5 |
GGA3 | golgi-associated, gamma adaptin ear containing, ARF binding protein 3 | Human | DNA Binding | 23163 | Q9NZ52 |
GGNBP2 | gametogenetin binding protein 2 | Human | DNA Binding | 79893 | Q9H3C7 |
GGPS1 | geranylgeranyl diphosphate synthase 1 | Human | DNA Binding | 9453 | O95749 |
GHITM | growth hormone inducible transmembrane protein | Human | DNA Binding | 27069 | Q9H3K2 |
GID8 | Glucose-induced degradation protein 8 homolog | Human | DNA Binding | 54994 | Q9NWU2 |
GIN1 | gypsy retrotransposon integrase 1 | Human | DNA Binding | NM_017676 | Q9NXP7 |
GINS1 | GINS complex subunit 1 (Psf1 homolog) | Human | DNA Binding | 9837 | Q14691 |
GIT1 | G protein-coupled receptor kinase interacting ArfGAP 1 | Human | DNA Binding | 28964 | Q59FC3 |
GJA3 | gap junction protein, alpha 3, 46kDa | Human | DNA Binding | 2700 | Q9Y6H8 |
GJA9 | gap junction protein, alpha 9, 59kDa | Human | DNA Binding | NM_030772 | P57773 |
GLG1 | golgi glycoprotein 1 | Human | DNA Binding | 2734 | Q92896 |
GLOD4 | glyoxalase domain containing 4 | Human | DNA Binding | 51031 | Q9HC38 |
GLTSCR1 | glioma tumor suppressor candidate region gene 1 | Human | DNA Binding | 29998 | Q9NZM4 |
GLUD1 | glutamate dehydrogenase 1 | Human | DNA Binding | 2746 | E9KL48 |
GMFB | glia maturation factor, beta | Human | DNA Binding | 2764 | P60983 |
GMNN | geminin, DNA replication inhibitor | Human | DNA Binding | 51053 | O75496 |
GMPR2 | guanosine monophosphate reductase 2 | Human | DNA Binding | NM_016576 | Q9P2T1 |
GMPS | guanine monphosphate synthetase | Human | DNA Binding | 8833 | A8K639 |
GNA13 | guanine nucleotide binding protein (G protein), alpha 13 | Human | DNA Binding | 10672 | Q14344 |
GNAL | guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type | Human | DNA Binding | NM_002071 | A8K1Y9 |
GNB1L | guanine nucleotide binding protein (G protein), beta polypeptide 1-like | Human | DNA Binding | 54584 | Q9BYB4 |
GNL3 | guanine nucleotide binding protein-like 3 (nucleolar) | Human | DNA Binding | 26354 | Q9BVP2 |
GNL3L | guanine nucleotide binding protein-like 3 (nucleolar)-like | Human | DNA Binding | 54552 | Q05DU1 |
GNPAT | glyceronephosphate O-acyltransferase | Human | DNA Binding | 8443 | O15228 |
GNPNAT1 | glucosamine-phosphate N-acetyltransferase 1 | Human | DNA Binding | 64841 | Q96EK6 |
GNS | glucosamine (N-acetyl)-6-sulfatase | Human | DNA Binding | 2799 | P15586 |
GOLGA4 | golgin A4 | Human | DNA Binding | 2803 | Q13439 |
GOLGA6L6 | golgin A6 family-like 6 | Human | DNA Binding | NM_001145004 | A8MZA4 |
GOLGB1 | golgin B1 | Human | DNA Binding | 2804 | F1T0J2 |
GON4L | gon-4-like (C. elegans) | Human | DNA Binding | 54856 | Q3T8J9 |
GORAB | golgin, RAB6-interacting | Human | DNA Binding | NM_001146039 | Q5T7V8 |
GORASP2 | golgi reassembly stacking protein 2, 55kDa | Human | DNA Binding | 26003 | Q9H8Y8 |
GOSR1 | golgi SNAP receptor complex member 1 | Human | DNA Binding | 9527 | O95249 |
GOSR2 | golgi SNAP receptor complex member 2 | Human | DNA Binding | 9570 | O14653 |
GOT2 | glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) | Human | DNA Binding | 2806 | P00505 |
GPATCH1 | G patch domain containing 1 | Human | DNA Binding | 55094 | Q9BRR8 |
GPATCH8 | G patch domain containing 8 | Human | DNA Binding | 23131 | Q9UKJ3 |
GPBP1 | GC-rich promoter binding protein 1 | Human | DNA Binding | 65056 | Q86WP2 |
GPBP1L1 | GC-rich promoter binding protein 1-like 1 | Human | DNA Binding | 60313 | Q9HC44 |
GPC1 | glypican 1 | Human | DNA Binding | 2817 | P35052 |
GPR101 | G protein-coupled receptor 101 | Human | DNA Binding | 83550 | Q96P66 |
GPR108 | G protein-coupled receptor 108 | Human | DNA Binding | 56927 | Q9NPR9 |
GPR126 | G protein-coupled receptor 126 | Human | DNA Binding | 57211 | Q86SQ4 |
GPR137 | Integral membrane protein GPR137 | Human | DNA Binding | 56834 | Q96N19 |
GPR177 | wntless Wnt ligand secretion mediator | Human | DNA Binding | NM_024911 | Q5T9L3 |
GPR63 | G protein-coupled receptor 63 | Human | DNA Binding | 81491 | A8K1C4 |
GPR84 | G protein-coupled receptor 84 | Human | DNA Binding | NM_020370 | Q9NQS5 |
GPSM3 | G-protein signaling modulator 3 | Human | DNA Binding | NM_022107 | A0A024RCP6 |
GPX8 | glutathione peroxidase 8 (putative) | Human | DNA Binding | 493869 | Q8TED1 |
GRAMD1A | GRAM domain containing 1A | Human | DNA Binding | 57655 | Q96CP6 |
GRAP | GRB2-related adaptor protein | Human | DNA Binding | NM_006613 | Q13588 |
GRID2 | glutamate receptor, ionotropic, delta 2 | Human | DNA Binding | 2895 | O43424 |
GRIN2D | glutamate receptor, ionotropic, N-methyl D-aspartate 2D | Human | DNA Binding | 2906 | O15399 |
GRIPAP1 | GRIP1 associated protein 1 | Human | DNA Binding | 56850 | Q4V328 |
GRK4 | G protein-coupled receptor kinase 4 | Human | DNA Binding | 2868 | P32298 |
GRPEL1 | GrpE-like 1, mitochondrial (E. coli) | Human | DNA Binding | 80273 | Q9HAV7 |
GRPEL2 | GrpE-like 2, mitochondrial (E. coli) | Human | DNA Binding | 134266 | Q8TAA5 |
GRSF1 | G-rich RNA sequence binding factor 1 | Human | DNA Binding | 2926 | Q12849 |
GRWD1 | glutamate-rich WD repeat containing 1 | Human | DNA Binding | 83743 | Q9BQ67 |
GSE1 | Genetic suppressor element 1 | Human | DNA Binding | 23199 | Q14687 |
GSK3A | glycogen synthase kinase 3 alpha | Human | DNA Binding | 2931 | P49840 |
GSPT1 | G1 to S phase transition 1 | Human | DNA Binding | 2935 | P15170 |
GSR | glutathione reductase | Human | DNA Binding | 2936 | P00390 |
GSTA4 | glutathione S-transferase alpha 4 | Human | DNA Binding | NM_001512 | A0A024RD58 |
GSTCD | glutathione S-transferase, C-terminal domain containing | Human | DNA Binding | 79807 | Q8NEC7 |
GSTO2 | glutathione S-transferase omega 2 | Human | DNA Binding | NM_183239 | Q9H4Y5 |
GTF2A1 | general transcription factor IIA, 1, 19/37kDa | Human | DNA Binding | 2957 | P52655 |
GTF2H4 | general transcription factor IIH, polypeptide 4, 52kDa | Human | DNA Binding | NM_001517 | Q92759 |
GTF2IRD1 | GTF2I repeat domain containing 1 | Human | DNA Binding | 9569 | Q9UHL9 |
GTF3C4 | general transcription factor IIIC, polypeptide 4, 90kDa | Human | DNA Binding | 9329 | B3KNH2 |
GTPBP1 | GTP binding protein 1 | Human | DNA Binding | 9567 | O00178 |
GTPBP3 | GTP binding protein 3 (mitochondrial) | Human | DNA Binding | 84705 | B7Z563 |
GTSF1 | gametocyte specific factor 1 | Human | DNA Binding | NM_144594 | A0A024RB57 |
GUCD1 | Protein GUCD1 | Human | DNA Binding | 83606 | Q96NT3 |
GULP1 | GULP, engulfment adaptor PTB domain containing 1 | Human | DNA Binding | 51454 | Q9UBP9 |
H19 | H19 fetal liver mRNA | Human | DNA Binding | 14955 | N/A |
H1FX | H1 histone family, member X | Human | DNA Binding | 8971 | Q92522 |
H1FX-AS1 | H1FX antisense RNA 1 | Human | DNA Binding | 339942 | Q4G0G2 |
H2AFV | H2A histone family, member V | Human | DNA Binding | 94239 | Q71UI9 |
H2AFY2 | Core histone macro-H2A.2 | Human | DNA Binding | 55506 | Q9P0M6 |
H2AFZ | H2A histone family, member Z | Human | DNA Binding | 3015 | P0C0S5 |
H3F3AP4 | H3 histone, family 3A, pseudogene 4 | Human | DNA Binding | 440926 | NA |
HACE1 | HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | Human | DNA Binding | 57531 | Q8IYU2 |
HAND1 | heart and neural crest derivatives expressed 1 | Human | Direct Regulation | 15110 | O96004 |
HAUS1 | HAUS augmin-like complex, subunit 1 | Human | DNA Binding | 115106 | Q96CS2 |
HBS1L | HBS1-like (S. cerevisiae) | Human | DNA Binding | 10767 | Q9Y450 |
HCFC1 | host cell factor C1 (VP16-accessory protein) | Human | DNA Binding | 3054 | P51610 |
HCFC2 | host cell factor C2 | Human | DNA Binding | 29915 | Q9Y5Z7 |
HDGF | hepatoma-derived growth factor | Human | DNA Binding | 3068 | P51858 |
HEATR2 | HEAT repeat containing 2 | Human | DNA Binding | 54919 | B3KPE2 |
HEATR6 | HEAT repeat containing 6 | Human | DNA Binding | 63897 | Q6AI08 |
HEBP1 | heme binding protein 1 | Human | DNA Binding | NM_015987 | A0A024RAS8 |
HECTD1 | HECT domain containing E3 ubiquitin protein ligase 1 | Human | DNA Binding | 25831 | Q9ULT8 |
HECTD2 | HECT domain containing E3 ubiquitin protein ligase 2 | Human | DNA Binding | 143279 | B3KV18 |
HELLS | helicase, lymphoid-specific | Human | DNA Binding | 3070 | Q9NRZ9 |
HELZ | helicase with zinc finger | Human | DNA Binding | 9931 | P42694 |
HERC3 | HECT and RLD domain containing E3 ubiquitin protein ligase 3 | Human | DNA Binding | 8916 | B4DK41 |
HERC4 | HECT and RLD domain containing E3 ubiquitin protein ligase 4 | Human | DNA Binding | 26091 | Q5GLZ8 |
HES7 | hes family bHLH transcription factor 7 | Human | DNA Binding | NM_001165967 | Q9BYE0 |
HEXIM2 | hexamethylene bis-acetamide inducible 2 | Human | DNA Binding | 124790 | Q96MH2 |
HEY1 | hes-related family bHLH transcription factor with YRPW motif 1 | Human | DNA Binding | NM_012258 | Q9Y5J3 |
HFE | hemochromatosis | Human | DNA Binding | 3077 | Q30201 |
HHLA3 | HERV-H LTR-associating 3 | Human | DNA Binding | NM_001036646 | Q9XRX5 |
HIAT1 | hippocampus abundant transcript 1 | Human | DNA Binding | 64645 | Q96MC6 |
HINT2 | histidine triad nucleotide binding protein 2 | Human | DNA Binding | NM_032593 | Q9BX68 |
HIPK2 | homeodomain interacting protein kinase 2 | Human | DNA Binding | 28996 | Q9H2X6 |
HIPK3 | Human | DNA Binding | |||
HIRA | HIR histone cell cycle regulation defective homolog A (S. cerevisiae) | Human | DNA Binding | 7290 | P54198 |
HIST1H1B | histone cluster 1, H1b | Human | DNA Binding | 3009 | P16401 |
HIST1H1C | histone cluster 1, H1c | Human | DNA Binding | 3006 | P16403 |
HIST1H2AB | histone cluster 1, H2ab | Human | DNA Binding | 8335 | P04908 |
HIST1H2AC | histone cluster 1, H2ac | Human | DNA Binding | 8334 | Q93077 |
HIST1H2AG | histone cluster 1, H2ag | Human | DNA Binding | 8969 | A4FTV9 |
HIST1H2AI | histone cluster 1, H2ai | Human | DNA Binding | 8329 | A4FTV9 |
HIST1H2BF | histone cluster 1, H2bf | Human | DNA Binding | 8343 | B2R4S9 |
HIST1H2BH | histone cluster 1, H2bh | Human | DNA Binding | NM_003524 | Q93079 |
HIST1H2BJ | histone cluster 1, H2bj | Human | DNA Binding | 8970 | P06899 |
HIST1H2BL | histone cluster 1, H2bl | Human | DNA Binding | NM_003519 | Q99880 |
HIST1H2BN | histone cluster 1, H2bn | Human | DNA Binding | 8341 | Q99877 |
HIST1H2BO | histone cluster 1, H2bo | Human | DNA Binding | 8348 | P23527 |
HIST1H3B | histone cluster 1, H3b | Human | DNA Binding | 8358 | P68431 |
HIST1H3D | histone cluster 1, H3d | Human | DNA Binding | 8351 | P68431 |
HIST1H3E | histone cluster 1, H3e | Human | DNA Binding | 8353 | P68431 |
HIST1H3F | histone cluster 1, H3f | Human | DNA Binding | 8968 | P68431 |
HIST1H3H | histone cluster 1, H3h | Human | DNA Binding | 8357 | P68431 |
HIST1H4B | histone cluster 1, H4b | Human | DNA Binding | 8366 | B2R4R0 |
HIST1H4C | histone cluster 1, H4c | Human | DNA Binding | 8364 | B2R4R0 |
HIST1H4E | histone cluster 1, H4e | Human | DNA Binding | 8367 | B2R4R0 |
HIST1H4J | histone cluster 1, H4j | Human | DNA Binding | 8363 | B2R4R0 |
HIST1H4K | histone cluster 1, H4k | Human | DNA Binding | 8362 | B2R4R0 |
HIST2H2AA3 | histone cluster 2, H2aa3 | Human | DNA Binding | 8337 | Q6FI13 |
HIST2H2AB | histone cluster 2, H2ab | Human | DNA Binding | 317772 | Q8IUE6 |
HIST2H2AC | histone cluster 2, H2ac | Human | DNA Binding | 8338 | Q16777 |
HJURP | Holliday junction recognition protein | Human | DNA Binding | 55355 | Q8NCD3 |
HMBOX1 | homeobox containing 1 | Human | DNA Binding | 79618 | Q6NT76 |
HMBS | hydroxymethylbilane synthase | Human | DNA Binding | NM_000190 | P08397 |
HMG20A | high mobility group 20A | Human | DNA Binding | 10363 | Q9NP66 |
HMGB1 | high-mobility group box 1 | Human | DNA Binding | 3146 | P09429 |
HMGB2 | high mobility group box 2 | Human | DNA Binding | 3148 | P26583 |
HMGN1 | high mobility group nucleosome binding domain 1 | Human | DNA Binding | 3150 | P05114 |
HMGN2 | high mobility group nucleosomal binding domain 2 | Human | DNA Binding | 3151 | P05204 |
HMGN4 | high mobility group nucleosomal binding domain 4 | Human | DNA Binding | 10473 | O00479 |
HMGXB4 | HMG box domain containing 4 | Human | DNA Binding | 10042 | Q7Z641 |
HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | Human | DNA Binding | 3178 | P09651 |
HNRNPA1P10 | heterogeneous nuclear ribonucleoprotein A1 pseudogene 10 | Human | DNA Binding | 664709 | NA |
HNRNPA3 | heterogeneous nuclear ribonucleoprotein A3 | Human | DNA Binding | 220988 | P51991 |
HNRNPC | heterogeneous nuclear ribonucleoprotein C (C1/C2) | Human | DNA Binding | 3183 | P07910 |
HNRNPH3 | heterogeneous nuclear ribonucleoprotein H3 (2H9) | Human | DNA Binding | 3189 | P31942 |
HNRNPR | heterogeneous nuclear ribonucleoprotein R | Human | DNA Binding | 10236 | O43390 |
HNRNPUL1 | heterogeneous nuclear ribonucleoprotein U-like 1 | Human | DNA Binding | 11100 | Q9BUJ2 |
HNRNPUL2-BSCL2 | HNRNPUL2-BSCL2 readthrough (NMD candidate) | Human | DNA Binding | 100534595 | NA |
HNRPA1L-2 | heterogeneous nuclear ribonucleoprotein A1 pseudogene 10 | Human | DNA Binding | NR_002944 | |
HNRPDL | heterogeneous nuclear ribonucleoprotein D-like | Human | DNA Binding | 9987 | O14979 |
HNRPLL | heterogeneous nuclear ribonucleoprotein L-like | Human | DNA Binding | 92906 | A8K894 |
HOMER3 | homer homolog 3 (Drosophila) | Human | DNA Binding | 9454 | Q9NSC5 |
HOMEZ | homeobox and leucine zipper encoding | Human | DNA Binding | NM_020834 | Q8IX15 |
HOXA2 | homeobox A2 | Human | DNA Binding | 3199 | O43364 |
HOXA3 | homeobox A3 | Human | DNA Binding | 3200 | O43365 |
HOXB2 | homeobox B2 | Human | DNA Binding | 3212 | P14652 |
HOXB3 | homeobox B3 | Human | DNA Binding | 3213 | B3KNJ7 |
HOXB4 | homeobox B4 | Human | DNA Binding | NM_024015 | P17483 |
HOXB7 | homeobox B7 | Human | DNA Binding | 3217 | P09629 |
HOXB8 | homeobox B8 | Human | DNA Binding | NM_024016 | P17481 |
HOXB9 | homeobox B9 | Human | DNA Binding | NM_024017 | B3KPJ1 |
HOXC10 | homeobox C10 | Human | DNA Binding | NM_017409 | Q53XI4 |
HOXC6 | homeobox C6 | Human | DNA Binding | 3223 | P09630 |
HOXC9 | homeobox C9 | Human | DNA Binding | NM_006897 | A0A024RAZ6 |
HP1BP3 | heterochromatin protein 1, binding protein 3 | Human | DNA Binding | 50809 | Q5SSJ5 |
HPD | 4-hydroxyphenylpyruvate dioxygenase | Human | DNA Binding | 3242 | P32754 |
HPS4 | Hermansky-Pudlak syndrome 4 | Human | DNA Binding | 89781 | A8K2E6 |
HSD17B11 | hydroxysteroid (17-beta) dehydrogenase 11 | Human | DNA Binding | NM_016245 | Q8NBQ5 |
HSD17B14 | hydroxysteroid (17-beta) dehydrogenase 14 | Human | DNA Binding | NM_016246 | Q9BPX1 |
HSP90AB1 | heat shock protein 90kDa alpha (cytosolic), class B member 1 | Human | DNA Binding | 3326 | P08238 |
HSPA6 | heat shock 70kDa protein 6 (HSP70B') | Human | DNA Binding | 3310 | P17066 |
HSPA8 | heat shock 70kDa protein 8 | Human | DNA Binding | 3312 | P11142 |
HSPBAP1 | HSPB1-associated protein 1 | Human | DNA Binding | 79663 | Q96EW2 |
HSPBP1 | HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 | Human | DNA Binding | 23640 | Q9NZL4 |
HSPE1 | heat shock 10kDa protein 1 (chaperonin 10) | Human | DNA Binding | 3336 | P61604 |
HUNK | hormonally up-regulated Neu-associated kinase | Human | DNA Binding | 30811 | P57058 |
HUS1 | HUS1 checkpoint homolog (S. pombe) | Human | DNA Binding | 3364 | A4D2F2 |
IARS | isoleucyl-tRNA synthetase | Human | DNA Binding | 3376 | P41252 |
IBA57 | IBA57, iron-sulfur cluster assembly homolog (S. cerevisiae) | Human | DNA Binding | 200205 | Q5T440 |
IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | Human | DNA Binding | 25998 | Q9P2D0 |
ICA1L | islet cell autoantigen 1,69kDa-like | Human | DNA Binding | NM_178231 | A0A024R3W3 |
ICK | intestinal cell (MAK-like) kinase | Human | DNA Binding | 22858 | Q9UPZ9 |
ICT1 | immature colon carcinoma transcript 1 | Human | DNA Binding | 3396 | Q14197 |
ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | Human | DNA Binding | 3397 | P41134 |
ID3 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | Human | DNA Binding | 3399 | Q02535 |
IER2 | immediate early response 2 | Human | DNA Binding | 9592 | Q9BTL4 |
IER3IP1 | immediate early response 3 interacting protein 1 | Human | DNA Binding | 51124 | Q9Y5U9 |
IER5 | immediate early response 5 | Human | DNA Binding | 51278 | Q5VY09 |
IFFO2 | intermediate filament family orphan 2 | Human | DNA Binding | 126917 | Q5TF58 |
IFRD1 | interferon-related developmental regulator 1 | Human | DNA Binding | 3475 | A4D0U1 |
IFRD2 | interferon-related developmental regulator 2 | Human | DNA Binding | 7866 | Q12894 |
IFT52 | intraflagellar transport 52 homolog (Chlamydomonas) | Human | DNA Binding | 51098 | Q9Y366 |
IFT74 | intraflagellar transport 74 | Human | DNA Binding | NM_001099222 | A0PJM7 |
IFT80 | intraflagellar transport 80 homolog (Chlamydomonas) | Human | DNA Binding | 57560 | Q9P2H3 |
IGDCC3 | Immunoglobulin superfamily DCC subclass member 3 | Human | DNA Binding | 9543 | Q8IVU1 |
IGF2BP1 | insulin-like growth factor 2 mRNA binding protein 1 | Human | DNA Binding | 10642 | Q9NZI8 |
IGF2BP3 | insulin-like growth factor 2 mRNA binding protein 3 | Human | DNA Binding | 10643 | O00425 |
IGFBP3 | insulin-like growth factor binding protein 3 | Human | DNA Binding | NM_000598 | B3KPF0 |
IGFL4 | IGF-like family member 4 | Human | DNA Binding | NM_001002923 | Q6B9Z1 |
IGHMBP2 | immunoglobulin mu binding protein 2 | Human | DNA Binding | 3508 | P38935 |
IKBIP | IKBKB interacting protein | Human | DNA Binding | 121457 | Q70UQ0 |
IKBKAP | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein | Human | DNA Binding | 8518 | O95163 |
IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | Human | DNA Binding | 3551 | O14920 |
IKZF5 | IKAROS family zinc finger 5 (Pegasus) | Human | DNA Binding | 64376 | Q9H5V7 |
IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | Human | DNA Binding | 3572 | P40189 |
ILF2 | interleukin enhancer binding factor 2 | Human | DNA Binding | 3608 | Q12905 |
ILF3 | interleukin enhancer binding factor 3, 90kDa | Human | DNA Binding | 3609 | Q12906 |
IMAA | solute carrier family 7 (amino acid transporter light chain, L system), member 5 pseudogene 2 | Human | DNA Binding | NR_002594 | Q9GIP4 |
IMMP1L | IMP1 inner mitochondrial membrane peptidase-like (S. cerevisiae) | Human | DNA Binding | 196294 | Q96LU5 |
IMP4 | IMP4, U3 small nucleolar ribonucleoprotein, homolog (yeast) | Human | DNA Binding | 92856 | Q3ZTT3 |
IMPA2 | inositol(myo)-1(or 4)-monophosphatase 2 | Human | DNA Binding | NM_014214 | O14732 |
IMPDH1 | IMP (inosine 5'-monophosphate) dehydrogenase 1 | Human | DNA Binding | 3614 | A4D0Z6 |
INA | internexin neuronal intermediate filament protein, alpha | Human | DNA Binding | 9118 | Q16352 |
ING1 | inhibitor of growth family, member 1 | Human | DNA Binding | 3621 | Q9UK53 |
ING3 | inhibitor of growth family, member 3 | Human | DNA Binding | 54556 | Q9NXR8 |
ING4 | inhibitor of growth family, member 4 | Human | DNA Binding | NM_001127583 | Q9UNL4 |
INHBC | inhibin, beta C | Human | DNA Binding | NM_005538 | P55103 |
INO80 | INO80 homolog (S. cerevisiae) | Human | DNA Binding | 54617 | Q9NUK2 |
INO80C | INO80 complex subunit C | Human | DNA Binding | NM_194281 | Q6PI98 |
INO80D | INO80 complex subunit D | Human | DNA Binding | 54891 | Q53TQ3 |
INSIG2 | insulin induced gene 2 | Human | DNA Binding | NM_016133 | A0A024RAI2 |
INSR | insulin receptor | Human | DNA Binding | 3643 | P06213 |
INTS2 | integrator complex subunit 2 | Human | DNA Binding | 57508 | Q9H0H0 |
INTS6 | integrator complex subunit 6 | Human | DNA Binding | 26512 | Q9UL03 |
INTS8 | integrator complex subunit 8 | Human | DNA Binding | 55656 | Q75QN2 |
INTS9 | integrator complex subunit 9 | Human | DNA Binding | 55756 | Q9NV88 |
INVS | inversin | Human | DNA Binding | 27130 | Q2M1I4 |
IP6K2 | inositol hexakisphosphate kinase 2 | Human | DNA Binding | 51447 | B2RCP4 |
IPO11 | importin 11 | Human | DNA Binding | 51194 | Q9UI26 |
IPO7 | importin 7 | Human | DNA Binding | 10527 | B3KNG9 |
IQCG | IQ motif containing G | Human | DNA Binding | NM_032263 | Q9H095 |
IRAK1BP1 | interleukin-1 receptor-associated kinase 1 binding protein 1 | Human | DNA Binding | NM_001010844 | Q5VVH5 |
IRF2 | interferon regulatory factor 2 | Human | DNA Binding | 3660 | P14316 |
IRF2BP1 | interferon regulatory factor 2 binding protein 1 | Human | DNA Binding | 26145 | Q8IU81 |
IRF2BPL | interferon regulatory factor 2 binding protein-like | Human | DNA Binding | 64207 | Q9H1B7 |
IRF8 | interferon regulatory factor 8 | Human | Direct Regulation | 3394 | Q02556 |
IRGQ | immunity-related GTPase family, Q | Human | DNA Binding | 126298 | Q8WZA9 |
IRS2 | insulin receptor substrate 2 | Human | DNA Binding | 8660 | Q9P084 |
ISCU | iron-sulfur cluster scaffold homolog (E. coli) | Human | DNA Binding | 23479 | Q9H1K1 |
ISG20L2 | interferon stimulated exonuclease gene 20kDa-like 2 | Human | DNA Binding | 81875 | Q9H9L3 |
ISL2 | ISL LIM homeobox 2 | Human | DNA Binding | 64843 | Q96A47 |
IST1 | IST1 homolog | Human | DNA Binding | 9798 | P53990 |
ITFG1 | integrin alpha FG-GAP repeat containing 1 | Human | DNA Binding | 81533 | Q8TB96 |
ITFG2 | Integrin-alpha FG-GAP repeat-containing protein 2 | Human | DNA Binding | 55846 | Q969R8 |
ITFG3 | integrin alpha FG-GAP repeat containing 3 | Human | DNA Binding | 83986 | Q9H0X4 |
ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | Human | DNA Binding | 3688 | P05556 |
ITPK1 | inositol-tetrakisphosphate 1-kinase | Human | DNA Binding | 3705 | Q13572 |
ITPKC | inositol-trisphosphate 3-kinase C | Human | DNA Binding | 80271 | Q96DU7 |
ITSN1 | intersectin 1 (SH3 domain protein) | Human | DNA Binding | 6453 | Q15811 |
JARID2 | jumonji, AT rich interactive domain 2 | Human | DNA Binding | 3720 | Q92833 |
JMJD5 | lysine (K)-specific demethylase 8 | Human | DNA Binding | NM_001145348 | Q8N371 |
JMY | junction mediating and regulatory protein, p53 cofactor | Human | DNA Binding | 133746 | Q8N9B5 |
JRKL | jerky homolog-like (mouse) | Human | DNA Binding | 8690 | Q9Y4A0 |
JTB | jumping translocation breakpoint | Human | DNA Binding | 10899 | O76095 |
JUB | ajuba LIM protein | Human | DNA Binding | 84962 | Q96IF1 |
JUND | jun D proto-oncogene | Human | DNA Binding | 3727 | P17535 |
KAAG1 | kidney associated antigen 1 | Human | DNA Binding | NM_181337 | Q9UBP8 |
KANSL1 | KAT8 regulatory NSL complex subunit 1 | Human | DNA Binding | 284058 | Q7Z3B3 |
KANSL1-AS1 | KANSL1 antisense RNA 1 | Human | DNA Binding | 644246 | NA |
KAT6A | K(lysine) acetyltransferase 6A | Human | DNA Binding | 7994 | A5PKX7 |
KAT6B | K(lysine) acetyltransferase 6B | Human | DNA Binding | 23522 | B2RWN8 |
KATNA1 | katanin p60 (ATPase containing) subunit A 1 | Human | DNA Binding | 11104 | O75449 |
KAZALD1 | Kazal-type serine peptidase inhibitor domain 1 | Human | DNA Binding | 81621 | Q96I82 |
KBTBD2 | kelch repeat and BTB (POZ) domain containing 2 | Human | DNA Binding | 25948 | Q8IY47 |
KBTBD3 | Kelch repeat and BTB domain-containing protein 3 | Human | DNA Binding | 143879 | Q8NAB2 |
KBTBD4 | kelch repeat and BTB (POZ) domain containing 4 | Human | DNA Binding | 55709 | Q9NVX7 |
KCMF1 | potassium channel modulatory factor 1 | Human | DNA Binding | 56888 | Q9P0J7 |
KCNG3 | potassium voltage-gated channel, subfamily G, member 3 | Human | DNA Binding | 170850 | Q8TAE7 |
KCNH1 | potassium voltage-gated channel, subfamily H (eag-related), member 1 | Human | DNA Binding | NM_002238 | O95259 |
KCTD1 | potassium channel tetramerisation domain containing 1 | Human | DNA Binding | 284252 | Q719H9 |
KCTD15 | potassium channel tetramerisation domain containing 15 | Human | DNA Binding | 79047 | Q96SI1 |
KCTD20 | potassium channel tetramerisation domain containing 20 | Human | DNA Binding | 222658 | Q7Z5Y7 |
KCTD3 | potassium channel tetramerisation domain containing 3 | Human | DNA Binding | 51133 | Q9Y597 |
KDELC1 | KDEL (Lys-Asp-Glu-Leu) containing 1 | Human | DNA Binding | 79070 | Q6UW63 |
KDELC2 | KDEL (Lys-Asp-Glu-Leu) containing 2 | Human | DNA Binding | 143888 | Q7Z4H8 |
KDELR2 | KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 | Human | DNA Binding | 11014 | P33947 |
KDM1A | lysine (K)-specific demethylase 1A | Human | DNA Binding | 23028 | O60341 |
KDM2A | lysine (K)-specific demethylase 2A | Human | DNA Binding | 22992 | D4QA03 |
KDM2B | lysine (K)-specific demethylase 2B | Human | DNA Binding | 84678 | Q8NHM5 |
KDM3A | lysine (K)-specific demethylase 3A | Human | DNA Binding | 55818 | Q9Y4C1 |
KDM3B | lysine (K)-specific demethylase 3B | Human | DNA Binding | 51780 | Q7LBC6 |
KDM4A | lysine (K)-specific demethylase 4A | Human | DNA Binding | 9682 | O75164 |
KDM4C | lysine (K)-specific demethylase 4C | Human | DNA Binding | 23081 | Q9H3R0 |
KDM4D | lysine (K)-specific demethylase 4D | Human | DNA Binding | 55693 | Q6B0I6 |
KDM5A | lysine (K)-specific demethylase 5A | Human | DNA Binding | 5927 | P29375 |
KDM5B-AS1 | prostate cancer associated transcript 6 (non-protein coding) | Human | DNA Binding | 100506696 | NA |
KDM6A | lysine (K)-specific demethylase 6A | Human | DNA Binding | 7403 | O15550 |
KDSR | 3-ketodihydrosphingosine reductase | Human | DNA Binding | 2531 | Q06136 |
KIAA0101 | KIAA0101 | Human | DNA Binding | 9768 | A6NNU5 |
KIAA0182 | Gse1 coiled-coil protein | Human | DNA Binding | 23199 | Q14687 |
KIAA0195 | KIAA0195 | Human | DNA Binding | 9772 | Q12767 |
KIAA0232 | KIAA0232 | Human | DNA Binding | 9778 | Q92628 |
KIAA0317 | apoptosis resistant E3 ubiquitin protein ligase 1 | Human | DNA Binding | NM_001039479 | O15033 |
KIAA0355 | KIAA0355 | Human | DNA Binding | 9710 | O15063 |
KIAA0391 | KIAA0391 | Human | DNA Binding | 9692 | O15091 |
KIAA0406 | TELO2 interacting protein 1 | Human | DNA Binding | NM_014657 | O43156 |
KIAA0415 | adaptor-related protein complex 5, zeta 1 subunit | Human | DNA Binding | 9907 | O43299 |
KIAA0495 | TP73 antisense RNA 1 | Human | DNA Binding | NM_207306 | Q9UF72 |
KIAA0564 | von Willebrand factor A domain containing 8 | Human | DNA Binding | 23078 | A3KMH1 |
KIAA0586 | KIAA0586 | Human | DNA Binding | 9786 | Q6UV20 |
KIAA0753 | KIAA0753 | Human | DNA Binding | 9851 | Q2KHM9 |
KIAA0907 | KIAA0907 | Human | DNA Binding | 22889 | Q7Z7F0 |
KIAA0913 | zinc finger, SWIM-type containing 8 | Human | DNA Binding | NM_015037 | A7E2V4 |
KIAA1267 | KAT8 regulatory NSL complex subunit 1 | Human | DNA Binding | 284058 | Q7Z3B3 |
KIAA1310 | KAT8 regulatory NSL complex subunit 3 | Human | DNA Binding | 55683 | Q9P2N6 |
KIAA1429 | KIAA1429 | Human | DNA Binding | 25962 | Q69YN4 |
KIAA1430 | cilia and flagella associated protein 97 | Human | DNA Binding | NM_020827 | Q9P2B7 |
KIAA1524 | KIAA1524 | Human | DNA Binding | 57650 | Q8TCG1 |
KIAA1539 | family with sequence similarity 214, member B | Human | DNA Binding | NM_025182 | Q7L5A3 |
KIAA1549 | KIAA1549 | Human | DNA Binding | 57670 | Q9HCM3 |
KIAA1551 | Uncharacterized protein KIAA1551 | Human | DNA Binding | 55196 | Q9HCM1 |
KIAA1586 | KIAA1586 | Human | DNA Binding | 57691 | Q9HCI6 |
KIAA1737 | KIAA1737 | Human | DNA Binding | 85457 | Q9C0C6 |
KIAA1958 | KIAA1958 | Human | DNA Binding | 158405 | Q8N8K9 |
KIAA1984-AS1 | CCDC183 antisense RNA 1 | Human | DNA Binding | 100131193 | NA |
KIAA2026 | KIAA2026 | Human | DNA Binding | 158358 | Q5HYC2 |
KIF11 | kinesin family member 11 | Human | DNA Binding | 3832 | P52732 |
KIF13A | kinesin family member 13A | Human | DNA Binding | 63971 | Q9H1H9 |
KIF18A | kinesin family member 18A | Human | DNA Binding | 81930 | Q8NI77 |
KIF1B | kinesin family member 1B | Human | DNA Binding | 23095 | O60333 |
KIF20B | kinesin family member 20B | Human | DNA Binding | 9585 | Q96Q89 |
KIF27 | kinesin family member 27 | Human | DNA Binding | NM_017576 | Q86VH2 |
KIF3C | kinesin family member 3C | Human | DNA Binding | 3797 | O14782 |
KIF9-AS1 | KIF9 antisense RNA 1 | Human | DNA Binding | 285352 | NA |
KIFC1 | kinesin family member C1 | Human | DNA Binding | 3833 | Q9BW19 |
KISS1R | KISS1 receptor | Human | DNA Binding | NM_032551 | Q969F8 |
KLC1 | kinesin light chain 1 | Human | DNA Binding | 3831 | Q07866 |
KLC2 | kinesin light chain 2 | Human | DNA Binding | 64837 | Q9H0B6 |
KLF12 | Kruppel-like factor 12 | Human | DNA Binding | 11278 | Q8WWI3 |
KLF7 | Krueppel-like factor 7 | Human | DNA Binding | 8609 | O75840 |
KLHDC2 | kelch domain containing 2 | Human | DNA Binding | 23588 | Q9Y2U9 |
KLHL18 | kelch-like family member 18 | Human | DNA Binding | 23276 | O94889 |
KLHL21 | kelch-like family member 21 | Human | DNA Binding | 9903 | Q9UJP4 |
KLHL24 | kelch-like family member 24 | Human | DNA Binding | 54800 | Q6TFL4 |
KLHL28 | kelch-like 28 (Drosophila) | Human | DNA Binding | 54813 | Q9NXS3 |
KLHL35 | Kelch-like protein 35 | Human | DNA Binding | 283212 | Q6PF15 |
KLHL42 | kelch-like family member 42 | Human | DNA Binding | 57542 | B2RNT7 |
KLHL8 | kelch-like family member 8 | Human | DNA Binding | 57563 | Q49A95 |
KLLN | Killin | Human | DNA Binding | 100144748 | B2CW77 |
KNTC1 | kinetochore associated 1 | Human | DNA Binding | 9735 | P50748 |
KPNA1 | karyopherin alpha 1 (importin alpha 5) | Human | DNA Binding | 3836 | P52294 |
KPNA4 | karyopherin alpha 4 (importin alpha 3) | Human | DNA Binding | 3840 | O00629 |
KPNA5 | karyopherin alpha 5 (importin alpha 6) | Human | DNA Binding | 3841 | O15131 |
KPNA6 | karyopherin alpha 6 (importin alpha 7) | Human | DNA Binding | 23633 | O60684 |
KPTN | kaptin (actin binding protein) | Human | DNA Binding | 11133 | Q9Y664 |
KRIT1 | KRIT1, ankyrin repeat containing | Human | DNA Binding | NM_004912 | O00522 |
KRR1 | KRR1, small subunit (SSU) processome component, homolog (yeast) | Human | DNA Binding | 11103 | Q13601 |
LACE1 | lactation elevated 1 | Human | DNA Binding | 246269 | Q8WV93 |
LANCL1 | LanC lantibiotic synthetase component C-like 1 (bacterial) | Human | DNA Binding | 10314 | O43813 |
LANCL2 | LanC lantibiotic synthetase component C-like 2 (bacterial) | Human | DNA Binding | 55915 | B3KTN5 |
LAPTM4B | lysosomal protein transmembrane 4 beta | Human | DNA Binding | 55353 | Q86VI4 |
LARP7 | La ribonucleoprotein domain family, member 7 | Human | DNA Binding | NM_015454 | Q4G0J3 |
LAS1L | LAS1-like (S. cerevisiae) | Human | DNA Binding | 81887 | Q9Y4W2 |
LASP1 | LIM and SH3 protein 1 | Human | DNA Binding | NM_006148 | B4DIC4 |
LASS5 | ceramide synthase 5 | Human | DNA Binding | NM_147190 | Q8N5B7 |
LBR | lamin B receptor | Human | DNA Binding | 3930 | Q14739 |
LCA5 | Leber congenital amaurosis 5 | Human | DNA Binding | 167691 | Q86VQ0 |
LCMT1 | leucine carboxyl methyltransferase 1 | Human | DNA Binding | NM_016309 | Q9UIC8 |
LCORL | Ligand-dependent nuclear receptor corepressor-like protein | Human | DNA Binding | 254251 | Q8N3X6 |
LDB1 | LIM domain binding 1 | Human | DNA Binding | 8861 | Q86U70 |
LDHA | lactate dehydrogenase A | Human | DNA Binding | 3939 | P00338 |
LDLRAD4 | Low-density lipoprotein receptor class A domain-containing protein 4 | Human | DNA Binding | 753 | O15165 |
LENG1 | leukocyte receptor cluster (LRC) member 1 | Human | DNA Binding | NM_024316 | Q96BZ8 |
LENG9 | leukocyte receptor cluster (LRC) member 9 | Human | DNA Binding | NM_198988 | Q96B70 |
LETM2 | leucine zipper-EF-hand containing transmembrane protein 2 | Human | DNA Binding | 137994 | Q2VYF4 |
LIAS | lipoic acid synthetase | Human | DNA Binding | NM_194451 | O43766 |
LIG3 | ligase III, DNA, ATP-dependent | Human | DNA Binding | 3980 | E5KLB6 |
LIG4 | ligase IV, DNA, ATP-dependent | Human | DNA Binding | 3981 | P49917 |
LIMD1-AS1 | LIMD1 antisense RNA 1 | Human | DNA Binding | 644714 | NA |
LIMD2 | LIM domain-containing protein 2 | Human | DNA Binding | 80774 | Q9BT23 |
LIMS1 | LIM and senescent cell antigen-like domains 1 | Human | DNA Binding | 3987 | P48059 |
LIN28B | lin-28 homolog B (C. elegans) | Human | DNA Binding | 389421 | Q6ZN17 |
LIN52 | lin-52 DREAM MuvB core complex component | Human | DNA Binding | NM_001024674 | B3KN83 |
LIN7B | lin-7 homolog B (C. elegans) | Human | DNA Binding | NM_022165 | Q9HAP6 |
LINC00167 | long intergenic non-protein coding RNA 167 | Human | DNA Binding | 440072 | Q96N53 |
LINC00461 | long intergenic non-protein coding RNA 461 | Human | DNA Binding | 645323 | NA |
LINS | lines homolog (Drosophila) | Human | DNA Binding | 55180 | Q8NG48 |
LIPT1 | lipoyltransferase 1 | Human | DNA Binding | NM_145198 | Q9Y234 |
LMAN2 | lectin, mannose-binding 2 | Human | DNA Binding | 10960 | Q12907 |
LMAN2L | lectin, mannose-binding 2-like | Human | DNA Binding | 81562 | Q9H0V9 |
LMBR1 | limb region 1 homolog (mouse) | Human | DNA Binding | 64327 | Q8WVP7 |
LMTK2 | lemur tyrosine kinase 2 | Human | DNA Binding | 22853 | Q8IWU2 |
LNPEP | leucyl/cystinyl aminopeptidase | Human | DNA Binding | 4012 | Q9UIQ6 |
LOC100009676 | ZBTB11 antisense RNA 1 | Human | DNA Binding | NR_024407 | |
LOC100128164 | Human | DNA Binding | 100128164 | NA | |
LOC100128191 | TMPO antisense RNA 1 | Human | DNA Binding | NR_027157 | |
LOC100128398 | cDNA FLJ37429 fis, clone BRAWH2001666 | Human | DNA Binding | 100128398 | Q8N9G5 |
LOC100128788 | SRRM2 antisense RNA 1 | Human | DNA Binding | NR_027275 | |
LOC100128822 | long intergenic non-protein coding RNA 1003 | Human | DNA Binding | 100128822 | NA |
LOC100129250 | TOPORS antisense RNA 1 | Human | DNA Binding | 100129250 | NA |
LOC100129361 | small integral membrane protein 10 like 1 | Human | DNA Binding | 100129361 | NA |
LOC100129387 | GABPB1 antisense RNA 1 | Human | DNA Binding | NR_024490 | |
LOC100129716 | ARRDC3 antisense RNA 1 | Human | DNA Binding | NR_027435 | |
LOC100129722 | C9orf173 antisense RNA 1 | Human | DNA Binding | 100129722 | NA |
LOC100129726 | long intergenic non-protein coding RNA 1126 | Human | DNA Binding | NR_027251 | |
LOC100129961 | CCNT2 antisense RNA 1 | Human | DNA Binding | 100129961 | NA |
LOC100130155 | MIR124-2 host gene | Human | DNA Binding | 100130155 | NA |
LOC100130522 | PARD6G antisense RNA 1 | Human | DNA Binding | NR_028339 | |
LOC100130581 | long intergenic non-protein coding RNA 910 | Human | DNA Binding | NR_027412 | |
LOC100131691 | MZF1 antisense RNA 1 | Human | DNA Binding | NR_027334 | |
LOC100133091 | Human | DNA Binding | NR_029411 | ||
LOC100133315 | Putative short transient receptor potential channel 2-like protein | Human | DNA Binding | NR_029192 | Q6ZNB5 |
LOC100133612 | long intergenic non-protein coding RNA 1134 | Human | DNA Binding | 100133612 | NA |
LOC100216545 | KMT2E antisense RNA 1 (head to head) | Human | DNA Binding | NR_024586 | |
LOC100272217 | Human | DNA Binding | 100272217 | NA | |
LOC100289230 | Human | DNA Binding | 100289230 | NA | |
LOC100289361 | Human | DNA Binding | 100289361 | NA | |
LOC100289509 | KCNIP2 antisense RNA 1 | Human | DNA Binding | 100289509 | NA |
LOC100289511 | Human | DNA Binding | NR_029378 | ||
LOC100302401 | RASAL2 antisense RNA 1 | Human | DNA Binding | NR_027982 | |
LOC100306951 | PITPNA antisense RNA 1 | Human | DNA Binding | NR_028514 | |
LOC100499489 | Human | DNA Binding | 100499489 | NA | |
LOC100506421 | long intergenic non-protein coding RNA 1158 | Human | DNA Binding | 100506421 | NA |
LOC100506714 | NUP50 antisense RNA 1 (head to head) | Human | DNA Binding | 100506714 | NA |
LOC100506834 | Human | DNA Binding | 100506834 | NA | |
LOC100507217 | long intergenic non-protein coding RNA 1578 | Human | DNA Binding | 100507217 | NA |
LOC100507266 | STX18 antisense RNA 1 (head to head) | Human | DNA Binding | 100507266 | NA |
LOC100507557 | Human | DNA Binding | 100507557 | NA | |
LOC100507634 | Human | DNA Binding | 100507634 | NA | |
LOC100630918 | Human | DNA Binding | 100630918 | NA | |
LOC145783 | Human | DNA Binding | 145783 | NA | |
LOC150381 | PRR34 antisense RNA 1 | Human | DNA Binding | NR_027034 | |
LOC153684 | Human | DNA Binding | NR_015447 | ||
LOC202781 | PAXIP1 antisense RNA 1 (head to head) | Human | DNA Binding | 202781 | NA |
LOC254100 | SSSCA1 antisense RNA 1 (head to head) | Human | DNA Binding | 254100 | NA |
LOC254128 | NIFK antisense RNA 1 | Human | DNA Binding | 254128 | NA |
LOC256880 | Human | DNA Binding | 256880 | NA | |
LOC282997 | PDCD4 antisense RNA 1 | Human | DNA Binding | 282997 | NA |
LOC285550 | family with sequence similarity 200, member B | Human | DNA Binding | NM_001145191 | P0CF97 |
LOC285696 | HCG1815023 | Human | DNA Binding | 285696 | Q8NB94 |
LOC286016 | triosephosphate isomerase 1 pseudogene 2 | Human | DNA Binding | NR_002187 | |
LOC286190 | LACTB2 antisense RNA 1 | Human | DNA Binding | 286190 | NA |
LOC338799 | long intergenic non-protein coding RNA 1089 | Human | DNA Binding | NR_002809 | |
LOC344967 | Putative cytosolic acyl coenzyme A thioester hydrolase-like | Human | DNA Binding | 344967 | Q6ZUV0 |
LOC388692 | Human | DNA Binding | NR_027002 | ||
LOC388789 | long intergenic non-protein coding RNA 493 | Human | DNA Binding | NR_015432 | |
LOC389791 | Putative uncharacterized protein FLJ37218 | Human | DNA Binding | 389791 | Q8N1Y9 |
LOC400027 | long intergenic non-protein coding RNA 938 | Human | DNA Binding | NR_028408 | |
LOC400657 | long intergenic non-protein coding RNA 909 | Human | DNA Binding | 400657 | NA |
LOC400684 | LOC400684 protein | Human | DNA Binding | 400684 | Q9BVU7 |
LOC400931 | MIRLET7B host gene (non-protein coding) | Human | DNA Binding | NR_027033 | |
LOC440926 | H3 histone, family 3A, pseudogene 4 | Human | DNA Binding | NR_002315 | |
LOC492303 | gem (nuclear organelle) associated protein 8 pseudogene 4 | Human | DNA Binding | NR_002830 | |
LOC550643 | long intergenic non-protein coding RNA 1420 | Human | DNA Binding | NR_015367 | |
LOC554203 | JPX transcript, XIST activator (non-protein coding) | Human | DNA Binding | NR_024582 | |
LOC642502 | Human | DNA Binding | NM_001089593 | ||
LOC642826 | BMS1 pseudogene 6 | Human | DNA Binding | NR_024495 | |
LOC644656 | LOC644656 protein | Human | DNA Binding | 644656 | Q9BT31 |
LOC644961 | actin gamma 1 pseudogene 20 | Human | DNA Binding | 644961 | NA |
LOC646719 | NIPBL antisense RNA 1 (head to head) | Human | DNA Binding | 646719 | NA |
LOC646903 | Human | DNA Binding | 646903 | NA | |
LOC729013 | ZBED5 antisense RNA 1 | Human | DNA Binding | 729013 | NA |
LOC729683 | Human | DNA Binding | 729683 | NA | |
LOC729970 | Human | DNA Binding | 729970 | NA | |
LOC730183 | Human | DNA Binding | 730183 | NA | |
LOC84989 | JMJD1C antisense RNA 1 | Human | DNA Binding | NR_027182 | |
LOC93622 | Human | DNA Binding | NR_015433 | ||
LOX | lysyl oxidase | Human | Direct Regulation | 4015 | B7ZAJ4 |
LPGAT1 | lysophosphatidylglycerol acyltransferase 1 | Human | DNA Binding | 9926 | Q53YL2 |
LPIN1 | lipin 1 | Human | DNA Binding | 23175 | B4DGS4 |
LPIN2 | lipin 2 | Human | DNA Binding | NM_014646 | Q92539 |
LPXN | leupaxin | Human | DNA Binding | 9404 | O60711 |
LRCH4 | Leucine-rich repeat and calponin homology domain-containing protein 4 | Human | DNA Binding | 4034 | O75427 |
LRFN1 | leucine rich repeat and fibronectin type III domain containing 1 | Human | DNA Binding | 57622 | Q9P244 |
LRFN3 | leucine rich repeat and fibronectin type III domain containing 3 | Human | DNA Binding | 79414 | Q9BTN0 |
LRFN4 | leucine rich repeat and fibronectin type III domain containing 4 | Human | DNA Binding | 78999 | Q6PJG9 |
LRP12 | low density lipoprotein receptor-related protein 12 | Human | DNA Binding | 29967 | Q59H02 |
LRP3 | Human | DNA Binding | |||
LRP4-AS1 | LRP4 antisense RNA 1 | Human | DNA Binding | 100507401 | NA |
LRP6 | low density lipoprotein receptor-related protein 6 | Human | DNA Binding | 4040 | O75581 |
LRP8 | low density lipoprotein receptor-related protein 8, apolipoprotein e receptor | Human | DNA Binding | 7804 | Q14114 |
LRRC14 | leucine rich repeat containing 14 | Human | DNA Binding | 9684 | Q15048 |
LRRC16A | leucine rich repeat containing 16A | Human | DNA Binding | 55604 | Q5VZK9 |
LRRC20 | leucine rich repeat containing 20 | Human | DNA Binding | 55222 | Q8TCA0 |
LRRC27 | leucine rich repeat containing 27 | Human | DNA Binding | 80313 | B3KUK5 |
LRRC37B2 | leucine rich repeat containing 37B pseudogene 1 | Human | DNA Binding | NR_015341 | |
LRRC41 | leucine rich repeat containing 41 | Human | DNA Binding | NM_006369 | Q15345 |
LRRC47 | leucine rich repeat containing 47 | Human | DNA Binding | 57470 | Q8N1G4 |
LRRC48 | leucine rich repeat containing 48 | Human | DNA Binding | NM_001130092 | B3KSC6 |
LRRC4B | Human | DNA Binding | |||
LRRC8C | leucine rich repeat containing 8 family, member C | Human | DNA Binding | 84230 | Q8TDW0 |
LRRFIP2 | leucine rich repeat (in FLII) interacting protein 2 | Human | DNA Binding | 9209 | Q9Y608 |
LSM1 | LSM1 homolog, U6 small nuclear RNA associated (S. cerevisiae) | Human | DNA Binding | 27257 | O15116 |
LSM14A | LSM14A, SCD6 homolog A (S. cerevisiae) | Human | DNA Binding | 26065 | Q8ND56 |
LSM14B | LSM14B, SCD6 homolog B (S. cerevisiae) | Human | DNA Binding | 149986 | Q9BX40 |
LSM2 | LSM2 homolog, U6 small nuclear RNA associated (S. cerevisiae) | Human | DNA Binding | 57819 | Q9Y333 |
LSM4 | LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae) | Human | DNA Binding | 25804 | Q9Y4Z0 |
LSM8 | LSM8 homolog, U6 small nuclear RNA associated (S. cerevisiae) | Human | DNA Binding | NM_016200 | A4D0W0 |
LSMD1 | LSM domain containing 1 | Human | DNA Binding | 84316 | Q9BRA0 |
LTA4H | leukotriene A4 hydrolase | Human | DNA Binding | 4048 | P09960 |
LTV1 | LTV1 homolog (S. cerevisiae) | Human | DNA Binding | 84946 | Q96GA3 |
LUC7L | LUC7-like (S. cerevisiae) | Human | DNA Binding | 55692 | Q9NQ29 |
LUC7L2 | LUC7-like 2 (S. cerevisiae) | Human | DNA Binding | 51631 | Q9Y383 |
LYPLA1 | lysophospholipase I | Human | DNA Binding | 10434 | O75608 |
LYRM2 | LYR motif containing 2 | Human | DNA Binding | 57226 | Q9NU23 |
LZIC | leucine zipper and CTNNBIP1 domain containing | Human | DNA Binding | 84328 | Q8WZA0 |
LZTFL1 | leucine zipper transcription factor-like 1 | Human | DNA Binding | NM_020347 | Q9NQ48 |
LZTR1 | leucine-zipper-like transcription regulator 1 | Human | DNA Binding | 8216 | Q8N653 |
MAD2L1BP | MAD2L1 binding protein | Human | DNA Binding | 9587 | E9PAT7 |
MAD2L2 | MAD2 mitotic arrest deficient-like 2 (yeast) | Human | DNA Binding | 10459 | Q9UI95 |
MAEA | macrophage erythroblast attacher | Human | DNA Binding | 10296 | Q7L5Y9 |
MAF1 | MAF1 homolog (S. cerevisiae) | Human | DNA Binding | 84232 | Q9H063 |
MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) | Human | Protein Binding | 4097 | O15525 |
MAGEF1 | melanoma antigen family F, 1 | Human | DNA Binding | 64110 | Q9HAY2 |
MAGI1 | membrane associated guanylate kinase, WW and PDZ domain containing 1 | Human | DNA Binding | 9223 | Q96QZ7 |
MALAT1 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | Human | DNA Binding | NR_002819 | |
MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | Human | DNA Binding | 10892 | Q9UDY8 |
MAML1 | mastermind-like 1 (Drosophila) | Human | DNA Binding | 9794 | Q92585 |
MAML3 | mastermind-like 3 (Drosophila) | Human | DNA Binding | 55534 | Q96JK9 |
MAN2C1 | Alpha-mannosidase 2C1 | Human | DNA Binding | 4123 | Q9NTJ4 |
MANBA | mannosidase, beta A, lysosomal | Human | DNA Binding | 4126 | O00462 |
MANEAL | mannosidase, endo-alpha-like | Human | DNA Binding | 149175 | Q5VSG8 |
MANF | mesencephalic astrocyte-derived neurotrophic factor | Human | DNA Binding | NM_006010 | A8K878 |
MAP2 | Microtubule-associated protein 2 | Human | DNA Binding | 4133 | P11137 |
MAP2K4 | mitogen-activated protein kinase kinase 4 | Human | DNA Binding | 6416 | P45985 |
MAP2K5 | mitogen-activated protein kinase kinase 5 | Human | DNA Binding | 5607 | Q13163 |
MAP3K1 | mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase | Human | DNA Binding | 4214 | Q13233 |
MAP3K12 | mitogen-activated protein kinase kinase kinase 12 | Human | DNA Binding | 7786 | Q12852 |
MAP3K4 | mitogen-activated protein kinase kinase kinase 4 | Human | DNA Binding | 4216 | Q9P1M2 |
MAP3K7 | mitogen-activated protein kinase kinase kinase 7 | Human | DNA Binding | 6885 | O43318 |
MAP3K7IP2 | TGF-beta activated kinase 1/MAP3K7 binding protein 2 | Human | DNA Binding | NM_015093 | Q9NYJ8 |
MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | Human | DNA Binding | NM_005204 | P41279 |
MAP4 | microtubule-associated protein 4 | Human | DNA Binding | 4134 | P27816 |
MAP4K4 | mitogen-activated protein kinase kinase kinase kinase 4 | Human | DNA Binding | 9448 | O95819 |
MAP4K5 | mitogen-activated protein kinase kinase kinase kinase 5 | Human | DNA Binding | 11183 | B3KWC4 |
MAP6D1 | MAP6 domain containing 1 | Human | DNA Binding | NM_024871 | Q9H9H5 |
MAPK1 | mitogen-activated protein kinase 1 | Human | DNA Binding | 5594 | P28482 |
MAPK11 | mitogen-activated protein kinase 11 | Human | DNA Binding | 5600 | Q15759 |
MAPK1IP1L | mitogen-activated protein kinase 1 interacting protein 1-like | Human | DNA Binding | 93487 | Q8NDC0 |
MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | Human | DNA Binding | 23542 | Q13387 |
MAPKAPK5 | mitogen-activated protein kinase-activated protein kinase 5 | Human | DNA Binding | 8550 | Q8IW41 |
MAPKAPK5-AS1 | MAPKAPK5 antisense RNA 1 | Human | DNA Binding | 51275 | Q8N8E1 |
MAPKBP1 | mitogen-activated protein kinase binding protein 1 | Human | DNA Binding | NM_001128608 | O60336 |
MARCH7 | E3 ubiquitin-protein ligase MARCH7 | Human | DNA Binding | 64844 | Q9H992 |
MARK2 | MAP/microtubule affinity-regulating kinase 2 | Human | DNA Binding | 2011 | Q7KZI7 |
MARS | methionyl-tRNA synthetase | Human | DNA Binding | 4141 | P56192 |
MARS2 | methionyl-tRNA synthetase 2, mitochondrial | Human | DNA Binding | 92935 | Q96GW9 |
MASTL | microtubule associated serine/threonine kinase-like | Human | DNA Binding | 84930 | Q96GX5 |
MAT2A | methionine adenosyltransferase II, alpha | Human | DNA Binding | 4144 | P31153 |
MAT2B | methionine adenosyltransferase II, beta | Human | DNA Binding | 27430 | Q9NZL9 |
MATR3 | matrin 3 | Human | DNA Binding | 9782 | P43243 |
MBL1P1 | mannose-binding lectin (protein A) 1, pseudogene | Human | DNA Binding | NR_002724 | |
MBLAC2 | Metallo-beta-lactamase domain-containing protein 2 | Human | DNA Binding | 153364 | Q68D91 |
MBNL1 | muscleblind-like splicing regulator 1 | Human | DNA Binding | 4154 | Q9NR56 |
MBOAT2 | membrane bound O-acyltransferase domain containing 2 | Human | DNA Binding | 129642 |